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Chapter 1
For several decades invasive coronary angiography (CA) has been the reference 
standard in the assessment of coronary artery disease (CAD) severity. Patients with 
high pre-test likelihood of CAD, receive a Class 1 indication for CA 1, 2. Several factors, 
however, motivate the need for a reliable non-invasive imaging modality, especially 
in patients with a high pre-test likelihood. Not only to rule out, but also to reliably 
diagnose coronary stenosis with functional consequences (significant CAD) and 
guide therapeutic decision making.
 Performance of CA in all patients with high pre-test likelihood of CAD has 
undeniable drawbacks. First of all, the prevalence of angiographically significant CAD 
in patients with high pre-test likelihood may be as low as 44-46% 3, 4. In real life, 
the prevalence of significant CAD in patients referred for CA is even lower at only 
36.7%, according to the national cardiovascular data registry of the United States 5. 
Secondly, angiographic severity of CAD does not reliably predict its main functional 
consequence: myocardial ischemia 6-8. Because evidence of myocardial ischemia is 
needed before deciding whether revascularization is necessary, additional (non-
) invasive tests are needed 2. Finally, CA comes with high costs as a result of the 
need for admission to a hospital or day-care facility and a low risk (0.1%) of serious 
adverse events 9. 
 With the advent of computed tomography coronary angiography (CCTA) and 
the known reliability of single photon emission computed tomography myocardial 
perfusion imaging (SPECT-MPI) a combination of non-invasive imaging modalities 
became available that potentially could reliably diagnose significant CAD. The high 
diagnostic accuracy of this combination has previously been shown in highly selected 
patient populations 10-14. Nevertheless, data demonstrating the applicability of hybrid 
SPECT and CCTA in diagnosing significant CAD in stable patients with an intermediate 
to high pre-test likelihood of CAD are still lacking. Furthermore, the contribution of 
these tests to therapeutic decision making in these patients is unknown. Providing 
evidence on both of these issues is the main objective of this thesis.
Non-invasive imaging in patients suspected of coronary artery disease
Diagnostic work-up of patients suspected of significant CAD begins with the 
assessment of pre-test likelihood according to risk scores (e.g. the Diamond and 
Forrester model or Duke Clinical Score) based on age, gender and angina typicality 
15, 16. After this, cardiologists choose from wide variety of (non-) invasive imaging 
procedures to diagnose the presence or absence of significant CAD. From the 
selection of non-invasive imaging procedures SPECT, CCTA and coronary calcium 
scoring (CCS) can be obtained from hybrid SPECT/CT imaging. 
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General introduction and outline of the thesis
Myocardial perfusion SPECT
Nuclear myocardial perfusion imaging (MPI) with single-photon emission computed 
tomography (SPECT) is known for its role in diagnosis, risk stratification and guidance 
of treatment decision making in patients with suspected significant CAD 17, 18. 
Patients with normal perfusion and function on ECG-gated SPECT have an excellent 
prognosis and are best served with primary prevention 19. Patients with a mild to 
moderate ischemic burden (<10% ischemic myocardium) benefit most from medical 
therapy whereas those with severe ischemia (>10% ischemic myocardium) benefit 
most from revascularization 20. These observations are reflected in current guidelines 
which recommend revascularization only in patients with (non-) invasive evidence of 
ischemia 2. 
 In patients with high pre-test likelihood of CAD, the diagnostic performance 
of SPECT is limited with estimates of sensitivity as low as 56% and specificity between 
39% and 62% 17, 21, 22. This limited accuracy is probably due to an  important fraction 
of non-conclusive results as a result of small perfusion defects (1-2 segments), 
inadequate heart rate response (e.g. failure to reach 85% of maximum predicted 
heart rate or 5 metabolic equivalents (MET) during exercise), and discrepant clinical 
data (e.g. typical angina per history or ≥2 mm ST-segment depression on ECG during 
exercise) 23. Additionally, in a substantial number of patients with high-risk CAD, the 
severity of ischemia could be underestimated or completely undetected due to 
balanced ischemia 24, 25.
Coronary calcium scoring
Coronary calcium scoring (CCS) is known for its role in risk prediction in asymptomatic 
patients. Asymptomatic patients with CCS <10 are at low risk for major adverse 
cardiovascular events during follow-up 26-29. As coronary calcium increases, so does 
the risk of cardiovascular events 26-29. In patients with an intermediate predicted risk, 
the amount of coronary calcium is helpful in reclassifying patients into low- or high 
risk groups 30. 
 The diagnostic value of CCS in patients with anginal complaints is disputed. 
The negative predictive value of a CCS of zero for the presence of significant CAD 
is reported to be almost 100% 31-33. However, the presence of a significant coronary 
stenosis as a result of non-calcified (soft) plaque is still possible in these patients. The 
prevalence of significant stenosis due to non-calcified plaque increases with the pre-
test likelihood of CAD to 12-65% 34, 35. In contrast, the presence of coronary calcium 
does not prove the presence of significant CAD 36. According to a pooled analysis, 
only approximately 35% of symptomatic patients with a CCS greater than 0 were 
found to suffer from CAD defined by a lumen reduction of greater than 50%37. 
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Chapter 1
Coronary computed tomography angiography
Three major trials established the role of CCTA in excluding significant CAD, reporting 
negative predictive values (NPV) ranging from 89%-99% 38-40. Due to a tendency to 
overestimate stenosis severity, positive predictive value (PPV) for significant CAD 
remains limited (48-83%), even with the newest generation of scanners 41. Patients 
with an intermediate- to high pre-test likelihood of CAD are specifically vulnerable 
to false positive or non-conclusive results due to coronary calcifications, evaluation 
of small vessels and artifacts caused by fast heart rates and prospective scanning 
modes 38-40, 42, 43.
 The exclusion of significant CAD by CCTA comes with an excellent prognosis 
in both patients with and without chest pain symptoms 44-47. An increasingly worse 
prognosis is described for patients without CAD, non-obstructive CAD, non-high 
risk obstructive CAD and high risk obstructive CAD respectively.  In these categories 
annual mortality rates were described of 0.65%, 1.14%, 1.41% and 2.63% respectively 
44, 45. High risk obstructive CAD was defined as 2 vessel disease (VD) including proximal 
left anterior descending (LAD), 3VD and left main stenosis.
 While it seems straightforward to initiate a primary or secondary preventive 
treatment regimen for patients without CAD or non-obstructive CAD on CCTA, 
respectively, treatment initiation (medical therapy or revascularization) based on 
CCTA findings alone have not been evaluated in a prospective study.  However, it 
was shown that the presence of high risk CAD on CCTA is associated with a benefit 
(lower all-cause mortality rate) from revascularization 47. In contrast, the presence 
of less severe forms of CAD was found to be associated with a benefit from optimal 
medical therapy in the same study 47. 
Hybrid myocardial perfusion SPECT and coronary CT angiography 
Current guidelines on hybrid SPECT/CCTA describe the main role of hybrid SPECT/
CCTA in patients with an intermediate to high risk of CAD and a non-conclusive 
result of either SPECT or CCTA as a standalone modality 48. 
 Thus far, five studies have described the diagnostic accuracy of hybrid SPECT/
CCTA for significant CAD versus CA as reference standard. Sensitivity and specificity 
values ranging from 89%-99% and 67-95% respectively, have been reported 10-14. 
However, the generalizeability of these studies is limited because hybrid imaging was 
studied as a standalone test in highly selected patient populations and an anatomical 
reference standard was used. Additionally, two studies used an obsolete imaging 
protocol 10-14. 
 Hybrid SPECT/CCTA findings can be categorized according to the concordance 
of a coronary stenosis on CCTA with a perfusion defect in the corresponding 
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General introduction and outline of the thesis
myocardial territory on SPECT, or vice versa. The prognostic usefulness of Hybrid 
SPEC/CCTA as well as it’s effect on choice of treatment strategy were studied in 
subgroups of patients with a matched stenosis and perfusion defect, an unmatched 
stenosis or perfusion defect and normal findings from both SPECT and CCTA 49, 50. A 
complete definition of matched, unmatched and normal hybrid SPECT/CCTA results 
is provided in chapter 7 of this thesis. An increased incidence of major adverse 
cardiac events has been found in patients with normal, unmatched and matched 
hybrid SPECT/CCTA findings during in a study with a median follow up of 2.8 years 49. 
However, whether the imaging result had any influence on the choice of treatment 
strategy remained unclear 50. 
Aims and outline of the thesis
This thesis aims to compare the diagnostic yield of hybrid SPECT/CCTA to the 
diagnostic yield of more established diagnostic procedures such as CCS and 
standalone SPECT or CCTA. Additionally, the effect of hybrid SPECT/CCTA on 
therapeutic decision making is studied.
The thesis is based on the patient population included in the High and intermediate 
Spect-Ct OPtimization study (HoRoSCOPe). The population for this study was 
prospectively acquired and the main inclusion criterion was an intermediate to high 
pre-test likelihood of CAD based on based on Diamond and Forrester criteria 15. The 
protocol for this study is described in detail in chapter 1.1.
 In chapter 2, a case report is presented that demonstrates the pitfalls of 
standalone anatomical imaging with CCTA and functional imaging with myocardial 
perfusion SPECT.
 Chapters 3 to 5 describe the single test accuracy of exercise stress 
electrocardiography (X-ECG), CCS, SPECT and CCTA and combinations thereof for the 
diagnosis of CAD in the HoRoSCOPe population. In chapter 3, we studied whether 
addition of X-ECG results is of value in the diagnostic work-up after the acquisition 
of CCS in these patients. As stand-alone procedures, X-ECG and CCS have limited 
diagnostic accuracy. We evaluated whether the combination of these tests leads to 
a more accurate exclusion of significant CAD. In chapter 4, we studied whether the 
combination of CCS and SPECT leads to a more accurate diagnosis of significant CAD. 
We specifically evaluated the incremental diagnostic accuracy of CCS in addition to 
SPECT. In chapter 5, we studied the diagnostic performance of hybrid SPECT/CCTA 
by comparing it to a reference standard of fractional flow reserve (FFR) measurements 
in a subgroup of patients from the HoRoSCOPe study with non-conclusive SPECT or 
CCTA results. We specifically evaluated the incremental diagnostic accuracy of the 
complementary nature of hybrid SPECT/CCTA imaging in these patients.  
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Chapter 1
 Hybrid imaging has an impressive diagnostic accuracy when evaluated as 
a single-test. In chapter 6, we studied whether hybrid SPECT/CCTA improves the 
diagnostic work-up beyond X-ECG, CCS and standalone SPECT or CCTA in the 
HoRoSCOPe population. 
 In chapter 7, we studied the applicability of hybrid SPECT/CCTA imaging in 
the process of clinical decision making. We evaluate whether hybrid SPECT/CCTA is 
able to accurately guide towards (a method of) revascularization in the presence of 
significant CAD or a medical treatment regimen if significant CAD is ruled out. 
 Chapters 8 and 9 are case reports. Chapter 8 describes hybrid SPECT/CCTA 
imaging in a patient with an unroofed coronary sinus without a persisting left superior 
vena cava. Chapter 9 describes CCTA imaging in a patient with a pseudoaneurysm of 
the aortic root. 
 In the general discussion, chapter 10, we discuss the challenges of hybrid 
image acquisition and reconstruction. Additionally, patient selection for hybrid 
imaging and the value of hybrid imaging in the process of therapeutic decision 
making is discussed. Finally, we present recommendations for further studies.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
15
1
2
3
4
5
6
7
8
9
10
11
General introduction and outline of the thesis
REfERENCE liST
(1)  Fox K, Garcia MA, Ardissino D et al. Guidelines on the management of stable angina pectoris: 
executive summary: The Task Force on the Management of Stable Angina Pectoris of the European 
Society of Cardiology. Eur Heart J 2006 June;27(11):1341-81.
(2)  Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization: The Task Force 
on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European 
Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010 October;31(20):2501-55.
(3)  Mollet NR, Cademartiri F, Van Mieghem C et al. Adjunctive value of CT coronary angiography in the 
diagnostic work-up of patients with typical angina pectoris. Eur Heart J 2007 August;28(15):1872-8.
(4)  Jensen JM, Ovrehus KA, Nielsen LH, Jensen JK, Larsen HM, Norgaard BL. Paradigm of pretest 
risk stratification before coronary computed tomography. J Cardiovasc Comput Tomogr 2009 
November;3(6):386-91.
(5)  Patel MR, Peterson ED, Dai D et al. Low diagnostic yield of elective coronary angiography. N Engl J 
Med 2010 March 11;362(10):886-95.
(6)  Brueren BR, ten Berg JM, Suttorp MJ et al. How good are experienced cardiologists at predicting 
the hemodynamic severity of coronary stenoses when taking fractional flow reserve as the gold 
standard. Int J Cardiovasc Imaging 2002 April;18(2):73-6.
(7)  White CW, Wright CB, Doty DB et al. Does visual interpretation of the coronary arteriogram predict 
the physiologic importance of a coronary stenosis? N Engl J Med 1984 March 29;310(13):819-24.
(8)  Tonino PA, Fearon WF, De BB et al. Angiographic versus functional severity of coronary artery 
stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J 
Am Coll Cardiol 2010 June 22;55(25):2816-21.
(9)  de BD. Complications of diagnostic cardiac catheterisation: results from 34,041 patients in 
the United Kingdom confidential enquiry into cardiac catheter complications. The Joint Audit 
Committee of the British Cardiac Society and Royal College of Physicians of London. Br Heart J 
1993 September;70(3):297-300.
(10)  Rispler S, Keidar Z, Ghersin E et al. Integrated single-photon emission computed tomography and 
computed tomography coronary angiography for the assessment of hemodynamically significant 
coronary artery lesions. J Am Coll Cardiol 2007 March 13;49(10):1059-67.
(11)  Santana CA, Garcia EV, Faber TL et al. Diagnostic performance of fusion of myocardial perfusion 
imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol 2009 
March;16(2):201-11.
(12)  Sato A, Nozato T, Hikita H et al. Incremental value of combining 64-slice computed tomography 
angiography with stress nuclear myocardial perfusion imaging to improve noninvasive detection of 
coronary artery disease. J Nucl Cardiol 2010 January;17(1):19-26.
(13)  Gaemperli O, Schepis T, Valenta I et al. Cardiac image fusion from stand-alone SPECT and CT: 
clinical experience. J Nucl Med 2007 May;48(5):696-703.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
16
Chapter 1
(14)  Slomka PJ, Cheng VY, Dey D et al. Quantitative analysis of myocardial perfusion SPECT anatomically 
guided by coregistered 64-slice coronary CT angiography. J Nucl Med 2009 October;50(10):1621-30.
(15)  Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-
artery disease. N Engl J Med 1979 June 14;300(24):1350-8.
(16)  Pryor DB, Shaw L, McCants CB et al. Value of the history and physical in identifying patients at 
increased risk for coronary artery disease. Ann Intern Med 1993 January 15;118(2):81-90.
(17)  Underwood SR, Anagnostopoulos C, Cerqueira M et al. Myocardial perfusion scintigraphy: the 
evidence. Eur J Nucl Med Mol Imaging 2004 February;31(2):261-91.
(18)  Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion 
single photon emission computed tomography for the prediction of cardiac death: differential 
stratification for risk of cardiac death and myocardial infarction. Circulation 1998 February 
17;97(6):535-43.
(19)  Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term 
survival benefit associated with revascularization compared with medical therapy in patients with 
no prior coronary artery disease undergoing stress myocardial perfusion single photon emission 
computed tomography. Circulation 2003 June 17;107(23):2900-7.
(20)  Shaw LJ, Berman DS, Maron DJ et al. Optimal medical therapy with or without percutaneous 
coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing 
Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 
2008 March 11;117(10):1283-91.
(21)  Groutars RG, Verzijlbergen JF, Tiel-van Buul MM et al. The accuracy of 1-day dual-isotope myocardial 
SPECT in a population with high prevalence of coronary artery disease. Int J Cardiovasc Imaging 
2003 June;19(3):229-38.
(22)  Hamirani YS, Isma’eel H, Larijani V et al. The diagnostic accuracy of 64-detector cardiac computed 
tomography compared with stress nuclear imaging in patients undergoing invasive cardiac 
catheterization. J Comput Assist Tomogr 2010 September;34(5):645-51.
(23)  Abidov A, Raff GL. Value of coronary CTA in patients with known or suspected CAD and non-
diagnostic initial myocardial perfusion testing: current evidence and clinical considerations. J Nucl 
Cardiol 2010 December;17(6):1101-6.
(24)  Lima RS, Watson DD, Goode AR et al. Incremental value of combined perfusion and function over 
perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel 
coronary artery disease. J Am Coll Cardiol 2003 July 2;42(1):64-70.
(25)  Berman DS, Kang X, Slomka PJ et al. Underestimation of extent of ischemia by gated SPECT 
myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007 
July;14(4):521-8.
(26)  O’Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC. Prognostic value of coronary electron-
beam computed tomography for coronary heart disease events in asymptomatic populations. Am 
J Cardiol 2000 April 15;85(8):945-8.
(27)  Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined 
with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004 January 
14;291(2):210-5.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
17
1
2
3
4
5
6
7
8
9
10
11
General introduction and outline of the thesis
(28)  Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk 
factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart 
Study. J Am Coll Cardiol 2005 July 5;46(1):158-65.
(29)  Detrano R, Guerci AD, Carr JJ et al. Coronary calcium as a predictor of coronary events in four racial 
or ethnic groups. N Engl J Med 2008 March 27;358(13):1336-45.
(30)  Erbel R, Mohlenkamp S, Moebus S et al. Coronary risk stratification, discrimination, and 
reclassification improvement based on quantification of subclinical coronary atherosclerosis: the 
Heinz Nixdorf Recall study. J Am Coll Cardiol 2010 October 19;56(17):1397-406.
(31)  Perk J, De BG, Gohlke H et al. European Guidelines on cardiovascular disease prevention in 
clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology 
and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by 
representatives of nine societies and by invited experts). Developed with the special contribution of 
the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012 
July;33(13):1635-701.
(32)  Sarwar A, Shaw LJ, Shapiro MD et al. Diagnostic and prognostic value of absence of coronary artery 
calcification. JACC Cardiovasc Imaging 2009 June;2(6):675-88.
(33)  Nieman K, Galema TW, Neefjes LA et al. Comparison of the value of coronary calcium detection to 
computed tomographic angiography and exercise testing in patients with chest pain. Am J Cardiol 
2009 December 1;104(11):1499-504.
(34)  Hausleiter J, Meyer T, Hadamitzky M, Kastrati A, Martinoff S, Schomig A. Prevalence of noncalcified 
coronary plaques by 64-slice computed tomography in patients with an intermediate risk for 
significant coronary artery disease. J Am Coll Cardiol 2006 July 18;48(2):312-8.
(35)  Gottlieb I, Miller JM, Arbab-Zadeh A et al. The absence of coronary calcification does not exclude 
obstructive coronary artery disease or the need for revascularization in patients referred for 
conventional coronary angiography. J Am Coll Cardiol 2010 February 16;55(7):627-34.
(36)  Oudkerk M, Stillman AE, Halliburton SS et al. Coronary artery calcium screening: current status and 
recommendations from the European Society of Cardiac Radiology and North American Society for 
Cardiovascular Imaging. Int J Cardiovasc Imaging 2008 August;24(6):645-71.
(37)  O’Rourke RA, Brundage BH, Froelicher VF et al. American College of Cardiology/American Heart 
Association Expert Consensus document on electron-beam computed tomography for the 
diagnosis and prognosis of coronary artery disease. Circulation 2000 July 4;102(1):126-40.
(38)  Budoff MJ, Dowe D, Jollis JG et al. Diagnostic performance of 64-multidetector row coronary 
computed tomographic angiography for evaluation of coronary artery stenosis in individuals 
without known coronary artery disease: results from the prospective multicenter ACCURACY 
(Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive 
Coronary Angiography) trial. J Am Coll Cardiol 2008 November 18;52(21):1724-32.
(39)  Meijboom WB, Meijs MF, Schuijf JD et al. Diagnostic accuracy of 64-slice computed tomography 
coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol 2008 
December 16;52(25):2135-44.
(40)  Miller JM, Rochitte CE, Dewey M et al. Diagnostic performance of coronary angiography by 64-row 
CT. N Engl J Med 2008 November 27;359(22):2324-36.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
18
Chapter 1
(41)  van Velzen JE, Schuijf JD, de Graaf FR et al. Diagnostic performance of non-invasive multidetector 
computed tomography coronary angiography to detect coronary artery disease using different 
endpoints: detection of significant stenosis vs. detection of atherosclerosis. Eur Heart J 2011 
March;32(5):637-45.
(42)  Cademartiri F, Maffei E, Notarangelo F et al. 64-slice computed tomography coronary angiography: 
diagnostic accuracy in the real world. Radiol Med 2008 March;113(2):163-80.
(43)  Husmann L, Herzog BA, Gaemperli O et al. Diagnostic accuracy of computed tomography coronary 
angiography and evaluation of stress-only single-photon emission computed tomography/
computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering 
vs. retrospective gating. Eur Heart J 2009 March;30(5):600-7.
(44)  Chow BJ, Small G, Yam Y et al. Incremental prognostic value of cardiac computed tomography 
in coronary artery disease using CONFIRM: COroNary computed tomography angiography 
evaluation for clinical outcomes: an InteRnational Multicenter registry. Circ Cardiovasc Imaging 
2011 September;4(5):463-72.
(45)  Cho I, Chang HJ, Sung JM et al. Coronary computed tomographic angiography and risk of all-
cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from 
the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international 
multicenter registry). Circulation 2012 July 17;126(3):304-13.
(46)  Min JK, Shaw LJ, Devereux RB et al. Prognostic value of multidetector coronary computed 
tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 2007 September 
18;50(12):1161-70.
(47)  Min JK, Berman DS, Dunning A et al. All-cause mortality benefit of coronary revascularization vs. 
medical therapy in patients without known coronary artery disease undergoing coronary computed 
tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinical 
Outcomes: An InteRnational Multicenter Registry). Eur Heart J 2012 December;33(24):3088-97.
(48)  Flotats A, Knuuti J, Gutberlet M et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position 
statement by the European Association of Nuclear Medicine (EANM), the European Society of 
Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med 
Mol Imaging 2011 January;38(1):201-12.
(49)  Pazhenkottil AP, Nkoulou RN, Ghadri JR et al. Prognostic value of cardiac hybrid imaging integrating 
single-photon emission computed tomography with coronary computed tomography angiography. 
Eur Heart J 2011 June;32(12):1465-71.
(50)  Pazhenkottil AP, Nkoulou RN, Ghadri JR et al. Impact of cardiac hybrid single-photon emission 
computed tomography/computed tomography imaging on choice of treatment strategy in 
coronary artery disease. Eur Heart J 2011 November;32(22):2824-9.
Chapter 1.1
The High and intermediate Risk Spect-Ct oPtimization 
(HoRoSCoPe) study 
Chapter 1.1
The High and intermediate Risk Spect-Ct oPtimization 
(HoRoSCoPe) study 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
20
Chapter 1.1
The current thesis is based on the High and intermediate Risk Spect-Ct OPtimization 
study (HoRoSCOPe). This study was conducted in the St. Antonius Hospital, 
Nieuwegein, The Netherlands, between September 2009 and March 2012. The 
main objective of the study was to evaluate the clinical value of hybrid myocardial 
perfusion SPECT (SPECT) and coronary computed tomography angiography (CCTA) 
in an unselected, prospectively acquired population. Patients with stable chest pain 
symptoms referred for SPECT and an intermediate to high pre-test likelihood of CAD 
based on Diamond and Forrester criteria were included 1. Patients with a history 
of surgical revascularization, stent implantation, an unstable cardiac condition or a 
cardiac rhythm other than sinus rhythm were excluded. 
figure 1  Sequence of diagnostic work-up. Prior to the first imaging day all patients 
stopped rate limiting medication. At the start of stress testing all patients received 
oral metoprolol tartrate. Either exercise stress electrocardiography (X-ECG) or 
pharmacological stress was performed prior to myocardial perfusion SPECT (SPECT) 
acquisition. This was directly followed by a non-enhanced CT scan to calculate 
coronary calcium score (CCS) and coronary CT angiography (CCTA) acquisition. 
On the second imaging day optional rest SPECT imaging and invasive coronary 
angiography (CA) including fractional flow measurements (FFR) was performed. In 
the presence of a normal stress SPECT (normal perfusion and gated data) the rest 
SPECT was omitted. 
As described in Figure 1 all patients were scheduled for hybrid SPECT/CCTA 
imaging and invasive coronary angiography (CA) with fractional flow reserve (FFR) 
measurements. Non-invasive imaging acquisition was performed on a hybrid SPECT-
CT system, CardioMD gamma camera and Brilliance 64-slice CT scanner (Philips 
Medical Systems, Best, The Netherlands) (Figure 2). The components share a common 
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The High and intermediate Risk Spect-Ct OPtimization (HoRoSCOPe) study 
table that is aligned to allow sequential image acquisition, without the need for the 
patient to physically move from one scanner to another. On day one the hybrid SPECT/
CCTA imaging protocol consisted of exercise stress electrocardiography (X-ECG) or 
pharmacological stress preceding stress SPECT acquisition. Directly following stress 
SPECT, coronary calcium score (CCS) and CCTA imaging was performed. Within 14 
days, on the second day of the protocol, rest SPECT acquisition and invasive CA with 
FFR-measurements were scheduled. In patients with a normal stress SPECT (normal 
perfusion and gated data) no rest SPECT was acquired. Directly following the second 
day, all data were available for the routine clinical heart-team meeting that would 
formulate a treatment advice which was actually carried out in the outpatient clinic. 
Subsequently, blinded imaging analysis according to the pre-defined study protocol 
was conducted. Also, panel sessions were held to evaluate the level of agreement 
of treatment decisions based on the diagnostic work-up using hybrid SPECT/CCTA 
imaging and the traditional diagnostic work-up using SPECT and CA.
figure 2 Hybrid SPECT-CT system, CardioMD gamma camera in the front and Brilliance 
64-slice CT scanner in the back (Philips Medical Systems, Best, The Netherlands). 
The components share a common table (not in the picture) that is aligned to allow 
sequential image acquisition.
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iNTRoduCTioN
With the advent of integrated single-photon emission computed tomography 
(SPECT) and Computed Tomography (CT) systems and the use of low dose coronary 
calcium scoring (CCS) scans for attenuation correction purposes, high quality 
anatomical and functional data become readily available for patients with suspected 
coronary artery disease (CAD) 1, 2. Myocardial ischemia detected by nuclear perfusion 
imaging is associated with high CCS. Vice versa it has been suggested that a low CCS 
in these patients could obviate the need for further invasive testing 3, 4. However, in 
patients with a normal myocardial perfusion SPECT, a high CCS could be suggestive 
of significant coronary artery disease 5-7. In the current case, we present a patient 
with intermediate pre-test likelihood of CAD who was referred for SPECT scanning. 
She was enrolled in a prospective study to evaluate the additive value of CT coronary 
angiography (CT-A) to SPECT in the diagnosis of significant CAD. In this case no 
coronary calcium was present and the result of the SPECT study was equivocal. 
CT-A showed a severe left main stenosis, which was confirmed by invasive coronary 
angiography (CA).
Case Report
A 58 year-old female patient with no previous history of cardiac disease was 
referred for non-invasive imaging by myocardial perfusion SPECT. Several months 
before presentation she had developed typical anginal complaints on moderate 
physical exertion. Her risk profile constituted of a history of smoking, documented 
dyslipidaemia treated with statin therapy, diabetes mellitus and a family history of 
premature CAD. Physical examination revealed no relevant abnormalities. The pre-
test likelihood for presence of CAD was 73% according to Diamond and Forrester 
criteria 8. She underwent non-invasive imaging. Gated stress and rest SPECT and 
CT-A including CCS were acquired on a Hybrid SPECT-CT system, CardioMD 
gamma camera and Brilliance 64-slice CT scanner (Philips Medical Systems, Best, 
The Netherlands). Attenuation correction was performed for all images using the CT 
non-enhanced calcium scan. A weight-adjusted dose of 413MBq 99mTc-sestamibi was 
administered during maximal bicycle exercise according to a stepwise protocol. At 
maximum stress of 96 Watts, 92% of the predicted capacity, she had a heart rate of 
146 bpm (90% of the predicted heart rate), and a blood pressure of 154/83 mmHg. 
Atropine infusion was necessary to reach the target heart rate and she complained 
of angina pectoris during recovery from stress.
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 The result of exercise electrocardiography (ECG) should be considered non 
diagnostic. It did reveal ST segment depression at maximal exertion, although in 
the absence of a stable baseline. (Figure 1) After attenuation correction, SPECT 
showed a partially reversible mild perfusion defect in the distal anterior segment 
and apex, summed stress score (SSS) of 2. (Figure 2) No transient ischemic dilatation 
was observed. End-diastolic volumes post stress and at rest were 56 ml and 49 ml, 
respectively. Left ventricle ejection fraction (LVEF) post stress and at rest were similar, 
68% and 71% respectively. No wall motion abnormalities were present. CT-A was 
performed which revealed no coronary calcifications. However, a severe left main 
stenosis was observed. (Figure 3) On the second day of imaging, rest SPECT images 
and CA were acquired. The latter confirmed the severe left main stenosis. (Figure 
4) Neither CA nor CT-A revealed signs of atheroscleroses in the remainder of the 
coronary artery tree. The patient was scheduled for coronary bypass surgery, which 
was performed uneventfully. One year after the procedure she continues to do well 
with no relapse of anginal complaints.
figure 1.  ECG obtained during maximum bicycle stress exercise. No anginal complaints 
during this stage. ECG should be considered non-diagnostic, it does reveal ST 
segment depression in leads V4-V6, although in the absence of a stable baseline.
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figure 2.  Attenuation corrected myocardial perfusion SPECT. After stress a mild perfusion 
defect is present in the distal anterior and apical region. This partially persists during 
rest imaging. This is suggestive of mild ischemia with an SSS of 2. Although it could 
be interpreted as an attenuation artefact due to breast tissue in the presence of 
normal wall motion and normal LVEF.
figure 3.  Axial image of CT coronary angiogram showing a severe left main coronary artery 
stenosis. No calcifications were present in the entire coronary artery tree.
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figure 4.  Left caudal view of invasive coronary angiogram confirms the presence of a severe 
left main coronary artery stenosis.
diSCuSSioN
The current case describes the unusual case of a female patient with a CCS of zero in 
the presence of a severe left main stenosis, and an equivocal stress ECG and SPECT 
result.
 Exercise ECG is known to have limited value in the work-up of women 
with anginal complaints, with sensitivity and specificity values of 46-79% and 48-
86% respectively 9. Therefore non-invasive imaging frequently is the first step in 
the diagnostic workup of women. In the overall patient population with anginal 
complaints, SPECT has a good diagnostic performance. Well-designed studies 
showed sensitivities ranging from 85-90%. If ECG gated information and attenuation 
correction algorithms are used, specificity values range between 80 and 90% 10, 11. 
However, an important limitation is the rate of false-negative SPECT in patients with 
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three-vessel disease or left main stenosis. Balanced ischemia has been proposed as 
the mechanism for the lack of perfusion defects in these patients. Due to the principle 
of interregional flow comparison in SPECT, patients with perfusion abnormalities in 
all coronary artery territories could have a false negative result. Sensitivity values of 
80% to 95% have been reported for the detection of three-vessel disease by SPECT 12, 
13. Symptomatic patients with a normal exercise SPECT study have an annual cardiac 
death or myocardial infarction rate comparable to the asymptomatic population; 
0.7% 10, 11.  The question whether our patient would have had this excellent prognosis 
remains unanswered. Patients with significant left main stenosis are known to have 
the worst prognosis of any form of CAD 14.
 Our patient, however, had equivocal stress ECG and SPECT results. She had 
a borderline normal stress ECG and developed anginal complaints during recovery 
from stress. SPECT imaging was not completely normal; it was suggestive of mild 
ischemia with an SSS of 2. However, the perfusion defect partially persists during rest 
and could be interpreted as an attenuation artifact in the presence of normal wall 
motion and a more severe perfusion defect in the non attenuation corrected images 
after stress and rest. As such, the combined stress ECG and SPECT result should be 
regarded inconclusive. These inconclusive SPECT results have a heterogeneous set 
of causes. Equivocal tests due to artifacts as a result of attenuation or conduction 
disturbances are from a different order than discrepant tests due to abnormal clinical 
(typical angina during stress or significant ECG changes) or gated perfusion data 
(transient ischemic dilatation or loss of LVEF) 15.
 With both imaging data sets available, it was postulated that in the presence 
of normal SPECT scans, high CCS is predictive of significant CAD. A low CCS in these 
patients is regarded as predictive of the absence of significant CAD 3-7. CCS per se is 
known for its role in risk prediction in asymptomatic patients as well as symptomatic 
patients. Patients with a low to intermediate pre-test likelihood of CAD and no 
evidence of coronary calcifications have a very low likelihood of CAD and a low 
risk of adverse cardiac events 16, 17. On the other hand, in a population of patients 
referred for CA, the incidence of significant CAD and a CCS of zero is 15-19% 18. It is 
questionable whether the crude depiction of coronary anatomy by CCS could solve 
all diagnostic inaccuracy; in our patient the combined results of stress ECG, SPECT 
and CCS still would have resulted in a false negative test. Therefore we postulate 
that CCS cannot be considered definite for excluding obstructive CAD in this setting. 
The case demonstrates the superiority of CT-A compared to CCS, for confirmatory 
testing in patients with typical symptoms for CAD and equivocal results on stress 
ECG and SPECT MPI.
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AbSTRACT
objectives
Coronary calcium scoring (CCS) has emerged as non-invasive imaging tool to rule 
out coronary artery disease (CAD) in symptomatic patients. Absence of coronary 
calcium is associated with a very low prevalence of significant disease and 
favourable clinical outcome in this population. However, in symptomatic patients 
with an intermediate pre-test likelihood of CAD and a CCS of zero, the prevalence 
of significant CAD still could be 12-65%. Also, a large percentage of patients with 
coronary calcifications have no significant CAD. We evaluate the performance of 
exercise stress electrocardiography (X-ECG) in addition to CCS in predicting the 
presence of significant CAD.
Methods
In total, 136 patients (age 63.5±10.2 years, 62.5% male) with an intermediate to high 
pre-test likelihood of CAD (median 87%, range 22-95) were prospectively included 
in this study. Of these patients X-ECG, CCS and invasive coronary angiography (CA) 
were available. Patients were categorized according to three groups of CCS; >400, 0.1 
– 400 and CCS 0. X-ECG was defined abnormal in the presence of positive (≥0.1mV 
ST-segment depression 80ms after the J-point) or non-conclusive results. A luminal 
loss >50% on CA served as reference standard for significant CAD.
Results
 A CCS>400 (P = 0.034) and a positive X-ECG (P< 0.005) were independently predictive 
for the presence of significant CAD by multivariate analysis. ROC curve analysis 
revealed an increased diagnostic yield for significant CAD for the combination 
of CCS and X-ECG (AUC 0.84) versus standalone CCS (AUC 0.69) or X-ECG (AUC 
0.65). However, 6 (9%) patients with CCS 0 – 400 and negative X-ECG suffered form 
significant CAD and 37 (54%) patients with either CCS >400 or abnormal X-ECG were 
free from significant CAD.
Conclusions
Despite increased diagnostic yield for the combination of CCS and X-ECG, in clinical 
practice a substantial number of patients without significant CAD would be unduly 
sent for invasive coronary angiography. Also, 9% of patients with significant CAD 
would remain undetected.
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Is exercise stress electrocardiography in addition to coronary calcium scoring able to diagnose 
significant coronary artery disease in patients with an intermediate or high pre-test likelihood?
iNTRoduCTioN
Coronary calcium scoring (CCS) has emerged as non invasive tool to rule out coronary 
artery disease (CAD) in patients with symptoms of chest discomfort. Absence of 
coronary calcium in this heterogeneous population is associated with very low 
prevalence of significant disease and favourable clinical outcome (1, 2). Whereas 
increasing coronary calcium scores in these patients is associated with increased 
prevalence of significant CAD (3). However, in the group of symptomatic patients 
with (a-) typical anginal complaints and a CCS of zero, the prevalence of significant 
CAD might still be 12-65% (4-6). Also, in patients with an intermediate or even high 
pre-test likelihood of CAD, the mere presence or absence of coronary calcium is 
not diagnostic for significant CAD (7, 8). As such, in these patients additional (non-)
invasive tests are needed. 
 Exercise stress ECG (X-ECG) has been in use as first line test in the evaluation 
of patients with symptoms of chest discomfort for decades. Guidelines still advocate 
its role in the majority of patients with stable symptoms since it is widely available, 
well established and is of low cost. On the other hand X-ECG has limited diagnostic 
performance and a considerable number of inconclusive results (9, 10). Comparable 
to the situation with CCS, an additional test is needed in many patients to reliably 
diagnose significant CAD.
 We seek to evaluate whether the combination of these tests could serve 
as a non-invasive modality to rule out CAD in a population of patients with an 
intermediate to high pre-test likelihood of CAD. 
METHodS
Patient population
For the current analysis we used a patient population enrolled in a study to evaluate 
hybrid myocardial perfusion single photon emission computed tomography and 
coronary computed tomography angiography (hybrid SPECT-CCTA) in the diagnosis 
of significant CAD. Of 204 patients scheduled for hybrid SPECT-CCTA, 136 (67%) 
had both X-ECG and CCS available and were included in this analysis (Figure 1). 
Pre-test likelihood was calculated according to Diamond and Forrester criteria (11). 
Exclusion criteria were a history of coronary artery disease, an unstable cardiac 
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condition or a cardiac rhythm other than sinus rhythm. The study conformed to the 
principles outlined in the declaration of Helsinki and was approved by the local ethics 
committee. Written informed consent was obtained from all patients.
figure 1. Flowchart for patients included in this analysis
Hybrid SPECT-CCTA=Hybrid myocardial perfusion single photon emission computed 
tomography and CT coronary angiography; CA = invasive coronary angiography; CAD = 
coronary artery disease.
Coronary calcium scoring
Imaging data were acquired on a hybrid SPECT-CT system, CardioMD gamma camera 
and Brilliance 64-slice CT scanner (Philips Medical Systems, Best, The Netherlands). 
All patients scheduled for prospectively ECG-triggered axial CCTA received oral 
metoprolol tartrate at the start of the stress test preceding SPECT imaging. Patients 
with an initial heart rate below 60 bpm received 50mg and patients with an initial 
heart rate over 60 bpm received 100mg metoprolol tartrate. Preceding CT scanning 
additional intravenous metoprolol was administered in 79 patients (mean dose of 
13.7±6.0 mg) to achieve a heart rate below 62 bpm. Prior to CCTA, a non-enhanced 
scan to calculate the CCS was performed with the following scanning parameters: 
prospective ECG triggered axial scan mode, at inspiration, 2.5mm slice thickness, 
120kV tube voltage, 55mAs tube current. The CCS was obtained by multiplying each 
area of interest with a factor indicating peak density within the individual area, as was 
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proposed by Agatston et al. (12). Patients were then categorized according to three 
groups of CCS; >400, 0.1 – 400 and CCS 0.
Exercise stress electrocardiography
Bicycle stress electrocardiography was performed according to a previously described 
stepwise protocol (13). Prior to stress testing all patients stopped rate limiting anti 
anginal medications. In 45 (33%) patients atropine was required to reach adequate 
heart rate response. All X-ECG results were reviewed in consensus by two physicians 
(JS and RMK). Positive X-ECG was defined as ≥0.1mV horizontal shift of the ST 
segment at 80ms after the J-point in chest leads #5 and #6. Non-conclusive X-ECG 
was defined as typical angina or >30mmHg decrease in systolic blood pressure 
during stress without electrocardiographic evidence of ischemia or uninterpretable 
ECG as a result of an unstable baseline or inability to reach at least 85% of the 
predicted heart rate (according to gender and age of the subject) without ≥0.1mV 
horizontal shift of the ST segment at 80ms after the J point. The predicted heart rate 
was corrected for length, age and sex, using a standardized table (13). Normal X-ECG 
was defined as the absence of any of the aforementioned criteria. Abnormal X-ECG 
was defined as a non-conclusive or positive X-ECG result.
invasive coronary angiography
As part of the prospective study, CA was performed in all patients, including those 
with normal non-invasive test results. CA was acquired on Allura (Philips Medical 
Systems, Best, The Netherlands) catheterization equipment via femoral or radial 
artery access. In all patients biplane views were acquired from all major coronary 
arteries. Additional views were obtained at the discretion of the performing operator. 
The angiograms were visually evaluated for lesion severity according to 5 categories 
of diameter loss; no CAD (0% diameter loss), mild lesion severity (diameter loss 0 – 
50%), intermediate lesion severity (diameter loss 50 – 70%), severe lesions (diameter 
loss 70 – 99%) and total occlusion. Interpretation was performed on a consensus 
basis by two experienced cardiologists blinded for clinical and other imaging data. 
Significant disease was defined as >50% luminal loss on CA.
Statistical analysis
Statistical analyses were performed with SPSS software (V. 18.0, IBM Corporation, 
Somers, New York, USA). Variables were expressed as mean±standard deviation 
(SD) or median and range, and categorical variables as frequencies and percentages. 
Continuous variables where compared by means of Students T test or Mann-Whitney 
U test where appropriate. Categorical variables were compared by means of the Chi-
square test. Odds ratios for significant CAD were calculated by means of univariate 
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and multivariate binary logistic regression analysis. As a measure of discrimination 
we calculated the area under the ROC curve (AUC) with 95% confidence intervals for 
X-ECG, CCS and the multivariate model of gender, age, pre-test likelihood according 
to Diamond and Forrester criteria, X-ECG and CCS.  We calculated the number of 
patients that would have been classified as with or without significant CAD according 
to standalone and combined CCS and X-ECG results. For this analysis we defined the 
cut-off value for CCS that was found independently predictive of significant CAD 
abnormal. Also, we defined a positive or non-conclusive X-ECG result abnormal to 
resemble clinical practice.  A p-value of <0.05 was considered statistically significant.
RESulTS
Study population
In total, 136 patients (mean age 63.5±10.2 years, 62.5% male) with stable angina 
pectoris were included in this study. Median pre-test likelihood of CAD was 87% 
(range 22-95). Of 204 patients scheduled for hybrid SPECT-CCTA 68 patients (33%) 
were excluded from the current analysis. Of these, 37 patients (18%) had no X-ECG 
available as a result of adenosine stress prior to hybrid SPECT-CCTA acquisition. 
Thirty-one patients (15%) were excluded due to the unavailability of the reference 
standard; in case of an unsuccessful CCTA the study protocol did not allow for further 
invasive imaging to limit radiation exposure and adverse events as a result of CA 
(Figure 1). Characteristics of the study population are presented in Table 1.
Exercise stress ECG
112 patients (82%) had a diagnostic X-ECG test. 24 patients (18%) had non-
conclusive X-ECG results; one patient (1%) was unable to reach at least 85% of 
predicted maximum heart rate, 5 patients (4%) had an uninterpretable X-ECG as a 
result of an unstable baseline. Furthermore, 18 patients (13%) experienced typical 
anginal complaints without evidence of ischemia on stress ECG (Table 1). Of the 
patients with normal and positive X-ECG, 12 (18%) and 46 (68%) had significant CAD 
on CA respectively (Table 1). Of 24 patients with non-conclusive X-ECG 10 (42%) 
had significant CAD. Multivariate analysis revealed that positive X-ECG result was 
independently predictive of significant CAD (P <0.005) (Table 1). ROC curve analysis 
resulted in an AUC of 0.65 (95% CI 0.55 – 0.74) for the diagnosis of significant CAD. 
The ROC curve crosses the reference line, resembling the fact that the presence of an 
uninterpretable X-ECG is suggestive of absence of significant CAD (Figure 2). 
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Coronary calcium scoring
A CCS of 0 was observed in 32 patients (23.5%), of these patients 6 (19%) had 
significant CAD on CA. Fifty four patients had a CCS of 0.1 – 400, of which 28 
(52%) had significant CAD on CA. Of the patients with a CCS >400 (N = 50), 34 
(68%) had significant CAD on CA. Multivariate analysis revealed that CCS >400 was 
independently predictive of significant CAD (P= 0.034) (Table 1). ROC curve analysis 
resulted in an AUC of 0.69 (95% CI 0.61 – 0.83) for the diagnosis of significant CAD 
(Figure 2).
Exercise stress electrocardiography in addition to coronary calcium scoring
The multivariate model of gender, age, pre-test likelihood, X-ECG and CCS had an 
AUC of 0.84 (95% CI 0.77 – 0.91) for the diagnosis of CAD (Figure 2). 
 Of 68 patients without significant CAD 37 (54%) had either a CCS >400 or an 
abnormal X-ECG result. Of 68 patients with significant CAD 6 (9%) patients had both 
a CCS of 0-400 and a negative X-ECG result (Table 2). Two patients had both a CCS 
of 0 and a negative X-ECG result.
figure 2.  Incremental diagnostic yield of exercise stress ECG added to coronary calcium 
score in the diagnosis of coronary artery disease in an intermediate to high pre-test 
likelihood population ROC curves for CCS (0, 0.1-400 and >400), exercise stress 
ECG (X-ECG) (negative, non-conclusive and positive) and the multivariate model 
(Model) (age, gender, risk factors, pre-test likelihood according to Diamond and 
Forrester criteria, X-ECG and CCS). Differences in area under the curve (AUC) show 
comparable diagnostic yield of stand alone X-ECG and CCS. X-ECG added to CCS 
shows incremental diagnostic yield.
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Table 2. Reclassification of patients after addition of X-ECG to CCS and vice versa results in 
significant numbers of false positive or negative test results.
CCS
>400
CCS 
and 
X-ECG
X-ECG 
abnormal
Significant CAD
N = 68
TP 34 0 62 0 56
fN 34 28 6 6 12
No Significant CAD
N = 68
TN 52 15 31 8 39
fP 16 0 37 0 39
Coronary calcium score (CCS) >400 was defined abnormal. Exercise stress electrocardiography 
(X-ECG) was defined abnormal in the presence of a positive or non-conclusive result to 
resemble clinical practice. As such a sensitivity, specificity, positive- and negative predictive 
value of 91.2% (95%CI 82-96), 45.6% (95%CI 34-57), 62.6 (95%CI 53-72) and 83.8% (95%CI 
69-92) respectively, were calculated. True positive (TP), false negative (FN), true negative (TN) 
and false positive (FP) findings are given for each test. Numbers above or beneath the arrows 
indicate the number of diagnoses that evolve from a TP to a FN and a TN to a FP diagnosis 
and vice versa.
diSCuSSioN
The principal finding of this study is that despite an increased diagnostic yield of 
combined CCS and X-ECG in patients with an intermediate to high pre-test likelihood 
of CAD, in clinical practice still a substantial number of patients without significant 
CAD (54%) are wrongly classified as suffering from significant CAD. In the current 
population 9% of patients suffered from significant CAD despite a CCS <400 and a 
negative X-ECG result. 
 With the knowledge that in a considerable number of patients referred 
for CA no significant CAD is found, the need for an accurate and cost-effective 
non-invasive diagnostic work up remains high (14). From a very diverse palette of 
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available diagnostic procedures CCS and X-ECG probably are the most available, fast 
and inexpensive non-invasive diagnostic procedures that are least prone to adverse 
events (9, 15, 16). Previous reports have shown that in patients with low pre-test 
likelihood of CAD CCS was more reliable in ruling out CAD than X-ECG with cut-off 
value for CCS of 0 or <2 (17, 18). Diagnostic accuracy was comparable in patients 
with an intermediate pre-test likelihood of CAD (8, 17). Determining the absence of 
coronary calcium could obviate the need for further testing(17). In a study by Dedic 
et al, also a group of patients with high pre-test likelihood is described, defined as 
>70% based on the Duke Clinical Score. It was stated that these patients do not 
seem to benefit from either CCS or X-ECG in the exclusion from significant CAD (17). 
However, it remains unclear whether the combination of both sets of information 
could add to the diagnostic performance of each test as standalone diagnostic 
procedure. 
 With our study we were able to confirm the absence of sufficient diagnostic 
performance of either CCS or X-ECG as standalone diagnostic procedures in 
intermediate to high pre test likelihood patients. The combination of both diagnostic 
modalities leads to an increased diagnostic performance. The AUC for the diagnosis 
of significant CAD increases from 0.65 for standalone X-ECG and 0.69 for standalone 
CCS to 0.84 for the multivariate model of gender, age, pre-test likelihood, X-ECG 
and CCS. Both a positive X-ECG and a CCS > 400 are independent predictors 
for the presence of significant CAD, according to our multivariate analysis. The 
presence of these diagnostic results should make physicians alert for the presence 
of significant CAD. However, considerable diagnostic uncertainty remains. Not only 
due to inconclusive X-ECG results, that make up 18% of our population. Also, the 
poor diagnostic accuracy of standalone CCS and X-ECG result in a limited diagnostic 
accuracy of these modalities combined. As demonstrated, in clinical practice the PPV 
of 63% and NPV of 84% of combined CCS and X-ECG will result in a considerable 
number of additional invasive or non-invasive imaging procedures.
Several limitations should be taken into account when interpreting the results of 
this study. Acquisition of an X-ECG after imaging the amount of coronary calcium 
is not standard, which makes the current analysis somewhat hypothetical. The 
same applies to the reverse acquisition protocol, however. We have shown that the 
combination of both tests admittedly leads to a more reliable result when compared 
with the standalone tests. It is doubtful whether an AUC of 0.84 is sufficient to reliably 
establish or exclude CAD. The sample size for the current analysis is rather small and 
the possibility of selection bias cannot be excluded since a considerable number of 
patients from the original population were excluded from this analysis due to an 
unavailable X-ECG or reference standard. Gold standard in our study was a > 50% 
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luminal loss on CA as diagnostic for significant CAD. An anatomical parameter as 
reference standard has known limitations for the judgement of functional relevance 
of CAD (19).
CoNCluSioN
 In conclusion, in patients with an intermediate to high pre-test likelihood 
of CAD the acquisition of X-ECG after CCS results in increased diagnostic yield in 
the evaluation of patients for the presence of significant CAD. A high coronary 
calcium score (> 400) or a positive X-ECG increases the likelihood of the presence of 
significant CAD. However, considerable diagnostic uncertainty remains mainly due to 
a large number of false positive results which wilt result in additional (non-) invasive 
imaging procedures.
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AbSTRACT
Purpose 
Coronary calcium scoring (CCS) adds to the diagnostic performance of myocardial 
perfusion SPECT (SPECT) to assess the presence of significant coronary artery disease 
(CAD). Patients with a high pre-test likelihood are expected to have a high CCS which 
potentially could enhance the diagnostic performance of myocardial perfusion 
SPECT in this specific patient group. We evaluated the added value of CCS to SPECT 
in the diagnosis of significant CAD in patients with an intermediate to high pre-test 
likelihood.
Methods 
In total, 129 patients (mean age 62.7±9.7 years, 65% male) with stable anginal 
complaints and intermediate to high pre-test likelihood of CAD (median 87%, range 
22 - 95) were prospectively included in this study. All patients received SPECT and 
CCS imaging preceding invasive coronary angiography (CA). Fractional flow reserve 
(FFR) measurements were acquired from patients with angiographically estimated 
50-95% obstructive CAD. For SPECT a SSS > 3 was defined significant CAD. For CCS 
the optimal cut-off value for significant CAD was determined by ROC curve analysis. 
The reference standard for significant CAD was a FFR of <0.80 acquired by CA.
Results 
Significant CAD was demonstrated in 64 patients (49.6%). Optimal CCS cut-off value 
for significant CAD was >182.5. ROC curve analysis for prediction of the presence of 
significant CAD for SPECT, CCS and the combination of CCS and SPECT resulted in 
an area under the curve (AUC) of 0.88 (95%CI 81-94), 0.75 (95%CI 66-83%) and 0.92 
(95%CI 87%-97%) respectively. The difference of the AUC between SPECT and the 
combination of CCS and SPECT was 0.05 (P = 0.12).
Conclusion 
The addition of CCS did not significantly improve the diagnostic performance of 
SPECT in the evaluation of patients with a predominantly high pre-test likelihood of 
CAD.
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iNTRoduCTioN
According to current guidelines invasive coronary angiography (CA) is a suitable 
diagnostic procedure for patients with a high pre-test likelihood of significant 
coronary artery disease either with or without troublesome symptoms or clinical 
findings 1, 2. In this population the reported diagnostic yield of invasive CA is 44-
88% 3-5. In real life invasive CA has an even lower diagnostic yield of obstructive 
CAD of about 38% 6.  Non-invasive testing could be of value to defer from invasive 
diagnostic procedures, even in a subset of patients with an intermediate to high pre-
test likelihood of CAD. 
 Nuclear myocardial perfusion imaging (MPI) with single-photon emission 
computed tomography (SPECT) is known for its role in diagnosis, risk stratification 
and guidance of treatment decision making in the general population 7, 8. However, 
diagnostic performance in patients with a high pre-test likelihood of CAD is low with 
a sensitivity of 56% to 94% 3, 9. Additional anatomical information could be of value 
to increase diagnostic performance in this subset of patients. 
Coronary calcium scoring (CCS) is known for its role in risk prediction for a-symptomatic 
patients. Patients with CCS <10 are at low risk of major cardiovascular events during 
follow-up 10, 11. In symptomatic patients the value of CCS is disputed. Although the 
prevalence of significant disease is low and the follow-up is favorable in patients with 
a CCS <10, the prevalence of >50% stenosis in this category might still be 12-65% 
12-16. Functional imaging could be of added value to identify these patients.
 With the advent of integrated SPECT and Computed Tomography (CT) 
systems and the use of low dose CCS scans for attenuation correction purposes, 
high quality anatomical and functional data are readily available 17, 18. SPECT findings 
suggestive of myocardial ischemia are associated with high CCS, vice versa it was 
suggested that low CCS associated with these findings could obviate the need for 
further invasive testing 19, 20. On the other hand in patients with normal SPECT findings 
a high CCS could be suggestive of significant CAD 21-23.
 We evaluated the influence of the pre-test likelihood of significant CAD on 
these findings and hypothesized that in a subset of patients with an intermediate to 
high pre-test likelihood of CAD there would be added value of CCS to the diagnostic 
performance of SPECT. 
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MATERiAlS ANd METHodS
Study population.
Patients with an intermediate to high pre-test likelihood of CAD were prospectively 
enrolled in this study. Pre-test likelihood was calculated according to Diamond and 
Forrester criteria 24. Intermediate pre-test likelihood was defined as 13% - 87% and 
high pre-test likelihood was defined as >87%, similar to boundaries used in literature 
2. Excluded were patients with a known history of CAD defined as any unstable 
coronary condition, myocardial infarction, coronary revascularization or diagnostic 
Q wave on baseline ECG. Also patients with a known history of non-ischemic 
cardiomyopathy or a cardiac rhythm other than sinus rhythm were excluded.  By 
non-invasive assessment, CAD was defined as a summed stress score (SSS) of >3 
on SPECT or the presence of significant coronary calcification defined by a CSS cut-
off value of >0 or the cut-off value defined by receiver operating characteristics 
(ROC) curve analysis.  Fractional flow reserve measurements served as the standard 
of reference, an FFR <0.80 was used for de definition of hemodynamically significant 
CAD. The study conformed to the principles outlined in the declaration of Helsinki 
and was approved by the local ethics committee. Written informed consent was 
obtained from all patients.
 
image acquisition
All patients received SPECT and CCS imaging followed by CA, including those 
patients with normal SPECT and CCS results as part of the prospective study. Gated 
SPECT and CCS images were acquired from a Hybrid SPECT-CT system, CardioMD 
gamma camera and Brilliance 64-slice CT scanner (Philips Medical Systems, Best, 
The Netherlands) with a 2-day stress/rest MPI protocol.  Stress images were 
considered normal if no perfusion defect was visualized, SSS was <3, no wall motion 
abnormalities (WMA) or >10% transient ischemic dilatation (TID) were present and 
left ventricular ejection fraction (LVEF) was >50% (male and female). Patients with 
abnormal stress SPECT findings underwent rest imaging and CA at the second day 
of imaging. Patients with normal stress SPECT findings only underwent CA at the 
second day. The second imaging day was scheduled within 14 days of the first. CCS 
was performed in the stress SPECT imaging session.
 Bicycle stress according to a stepwise protocol or pharmacological stress 
(adenosine at standard rate of 0.14 mg/kg/min over 6 min) was performed for stress 
image acquisition. In case the target heart rate was not reached at maximum exercise 
stress, atropine was given at the discretion of the attending physician. For stress and 
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rest SPECT a weight adjusted dose of 400-600 MBq of 99mTc-sestamibi was used. 
Attenuation correction was performed for all images using the CT non-enhanced 
calcium scan. SPECT data were analyzed by two experienced nuclear medicine 
physicians with regard to the presence of reversible and/or fixed perfusion defects 
on short axis and vertical and horizontal long axis slices. Semiquantitive perfusion 
data and gated data with respect to WMA, TID and LVEF were included in the analysis 
using the QGS/QPS software package (Cedars-Sinai Medical Center, Los Angeles, Ca, 
USA). 
 A nonenhanced scan to calculate the total CCS was performed with the 
following scanning parameters: prospective ECG triggering, at inspiration, 2.5mm slice 
thickness, 120kV tube voltage, 55 mAs tube current. Agatston scores were computed 
using the Extended Brilliance Workspace software (Philips Medical Systems, Best, The 
Netherlands).
 As part of the prospective study, CA was performed in all patients, including 
those with normal non-invasive test results. CA was acquired on Allura (Philips Medical 
Systems, Best, The Netherlands) catheterization equipment via femoral or radial 
artery access. From all patients biplane views were acquired from all major coronary 
arteries. Additional views were obtained at the discretion of the performing operator. 
FFR measurements were obtained from patients with angiographically estimated 
50-95% obstructive disease. During FFR measurement distal coronary pressure was 
measured with a pressure guidewire (Certus Wire, Radi Medical Systems, Uppsala, 
Sweden) during maximal hyperemia induced by adenosine intravenously at 0.14 mg/
kg/min, with simultaneous measurement of aortic pressure through the catheter. FFR 
was calculated as the ratio between mean distal pressure and mean aortic pressure 25. 
The angiograms were visually evaluated for lesion severity according to 5 categories 
of luminal loss: no CAD (0% luminal loss), mild lesion severity (luminal loss 0 – 50%), 
intermediate lesion severity (luminal loss 50 – 70%), severe lesions (luminal loss 70 
– 99%) and total occlusion. Interpretation was performed on a consensus basis by 
two experienced cardiologists. Occluded vessels were considered severely stenotic 
with an FFR of 0.50. Vessels with angiographically >95% obstructive disease were 
considered severely stenotic with an FFR <0.80. Normal vessels (<10% luminal loss) 
were considered not severely stenotic; FFR >0.80. As a result, FFR measurements were 
available from 47 of the patients with angiographically estimated 50-95% obstructive 
disease (84%). Significant disease was defined as an FFR <0.80.
 All imaging modalities were interpreted blinded for clinical data and the 
respective other modalities.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
50
Chapter 4
Statistical Analysis
Statistical analyses were performed with SPSS software (version 18.0, IBM Corporation, 
Somers, New York, USA). Continuous variables were expressed as mean ± standard 
deviation (SD) or median and range (if distribution was skewed), and categorical 
variables as numbers and percentages. Sensitivity, specificity, negative predictive 
value (NPV) and positive predictive value (PPV) with corresponding 95% confidence 
intervals (CI) were calculated. ROC curve analysis was performed to calculate the 
optimal cutoff value for the detection of significant CAD by CCS. As a measure of 
discrimination we calculated the area under the ROC curve (AUC) with 95% confidence 
intervals for CCS and SPECT for the detection of significant CAD. Also binary logistic 
regression analysis was used to construct the formula for the combination of SPECT 
and CCS in the evaluation of the presence of significant CAD. A p-value of <0.05 was 
considered statistically significant.
RESulTS
Study population
In total, 129 patients (mean age 62.7±9.7 years, 65% male) with stable anginal 
complaints and a predominantly high pre-test likelihood of CAD (median pre-test 
probability 87% (range 22-95)), were included in the study. Sixty-nine patients 
(53.5%) had more than three cardiovascular risk factors. Complete characteristics of 
the study population are presented in Table 1.
Coronary angiography
CA showed significant CAD in 64 patients (49.6%). The distribution of vessel 
involvement is presented in Table 2. From the 64 patients with significant CAD, 28 
(43.8%) patients underwent CABG, 26 (40.6%) patients underwent percutaneous 
coronary intervention (PCI) and 10 (15.6%) patients were treated conservatively 
because of peripheral or very diffuse disease. From the 66 patients without significant 
CAD, 1 patient (1.5%) underwent PCI, the remainder was treated conservatively.
Myocardial perfusion SPECT
Exercise stress prior to image acquisition was performed in 103 patients (79.8%), 
the remainder 26 (20.2%) patients underwent adenosine stress. 33 (32.0%) patients 
required atropine infusion to reach the target heart rate during exercise stress. Mean 
LVEF after stress was 61.5±9.0%, and at rest 64.9±10.1%. Mean transient ischemic 
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dilatation was 8.2±16.5ml (median 6.0ml, range -35 to 55). During stress testing, 32 
(31.1%) patients showed ECG changes suggestive of myocardial ischemia (at least 
2mm ST-segment depression), 52 (50.5%) patients had a negative stress test and 19 
(18.4%) had either uninterpretable or equivocal stress ECG results. During adenosine 
stress 3 (11.5%) patients had positive ECG findings. From the 57 patients with a SSS 
>3, 51 had significant CAD. From the 13 patients with a false negative SPECT eight 
had a pre-test likelihood ranging between 52 and 86%. The remaining five patients 
had a high pre-test likelihood, >90%. Data regarding the SPECT characteristics are 
presented in Table 2. Diagnostic performance of SPECT is presented in Table 3 and 
Figure 1.
figure. 1  ROC curve analysis for the detection of significant coronary artery disease (CAD) 
by the use of coronary calcium scoring (CCS), Single Photon Emission Tomography 
(SPECT) and the combination of CCS and SPECT. A fractional flow reserve of <0.80 
was defined significant CAD. A CCS of 182.5 was optimal cutoff for the detection 
of significant CAD. Area under the curve 0.75. The difference of the AUC between 
SPECT and the combination of CCS and SPECT was 0.05 (P = 0.12).
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Table 1  Characteristics of the patients included in the analysis
Age (years)* 62.7 ± 9.7
Men 84 65.1%
Women 45 34.9%
Cardiac History
Paroxysmal atrial fibrillation 6 4.7%
Pacemaker implantation 1 0.8%
Risk factors
 Smoking
    Current 29 22.5%
    History 24 18.6%
 Hypertension 84 65.1%
 Diabetes mellitus 16 12.4%
 Dyslipidaemia 70 68.0%
 Family history 79 61.2%
Risk factors ≥ 3 69 53.5%
Angina pectoris
 Non-anginal 1 0.8%
 Atypical 40 31.0%
 Typical 88 68.2%
CCS Angina Class
  Class I 8 6.2%
  Class II 111 86.0%
  Class III 10 7.8%
  Class IV 0 0.0%
Systolic blood pressure (mmHg) * 135 ± 21
Diastolic blood pressure (mmHg) * 78 ± 15
Body mass index (kg/m2) * 27.0 ± 4.0
Cockroft creatinin clearance (ml/min) * 93.4 ± 26.5
Pre-test likelihood † 0.87 (0.22 – 0.95)
 Low  0 0.0%
 Intermediate  56 43.4%
 High  65 50.4%
 Unknown  8 6.2%
Values are shown as number and percentage unless otherwise noted. * Values expressed as 
mean ± standard deviation, † Values expressed as median (range). CCS, Canadian Cardiovascular 
Society.
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Coronary Calcium Scoring
The median CCS of the study population was 145 (range 0 – 4142). For patients 
with significant CAD the median CCS was 363 (range 0 – 4142), for patients without 
significant CAD the median CCS was 28 (range 0 – 2891, p-value <0.001). From the 
97 patients with a CCS >0, 56 (58%) had significant CAD. From the 32 patients with 
a CCS of 0, eight (25%) patients had significant CAD. These patients had a pre-test 
likelihood of disease ranging from 73 – 93%. The distribution of CCS is presented 
in Table 2. ROC curve analysis for the detection of significant CAD using CCS in 
high pre-test likelihood patients gave an optimal cutoff value of 182.5 for significant 
CAD, yielding an area under the curve (AUC) of 0.75(95%CI 0.66-0.83). (Figure 1) The 
sensitivity, specificity, NPV, PPV and accuracy values of CCS are presented in Table 3.
Combined SPECT and CCS
Using a CCS cutoff value of >0 added to a SSS>3 on SPECT led to the diagnosis of 
significant CAD in 104 patients, 61 (58.6%) of these had significant CAD according 
to the reference standard. Despite a CCS of 0 and a SSS <3 on SPECT, 3 patients of 
a total of 22 (12%) had significant CAD. By introducing the CCS cutoff value of 182.5 
added to a SSS>3 on SPECT, the number of false positive results decreased without 
adding to the number of false negatives (Table 3). 
 CCS added to the diagnostic accuracy of SPECT in 10 patients. Eight patients 
with a normal SPECT had a CCS >1000. Two patients with a negative SPECT had a 
CCS of respectively 245 and 369; they had an intermediate pre-test likelihood of 
CAD. SPECT added to the diagnostic accuracy of CCS in 5 patients. Three patients 
with significant CAD and a CCS of 0 and a negative SPECT had an intermediate pre-
test likelihood of CAD (Table 4). 
 ROC curve analysis for CCS, SPECT and the combination of SPECT and 
CCS resulted in an AUC of 0.75, 0.88 and 0.92 respectively. Both SPECT and the 
combination of SPECT and CCS performed significantly better in the evaluation of 
the presence of significant CAD than CCS, P = 0.0093 and P < 0.0001 respectively. 
However the combination of SPECT and CCS performed comparable to standalone 
SPECT, difference in AUC 0.05, P = 0.12 (Figure 1).
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Table 2  Results of coronary calcium scoring, myocardial perfusion SPECT and invasive 
coronary angiography
Coronary Calcium Scoring 
0 32 24.8%
1-10 8 6.2%
11-100 17 13.2%
101-400 27 20.9%
401-800 15 11.6%
>800 30 23.3%
Myocardial Perfusion SPECT
Exercise stress 103 79.8%
Adenosine stress 26 20.2%
Summed stress score 0 53 41.1%
Summed stress score 1 – 3 19 14.7%
Summed stress score > 3 57 44.2%
Stress SPECT, n=129
Left ventricle end diastolic volume, ml * 107.1 ± 44.7
Left ventricle end systolic volume, ml * 44.8 ± 30.8
Left ventricle ejection fraction, % * 61.5 ± 9.0
Rest SPECT, n=87
Left ventricle end diastolic volume, ml * 107.2 ±  46.3
Left ventricle end systolic volume, ml * 41.4 ± 34.1
Left ventricle ejection fraction, % * 64.9 ± 10.1
invasive Coronary Angiogram
Extent of significant CAD †
No significant CAD 65 50.4%
1-vessel disease 22 17.1%
2-vessel disease 23 17.8%
3-vessel disease or left main stenosis 19 14.7%
Values are shown as number and percentage unless otherwise noted. * Values expressed 
as mean ± standard deviation. SPECT, single photon emission computed tomography. CAD, 
coronary artery disease. † A fractional flow reserve of <0.80 was defined significant CAD.
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Table 3 Diagnostic performance of SPECT, CCS and the combination of SPECT and CCS
Sensitivity Specificity PPV NPV TP/fP/TN/fN Accuracy
CCS >0 88 37 58 75 56/41/24/8 62
CCS > 182.5 66 71 69 68 42/19/46/22 68
SSS >3 80 91 90 82 51/6/59/13 85
CCS >0 or SSS 
>3
95 34 59 88 61/43/22/3 64
CCS >182.5 or 
SSS >3
95 66 74 94 61/22/43/3 81
Diagnostic performance of single photon emission computed tomography (SPECT), coronary 
calcium scoring (CCS) or combinations for the detection of significant coronary artery disease 
(CAD). A fractional flow reserve of <0.80 was defined significant CAD. PPP, positive predictive 
value. NPV, negative predictive value. TP, true positive. FP, false positive. TN, true negative. FN, 
false negative.
Table 4  Distribution of coronary calcium scores and summed stress scores for patients with 
significant coronary artery disease and either CCS = 0 (N=8) or SSS <3 (N=13).
SPECT SSS = 0 SPECT SSS = 1 – 3 SPECT SSS >3
CCS = 0 2 1 5
CCS = 1 – 10 
CCS = 11 – 100 
CCS = 101 – 400 1 1
CCS = 401 – 1000
CCS > 1000 4 4
SPECT, single photon emission computed tomography. CCS, coronary calcium score. SSS, 
summed stress score.
diSCuSSioN
Our study shows no significant added value of CCS on top of SPECT in a population 
with a predominantly high pre-test likelihood of CAD. SPECT alone has a reasonable 
performance with an NPV of 82% and an AUC of 0.88 as determined by ROC curve 
analysis. By adding CCS information the NPV increased to 94%, but at the cost of a 
substantial number of false positives. As such the increased AUC of 0.92 did not differ 
significantly from SPECT as standalone procedure.  Moreover, it failed to identify 
three patients with significant CAD, a CCS of 0 and a negative SPECT result.
 In the overall patient population with anginal complaints SPECT has a good 
diagnostic performance. Well-designed studies have shown sensitivities ranging 
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from 85-90%. If ECG gated information and attenuation correction algorithms are 
used specificity values range between 80 and 90% 7, 8. In 123 patients with a high 
pre-test likelihood of disease Groutars et al demonstrated a sensitivity of 97% 
and a specificity of 59% for the detection of >70% lesions on CA 3. More recently, 
Hamirani et al. demonstrated a lower diagnostic performance of SPECT in a high 
pre-test likelihood population of 122 patients with sensitivity and specificity values 
of 58% and 43%, respectively 9. Both groups used a one day dual isotope imaging 
protocol with 201Tl rest imaging and 99mTc stress imaging. The former population was 
truly high risk with a mean pre-test likelihood of 92±20% and a prevalence of >70% 
stenosis in 80% of the patients. The latter was retrospectively constituted of patients 
who underwent SPECT, CT coronary angiography and CA. The prevalence of >70% 
stenosis was 64%, suggestive of a high risk population. In our hands SPECT had 
a reasonable performance with sensitivity and specificity values of 80% and 91% 
respectively and an AUC of 0.88 for the detection of significant CAD in a high pre-test 
likelihood population.
 Coronary calcium scoring is known for risk prediction, but it is unable to depict 
the coronary lumen and therefore not suitable for the diagnosis or exclusion of flow 
limiting CAD. In a population of patients referred for CA, the incidence of significant 
CAD in patients with a CCS of zero is 15-19%. In a large symptomatic population 
(N=291) with a predominantly intermediate pre-test likelihood of CAD, Gottlieb et al. 
found that among 72 patients with a CCS of zero, 15%  had a stenosis >70% on CA 
12. In our population 25% of the patients with a CCS of zero had significant CAD. This 
resulted in a sensitivity of 88% using a CCS greater than zero as a diagnostic tool for 
significant CAD. Conversely the specificity was just 37% using this cut-off value. The 
optimal CCS cut-off value in our population for the detection of significant CAD was 
182.5 as calculated by ROC curve analysis. In light of the inability of CCS to depict the 
coronary lumen, let alone the functional consequences, this value remains artificial. 
Which is demonstrated by an AUC of 0.75 as determined by ROC curve analysis.
 A false-negative SPECT in patients with balanced ischemia is a well-known 
pitfall for clinicians. Several authors have noted that a high CCS may have diagnostic 
value in this patient category 17, 22. Schepis et al showed that in patients with an 
intermediate risk of CAD a CCS >709 is predictive for significant CAD (>50% stenosis) 
in patients with a normal SPECT. When CCS at this cut-off value was added to SPECT, 
the sensitivity increased from 76% to 86% and specificity remained similar (91% and 
86%, respectively) when compared to SPECT alone 17. In a selected population of 50 
patients with a normal SPECT and a CCS>1000, Ghadri et al. found a 74% prevalence 
of stenosis >50% 22. Our data showed that out of the 13 patients with a false-negative 
SPECT, 8 had a CCS > 1000. And although median CCS in patients without significant 
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CAD was 29, still 5% of patients with a true negative SPECT had a CCS > 1000. 
If we used CCS >0 as a cut-off value for CAD we observed a NPV of 88% for the 
exclusion of significant CAD when added to SPECT, although at the cost of a high 
number of false positives, PPV 59%. Adding the optimal CCS cut-off value of 182.5 to 
SPECT, the number of false positive results decreased. The PPV improved from 59% 
to 74%, the NPV of 88% increased to 92%. However, AUC as determined by ROC 
curve analysis did not differ significantly between the combination of CCS and SPECT 
and standalone SPECT. This shows that in a group of patients with high risk of CAD, 
excluding the presence of coronary calcifications in patients with a normal SPECT 
makes the exclusion of significant CAD reliable. However, a relatively low or zero 
CCS does not completely rule out significant CAD in these patients. One of the three 
patients with a CCS of zero and a negative SPECT result had a significant left main 
stenosis. When the presence of calcifications is proven in patients with a negative 
SPECT result, however, the significance of CAD is not. 
 Several limitations of our study need to be taken into account when 
interpreting the results. First, our study population was at predominantly high-risk 
of CAD. Patients with an intermediate to high pre-test likelihood were allowed to be 
included and over 50% of patients had a high pre-test likelihood. Thus, this study is 
not exemplary for the general clinical population referred for SPECT. The majority of 
patients with false negative results had a high pre-test likelihood of disease. Second, 
for each patient we chose the optimal stress protocol, either adenosine or exercise. 
However, adenosine stress has a known limited diagnostic performance compared 
to exercise stress. The reason for not being able to reach an adequate heart rate 
response during exercise, not only could be the reason to switch to adenosine stress; 
this could also be the confounding factor for the increased presence of significant 
CAD (f.i. peripheral atherosclerotic disease or chronic obstructive pulmonary disease). 
As a result of the higher prevalence of significant CAD, negative predictive value of 
adenosine stress SPECT could be hampered. Despite the fact that almost a quarter of 
the patients received adenosine stress, the diagnostic performance of SPECT alone in 
this population is reasonable. FFR measurements were available from 84% of patients 
with angiographically 50-95% obstructive disease. According to available literature it 
is safe to assume that lesions with <50% stenosis have no hemodynamic significance 
26. Nine patients with angiographically 70-95% obstructive disease did not receive 
FFR measurements, mainly for practical reasons on a busy catherization laboratory. 
The impact of the possible error by the assumption that these lesions were indeed 
hemodynamically significant is limited 26.
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CoNCluSioN
When using coronary calcification as additional information to myocardial perfusion 
SPECT, physicians should be aware that in a population with a predominantly high 
pre-test likelihood of CAD, the presence of coronary calcifications does not reliably 
discriminate between the presence and absence of significant CAD. Indeed a high 
CCS, >1000 in literature and >182,5 in our population, can identify patients with 
significant CAD and a normal SPECT.  However, even in patients with significant CAD 
and a normal SPECT result, the calcium score may be as low as zero. 
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AbSTRACT
Aims
Hybrid myocardial perfusion imaging with single photon emission computed 
tomography (SPECT) and CT coronary angiography (CCTA) has the potential to play 
a major role in patients with non-conclusive SPECT or CCTA results. We evaluated 
the performance of hybrid SPECT/CCTA versus standalone SPECT and CCTA for the 
diagnosis of significant coronary artery disease (CAD) in patients with an intermediate 
to high pre-test likelihood of CAD. 
Methods and results
In total, 98 patients (mean age 62.5±10.1 years, 68.4% male) with stable anginal 
complaints and a median pre-test likelihood of 87% (range 22% – 95%), were 
prospectively included in this study. Hybrid SPECT/CCTA was performed prior 
to conventional coronary angiography (CA) including fractional flow reserve 
measurements (FFR). Hybrid analysis was performed by combined interpretation 
of SPECT and CCTA images. The sensitivity, specificity, positive (PPV) and negative 
(NPV) predictive values were calculated for standalone SPECT, CCTA and hybrid 
SPECT/CCTA on per patient level, using a FFR <0.80 as reference for significant CAD. 
Significant CAD was demonstrated in 56 patients (57.9%). Non-conclusive SPECT 
or CCTA results were found in 32 (32.7%) patients. SPECT had a sensitivity of 93%, 
specificity 79%, PPV 85%, NPV 89%. CCTA had a sensitivity of 98%, specificity 62%, 
PPV 77%, NPV 96%. Hybrid analysis of SPECT
 and CCTA improved the overall performance: sensitivity, specificity, PPV and NPV for 
the presence of significant CAD to 96%, 95%, 96% and 95%, respectively. 
Conclusions
In more than 40% of the patients with a high pre-test likelihood no significant CAD 
was demonstrated, emphasizing the value of accurate pretreatment cardiovascular 
imaging. Hybrid SPECT/CCTA was able to accurately diagnose and exclude significant 
CAD surpassing stand-alone myocardial SPECT and CCTA, versus a reference standard 
of FFR measurements.
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iNTRoduCTioN
Cardiac hybrid myocardial perfusion imaging with single photon emission computed 
tomography (SPECT) and CT coronary angiography (CCTA) has been proposed in 
patients with an intermediate risk of coronary artery disease (CAD) 1, 2. Hybrid cardiac 
imaging seems particularly useful in patients with multi-vessel disease, perfusion 
defects in the lateral and inferior wall, and in patients with non-conclusive results of 
either technique 1-4. 
 Diagnostic performance of stand-alone SPECT is limited in patients with 
intermediate to high pre-test likelihood of CAD with a broad range of reported 
sensitivities between 56% and 94% 5-7, probably due to an  important fraction of  non-
conclusive results 3. Small perfusion defects (1-2 segments), inadequate heart rate 
response (e.g. failure to reach 85% of maximum predicted heart rate or 5 metabolic 
equivalents (MET) during exercise), and discrepant clinical data (e.g. typical angina 
per history or ≥2 mm ST-segment depression on ECG during exercise) could be 
reasons to regard SPECT non-conclusive 8, 9. 
 In patients with an intermediate- to high pre-test likelihood also CCTA 
is prone to non-conclusive results. This is mainly due to non-evaluable coronary 
segments as a result of coronary calcifications and artifacts that decrease diagnostic 
performance 10-15. As such, even with the latest scanner generations, CCTA still has 
moderate specificity 10-12, 16, 17. 
Evidence is emerging that the diagnostic performance of hybrid SPECT/CCTA is 
superior to stand alone SPECT and CCTA 15, 18. In selected populations sensitivity and 
specificity values of 94-96% and 92-95% have been reported 15, 18.
In our study we focus on patients with an intermediate to high pre-test likelihood of 
CAD and subsequently high rates of equivocal and non diagnostic imaging results. 
We hypothesized that hybrid SPECT/ CCTA has incremental diagnostic accuracy over 
standalone SPECT or CCTA.
METHodS
Patient population and imaging schedule
We prospectively conducted a single center cross-sectional cohort study 19. Patients 
with an intermediate to high pre-test likelihood of CAD were consecutively recruited 
for this study from September 2010 until December 2011. Boundaries for low, 
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intermediate and high pre-test likelihood were set at <20%, 20-80% and > 80% 
respectively and calculated according to Diamond and Forrester criteria 20, 21. Excluded 
were patients with a history of surgical revascularization, stent implantation, patients 
with an unstable cardiac condition or a cardiac rhythm other than sinus rhythm. The 
study conformed to the principles outlined in the declaration of Helsinki and was 
approved by the local ethics committee. Written informed consent was obtained 
from all patients.
figure 1. Flowchart for patients included in this analysis. Hybrid SPECT/CCTA, Hybrid 
myocardial perfusion single photon emission computed tomography and CT 
coronary angiography. CA, invasive coronary angiography. FFR-measurement, 
fractional flow reserve measurement. 
 Of the 143 patients that underwent hybrid SPECT and prospectively 
triggered CCTA, 98 patients (69%) received invasive coronary angiography (CA) 
and fractional flow reserve (FFR) measurements (Figure 1). Gated SPECT and CCTA 
data were acquired on a Hybrid SPECT-CT system, CardioMD gamma camera and 
Brilliance 64-slice CT scanner (Philips Medical Systems, Best, The Netherlands). 
The components share a common table that is aligned to allow sequential image 
acquisition. On the first imaging day stress SPECT and CCTA data were acquired. 
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Patients started with bicycle or pharmacological stress after which stress SPECT was 
acquired directly followed by CCTA. In patients with a normal stress SPECT (normal 
perfusion and gated data) no rest SPECT was acquired. CA and FFR measurements 
were performed in all patients, including those with normal non-invasive test results, 
within 14 days from the first image acquisition. If indicated, CA was preceded by rest 
SPECT image acquisition.
Myocardial perfusion SPECT
SPECT images were acquired with a 2-day stress/rest MPI protocol. Of 98 patients 
included in the analysis 82 patients (83.7%) underwent bicycle stress according to a 
stepwise protocol for stress image acquisition. Sixteen (16.3%) patients underwent 
pharmacological stress (adenosine at standard rate of 0.14mg/kg/min over 6 min). For 
stress and rest SPECT a weight-adjusted dose of 400-600 MBq of 99mTc-sestamibi was 
used. SPECT imaging was performed using a dual headed gamma camera, equipped 
with low-energy, high-resolution collimators. Sixty-four projections were acquired 
with 40 seconds per projection and stored on a 64x64 matrix. Energy window was 
set at 20% around the 140-keV photon peak.  Reconstruction was performed by 
means of filtered back projection using a Butterworth filter, to produce transverse 
tomograms.  Short-axis, vertical and horizontal long-axis tomograms were produced 
from transverse tomograms by performing coordinate transformation. Attenuation 
correction was performed for all images using a non-enhanced CT scan. Semi-
quantitative visual analysis was performed in consensus by two experienced nuclear 
medicine physicians. Attenuation corrected and non-attenuation corrected images 
and auxiliary findings (results of stress testing, gated data and semi quantitative 
perfusion data) were included in the analysis. Stress and rest SPECT images were 
interpreted as previously described according to a 17-segment model and scored 
for perfusion defects using a five-point scoring system (0 = normal to 4 = absence 
of tracer uptake) 8, 22, 23. Gated data and semi quantitative perfusion data were 
assessed using the QGS/QPS software package (Cedars-Sinai Medical Center, Los 
Angeles, Ca, USA). The analyzing physicians were blinded for other imaging data. 
For the definition of normal, equivocal and abnormal myocardial perfusion on SPECT 
according to segmental scores we used the definition provided by Abidov et. al.8. 
SPECT with an equivocal perfusion score was regarded non-conclusive, a (probably-) 
normal perfusion score was regarded normal and a (probably-) abnormal perfusion 
score was regarded abnormal. 
Coronary computed tomography angiography
All patients underwent prospectively ECG-triggered axial CCTA according to 
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the guidelines provided by de society of cardiovascular computed angiography 
24.  All participants received oral metoprolol tartrate at the start of the stress test 
preceding SPECT imaging. Preceding CCTA additional intravenous metoprolol was 
administered  to achieve a heart rate below 62 bpm. Prior to CCTA, a non-enhanced 
scan to calculate the coronary calcium score (CCS) was performed. CCTA data were 
acquired with a collimation of 64 x 0.625 mm. A bolus tracking protocol was used to 
determine the time of optimal contrast. During CCTA 90-110ml iodinated contrast 
medium (lobitridol, Xenetix 350, Guerbet) was administered, followed by a saline 
flush. Tube current was 500mA at 80 to 120kV for patients according to their body 
weight. CCTA’s were read by two cardiologists for obstructive severity according to 
a 16-segment model and 5 categories of luminal loss: no CAD (0% area stenosis), 
mild lesion severity (0 – 50% area stenosis), intermediate lesion severity (50 – 70% 
area stenosis), severe lesions (70 – 99% area stenosis) and total occlusion. If the 
category of luminal loss could not be determined (e.g. due to motion artifact or 
severe calcifications) a segment was categorized as un-evaluable. Subsequently, 
a vessel-based analysis was performed from which diagnostic accuracy on a per-
patient level was determined. Vessels were categorized as normal if all segments were 
evaluable and none had lesions >50% area stenosis. Abnormal vessels (significant 
CAD) were defined as vessels with at least one segment with a lesion of >50% area 
stenosis. Vessels with at least one severe lesion were regarded completely evaluable 
despite any un-evaluable segments. Non-conclusive vessels were defined as vessels 
with at least one un-evaluable segment, without any segments with lesions >50% 
area stenosis. A CCTA was defined non-conclusive if one or more vessels were un-
evaluable and no vessel was abnormal.
invasive coronary angiography
As part of the prospective study, CA and FFR-measurement was performed in all 
patients, including those with normal non-invasive test results. CA was acquired on 
Allura (Philips Medical Systems, Best, The Netherlands) catheterization equipment. 
FFR measurements were obtained from all patients with angiographically estimated 
50-95% obstructive disease. Lesions with <50% obstructive disease (according to the 
interpretation on a consensus basis by two experienced cardiologists) were considered 
normal; no significant CAD 25. Occluded vessels were considered abnormal. Vessels 
with angiographically >95% obstructive disease were considered severely stenotic 
with an FFR <0.80. During FFR measurement distal coronary pressure was measured 
with a pressure guidewire (Certus Wire, Radi Medical Systems, Uppsala, Sweden) 
during maximal hyperemia induced by adenosine intravenously as previously 
described 26. A FFR-measurement <0.80 was defined abnormal and classified as 
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significant CAD. A FFR-measurement >0.80 was defined normal 27, 28. Vessel-based 
analysis was performed from which diagnostic accuracy on a per-patient level was 
determined.
Hybrid SPECT/CCTA imaging analysis
According to our pre-defined protocol all patients were included in hybrid image 
evaluation. Interpretation was performed by two experienced, independent 
physicians blinded for CA and FFR measurements. The integrated interpretation of 
all imaging data led to the categorization of all vessels and patients as normal or 
abnormal. Concordant normal or abnormal SPECT and CCTA findings led to a similar 
interpretation of the hybrid imaging result. Discordant SPECT and CCTA findings 
were interpreted as follows. In patients with normal CCTA and abnormal or non-
conclusive SPECT the hybrid imaging result was defined normal. In patients with non-
conclusive CCTA and normal SPECT the hybrid imaging result was defined normal. 
In patients with non-conclusive CCTA and abnormal SPECT the hybrid imaging 
result was defined abnormal. In patients with abnormal CCTA and normal SPECT, 
CCTA prevailed only in those patients with a definitely abnormal CCTA (Figure 5). In 
patients with abnormal CCTA and non-conclusive SPECT, the hybrid imaging result 
was defined abnormal 4.
Statistical analysis
Statistical analyses were performed with SPSS software (V. 18.0, IBM Corporation, 
Somers, New York, USA). Variables were expressed as mean±standard deviation 
(SD) or median and range, and categorical variables as frequencies and percentages. 
Continuous variables where compared by means of Students T test or Mann-Whitney 
U test where appropriate. Categorical variables were compared by means of the 
Chi-square test. Sensitivity, specificity, negative predictive value (NPV) and positive 
predictive value (PPV) with their 95% confidence intervals (CI) were calculated. A 
p-value of <0.05 was considered statistically significant. 
RESulTS
Study population
Of a total of 143 patients that underwent hybrid imaging, 98 patients with an FFR-
measurement were included in this study. During the first months of this study 
FFR measurement was performed at the discretion of the performing operator. 
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Afterwards the protocol was changed and FFR-measurement was performed in all 
patients. Baseline characteristics from patients excluded from this analysis (mean age 
61.8±10.2 years, 73% male and median pre-test likelihood 87% (range 22-95)) did not 
differ significantly from patients included in the analysis. Complete characteristics of 
the study population are presented in Table 1. In total 32 patients (32.7%) had either 
a non-conclusive SPECT or CCTA (Table 2). 
Table 1.  Characteristics of the patients included in the analysis, n = 98.
Age (years) * 62.5 ± 10.1
Gender, men / women 67 / 31 68.4 / 31.6 %
Risk factors
 Smoking
    Current 26 26.5%
    Past 13 13.3%
 Hypertension 62 63.3%
 Diabetes mellitus 12 12.2%
 Dyslipidaemia 59 60.2%
 Family history of premature atherosclerosis 60 61.2%
Risk factors ≥ 3 44 44.9%
Angina pectoris
 Non-anginal 0 0%
 Atypical 31 31.6%
 Typical 67 68.4%
CCS Angina Class
  Class I 7 7.1%
  Class II 80 81.6%
  Class III 11 11.2%
  Class IV 0 0%
Pre-test likelihood † 0.87 (0.22 – 0.95)
 Low  0 0%
 Intermediate  40 40.8%
 High  53 54.1%
 Unknown ‡ 5 5.1%
Values are shown as number and percentage unless otherwise noted. * Values expressed as 
mean ± standard deviation, † Values expressed as median (range). ‡ Patients with atypical 
angina pectoris and >70 years old. CCS, Canadian Cardiovascular Society.
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Table 2.  Characteristics of the imaging results of all patients, N = 98.
CT Coronary Angiogram
Coronary Calcium Scoring
0 26 26.5%
1 - 400 24 34.7%
>400 38 28.7%
CCS in patients with significant CAD * 497.5 (0 - 3719) 
CCS in patients without significant CAD * 1 (0 - 1966)
CT Coronary Angiography
Intravenous metoprolol prior to CCTA, mg † 13.1±6.1
Heart rate during CCTA, bpm † 59.9±4.8
Non-conclusive CCTA 23 23.5%
   Calcifications 18 18.4%
   Motion artifact 4 4.1%
   Poor contrast opacification 1 1.0%
Myocardial Perfusion SPECT
Exercise stress 82 83.7%
Adenosine stress 16 16.3%
Non-conclusive SPECT 11 11.2%
Non-conclusive SPECT or CCTA 32 32.7%
Conventional Coronary Angiogram with ffR - measurements
No significant CAD § 42 42.9%
1-vessel disease § 15 15.3%
2-vessel disease § 21 21.4%
3-vessel disease or left main stenosis § 20 20.4%
Values are shown as number and percentage unless otherwise noted. * Values expressed as 
median (range), significant CAD according to reference standard of fractional flow reserve (FFR) 
measurements. † Values expressed as mean ± standard deviation. § FFR < 0.80 was defined 
hemodynamically significant. CA, coronary angiography, CAD, coronary artery disease, CCS = 
Coronary Calcium Score, CCTA, CT coronary angiogram, ECG, electrocardiogram, SPECT, single 
photon emission computed tomography. 
invasive coronary angiography including ffR measurements
The CA showed significant CAD in 56 patients (57.1%). FFR-measurements were 
available from all patients with angiographically estimated 50-95% obstructive 
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disease and performed in 225 vessels (57.4%), (Table 2). FFR-measurements were 
positive in 80 vessels (35.6%).
Myocardial perfusion SPECT
Diagnostic accuracy of SPECT in all patients is presented in Figure 2. For this analysis 
non-conclusive scans (n=11) were regarded abnormal. Five of these patients (45%) 
suffered from significant CAD. None of the patients that underwent X-ECG prior to 
stress SPECT (N=82) had an inadequate heart rate response, we either administered 
atropine in these patients (N=28, 29%) or switched to adenosine stress (N=16, 16%). 
No patients with normal perfusion and anginal complaints during stress suffered 
from significant CAD. Out of the 4 patients with positive stress ECG findings (≥2 mm 
ST-segment depression) and normal perfusion, 2 patients suffered from significant 
CAD. 
figure 2. Diagnostic performance of myocardial perfusion SPECT, CT coronary angiography 
(CCTA) and hybrid SPECT/CCTA in all patients (N=98), using a fractional flow reserve 
<0.80 as reference standard. Patients with one or more non-conclusive vessels 
and no definitely abnormal vessels were considered abnormal. Patients with non-
conclusive SPECT results were considered normal. PPV = positive predictive value. 
NPV = negative predictive value.
 Eighty-seven (89%) patients had a conclusive SPECT, 51 (59%) of these 
patients suffered from significant CAD. Diagnostic performance of SPECT in patients 
with conclusive results is presented in Figure 3. 
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 SPECT had a sensitivity of 62% (95%CI 52-70), a specificity of 84% (95%CI 
77-88), a PPV of 70% (95%CI 60-78) and a NPV of 78% (95%CI 72-83) on a per vessel 
basis in all patients. 
figure 3. Diagnostic performance of standalone myocardial perfusion SPECT (SPECT) and 
hybrid SPECT/CCTA in patients with conclusive SPECT studies (N=87). Using a 
fractional flow reserve <0.80 as reference standard. PPV = positive predictive value. 
NPV = negative predictive value.
Coronary computed tomography angiography
Characteristics of CCTA scans are presented in Table 2. Diagnostic accuracy of CCTA 
in all patients is presented in Figure 2. For this analysis non-conclusive scans (n=23) 
were regarded abnormal. The majority of these patients (n= 17, 74%) suffered from 
significant CAD. 
 Seventy-five patients (77%) had a conclusive CCTA, 40 (53%) of these 
patients suffered from significant CAD. Diagnostic performance of CCTA in patients 
with conclusive results is presented in Figure 4. 
 CCTA had a sensitivity of 86% (95%CI 79-91), a specificity of 81% (95%CI 
76-81) a PPV of 67% (95%CI 59-74) and a NPV of 93% (95%CI 89-93) on a per vessel 
basis in all patients.
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figure 4. Diagnostic performance of standalone CT coronary angiography (CCTA) and hybrid 
SPECT/CCTA in patients with conclusive CCTA studies (N=75). Using a fractional 
flow reserve <0.80 as reference standard. PPV = positive predictive value. NPV = 
negative predictive value.
Hybrid SPECT/CCTA imaging
Hybrid SPECT/CCTA in all patients resulted in an improved diagnostic performance 
versus SPECT and CCTA as standalone imaging procedures. PPV of both SPECT (85%) 
and CCTA (77%) significantly improved to 96% (95%CI 88-99) for hybrid imaging 
analysis. NPV of SPECT (89%) improved to 95% (95%CI 84-99) if hybrid SPECT/CCTA 
was applied (Figure 2).  Hybrid imaging analysis of 4 patients still demonstrated 
false positive or false negative results. Both patients with false negative results had 
a largely unevaluable CCTA as a result of high CCS (>1500), in combination with a 
normal (false negative) SPECT. Both patients with false positive results had an un-
evaluable RCA with a small perfusion defect (SDS =2) in the myocardial territory 
subtended by this vessel. An example of the added value of hybrid imaging analysis 
is given in Figure 5.
 In patients with conclusive SPECT results hybrid imaging analysis mainly 
resulted in improved NPV (85%, 95%CI 71-93 vs. 95%, 95%CI 82-98), Figure 3.  A 
significant improvement of PPV (99%, 95%CI 91-100) was shown when hybrid 
imaging analysis was compared to conclusive CCTA results (PPV 81%, 95%CI 68-90), 
Figure 4. 
Hybrid SPECT/CCTA had reliable results in patients with non-conclusive SPECT or 
CCTA results; PPV 91% (95%CI 72-98) and NPV 90% (95%CI 60-98), Figure 6. 
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figure 5.  Example of a discordant hybrid finding with definitely abnormal CCTA and balanced 
ischemia on SPECT. A 61-year-old male with dypnoea during exercise. Hybrid 
imaging with myocardial perfusion SPECT (SPECT) showing normal perfusion (Panel 
A and B hybrid stress- and panel C and D hybrid rest imaging. Orange and white 
colours resemble normal perfusion, purple and blue colors resemble abnormal 
perfusion). CT coronary angiography (CCTA) showed significant left main stenosis 
(LM). With mild stenoses in the RCA and RCx. An intermediate lesion was visible 
in the proximal LAD. Coronary calcium score was 245. Conventional coronary 
angiography confirmed the significant LM stenosis, FFR 0.73. And mild stenosis of 
RCA, LAD and RCx (Panel E and F).
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figure 6. Diagnostic performance of hybrid myocardial perfusion SPECT (SPECT) and CT 
coronary angiography (CCTA) in patients with non-conclusive SPECT or CCTA 
studies (N=32). Using a fractional flow reserve <0.80 as reference standard. PPV = 
positive predictive value. NPV = negative predictive value.
Hybrid SPECT/CCTA had a sensitivity of 67% (95%CI 58-75), a specificity of 95% 
(95%CI 91-97) a PPV of 84% (95%CI 76-90), and a NPV of 87% (95%CI 82-90) on a 
per vessel basis in all patients.
Radiation dose analysis
The effective dose of the CT studies was quantified with a dose–length product 
conversion factor of 0.014 mSv/(mGy x cm) as described 29. Average effective dose 
of the complete CT studies, was 4.3±1.1 mSv. For SPECT the effective dose was 
calculated using a conversion factor of 7.9e-3 mSv/MBq for stress and 9.0e-3 mSv/MBq 
for rest acquisition 30. Average effective dose of SPECT per patient was 6.8±2.4 mSv. 
The calculated average effective dose of CA was 10.8±5.2 mSv, using a conversion 
factor of k = 0.22 for the registered dose area products (DAP). Mean total effective 
dose was 21.9±6.6 mSv per patient.
diSCuSSioN
The main finding of our study is that hybrid SPECT/CCTA has excellent diagnostic 
performance versus a reference standard of FFR measurements. In a patient 
population with a high pre-test likelihood of CAD and high rates of non-conclusive 
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results on either SPECT or CCTA, hybrid imaging analysis results in an improved PPV 
of 96% (versus PPV of 85% and 77% of SPECT and CCTA respectively) and a NPV of 
95% (versus NPV of 89% and 96% of SPECT and CCTA respectively) on a patient level. 
Even in patients with either non-conclusive SPECT or non-conclusive CCTA hybrid 
imaging analysis results in a NPV and PPV of 91% and 90% respectively.
 Current guidelines on hybrid SPECT/CCTA describe its main role in patients 
with an intermediate to high risk of CAD and a non-conclusive result of either 
modality 2. Five studies described the increased diagnostic performance of hybrid 
SPECT/CCTA, with reported sensitivities and specificities ranging from 89%-99% 
and 67-95% respectively for the hybrid technique 15, 18, 31-33. Besides the fact that the 
reference standard in all studies was CA as assessed by visual interpretation of the 
angiogram, these patient populations were limited in several other respects. Rispler 
et. al. evaluated 44 patients suspected to have CAD and scheduled for CA. Patients 
with unevaluable segments on CCTA however, were excluded 15. Gaemperli et. al. 
evaluated 38 patients with at least one fixed or reversible perfusion defect by hybrid 
SPECT/CCTA. Their population resembled a high risk population due to the presence 
of perfusion defects as a mandatory inclusion criterion. CA was not available from 
all patients in this study 32.  Santana et al. performed hybrid SPECT/CCTA imaging 
in 50 patients evaluating its performance in a population with low to intermediate 
pre-test likelihood of CAD. Performance of standalone CCTA in this population was 
not reported. 31. Slomka et. al. retrospectively evaluated automated co-registration, 
visualization and combined quantification of CCTA and SPECT from standalone 
scanners in 35 patients 33. 
 We evaluated the performance of hybrid SPECT/CCTA versus a reference 
standard of FFR measurements in the largest available patient cohort so far. Pre-
test likelihood and diagnostic performance of each non-invasive modality versus the 
reference standard of FFR measurements, were prospectively acquired and available 
from all patients. Coronary calcium score was high in patients with CAD, median 
497.5, resembling a true high risk population. At least one un-evaluable coronary 
segment on CCTA was present in 23.5% of the patients. Including non-conclusive 
SPECT results (11.2%), 33% of patients had either a non-conclusive SPECT or CCTA. 
Obviously, hybrid imaging was most complimentary in patients with a non-conclusive 
test, a false positive result of CCTA and a false negative result of SPECT imaging. 
As demonstrated in this manuscript the strong features of each test as standalone 
procedure compensate for the weaknesses of the other in a hybrid imaging setting. 
This results in an almost perfect diagnosis of the presence or absence of significant 
CAD. 
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 The current study is limited by the fact that FFR was not measured in vessels 
with <50% or >95% obstructive disease. Measurement of these vessels could 
have resulted in improved results. However, based on available literature it is safe 
to assume that vessels with very mild (<50%) and very severe (>95%) obstructive 
disease respectively have normal and positive FFR-measurements 25, 28. The study 
population is relatively small. However, hybrid SPECT/CCTA also had high diagnostic 
accuracy in the excluded patients with only CA as reference standard (N=45). 
Hybrid SPECT/CCTA had a PPV 94% (95%CI 73-99) and NPV 93% (95% CI 77-98) 
versus a reference standard of >50% stenosis on CA. The fact that more patients 
had a non-conclusive CCTA (23%) compared to the number of patients with a non-
conclusive SPECT (11%) could be exemplary for the fact that CCTA is more prone 
to non-conclusive results due to higher CCS in patients with an intermediate- to 
high pre-test likelihood of disease. Hybrid imaging analysis of SPECT and CCTA is 
performed in several directions; both SPECT and CCTA were used as an adjunct to 
the other modality in conclusive and non-conclusive studies. The patient presented 
in Figure 5, could serve as an example in which CCTA proved to be complementary 
to a conclusive SPECT study. An equally compelling example could be found for a 
conclusive CCTA study. This leaves neither anatomical- nor functional imaging to 
trump the other modality and hybrid imaging without a categorical guideline for 
image interpretation. For each patient we chose the optimal stress protocol, either 
adenosine or exercise. However, adenosine stress has a known limited diagnostic 
performance compared to exercise stress. Despite the fact that almost a quarter of 
the patients received adenosine stress, the diagnostic performance of SPECT alone 
in this population is reasonable, and comparable to what has been reported in the 
past 5-7. CCTA has a higher number of unevaluable segments and lower diagnostic 
performance compared to previous reports. This may be explained by the fact that 
patients were not excluded from further CT angiography based on the height of their 
CCS, which led to a high number of unevaluable segments (5.1%) 17. Also, to limit 
the overall radiation dose an axial CT scan protocol without availability of multiple 
cardiac phases was employed, which may have contributed to the lower performance 
of CCTA 10-12, 17.
CoNCluSioN
 The advantage of hybrid imaging lies in the compensation for the weak 
properties of CCTA and SPECT, and the dissolution of non-conclusive results of both 
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as standalone imaging procedures. This advantage is best reflected in a group of 
patients with intermediate to high risk of CAD, as is demonstrated in this study. 
In over 40% of this category of patients, CAD can be reliably excluded due to the 
complementary nature of hybrid SPECT/CCTA.
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AbSTRACT
Aims
Hybrid SPECT/CCTA has only been evaluated for its diagnostic accuracy as a single 
test in patients suspected of significant coronary artery disease (CAD). Added value 
of hybrid SPECT/CCTA beyond usual clinical work-up, or use of each of these tests 
separately, remains unclear. We evaluated the added value of hybrid myocardial 
perfusion SPECT (SPECT) and coronary CT angiography (CCTA), beyond pre-test 
likelihood and exercise stress ECG (X-ECG), in the diagnosis of CAD.
Methods and Results
205 patients with stable angina pectoris and intermediate- to high pre-test likelihood 
were prospectively included. All patients underwent clinical history and examination, 
X-ECG, stress and rest SPECT, coronary calcium scoring (CCS) and CCTA. Fractional 
flow reserve measurement <0.80 or a lesion >50% on coronary angiography (CA) 
served as reference standard for significant CAD. Multiple imputations were used to 
correct for missing test results (17-20%). Added value of hybrid SPECT/CCTA to the 
basic model of pre-test likelihood plus X-ECG was quantified using logistic regression 
analysis. Model differences were then assessed using differences in C-index and 
in net reclassification improvement (NRI). The basic model had a C-index of 0.73 
(95%CI 0.66-0.80). This significantly increased to 0.85 (95%CI 0.80-0.91) by addition 
of only SPECT, to 0.90 (95%CI 0.85-0.94) when adding only CCS and CCTA, and to 
0.96 (95%CI 0.92-0.99) when adding hybrid SPECT/CCTA. The accompanying NRIs 
were 0.82 (95%CI 0.62-1.02), 0.86 (95%CI 0.66–1.06) and 1.57 (95%CI 1.11-1.59) 
respectively.
Conclusion
Current analysis resembles clinical routine of layered testing and shows that hybrid 
SPECT/CCTA imaging has a substantially higher yield than standalone SPECT or CCTA 
in the diagnosis of patients suspected of significant CAD. 
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iNTRoduCTioN
 Patients with a high pre-test likelihood of significant coronary artery disease 
(CAD) have a class 1A indication for invasive coronary angiography (CA) 1. However, 
only 36% of patients referred for CA prove to suffer from significant CAD 2. A reliable 
non-invasive imaging technique that accurately discriminates between the presence 
or absence of significant CAD in these patients would be of great value.
 The work-up of patients with anginal complaints in many outpatient 
clinics routinely starts with exercise stress electrocardiography (X-ECG) 3, 4. Several 
reports describe the use of coronary calcium scoring (CCS) for diagnostic purposes 
in symptomatic patients 5-7. However, according to current guidelines it is not 
recommended to use these tests in intermediate- to high pre-test likelihood patients 
(based on gender, age, clinical history and examination) 1, 7-10. As such, many patients 
are referred for further non-invasive imaging to defer from CA or to exclude high 
risk CAD 1, 3, 4. From all non-invasive imaging modalities, including myocardial 
perfusion single photon emission computed tomography (SPECT), positron emission 
tomography (PET), CT coronary angiography (CCTA), stress echocardiography 
and cardiac MRI, hybrid SPECT or PET/CCTA probably have the highest diagnostic 
yield. Sensitivity and specificity values of 94-96% and 92-100% for the diagnosis of 
significant CAD have been reported 11-17. 
However, hybrid SPECT/CCTA has only been evaluated for its diagnostic 
accuracy as a single test. But in the routine work-up of patients with angina pectoris 
not only the result of the last imaging procedure is taken into account, also clinical 
history, examination and the results of other tests are always considered to decide 
whether or not to perform CA 18. As such, the single test accuracy estimates do not 
indicate whether pre-test likelihood and X-ECG either in combination with standalone 
SPECT, with standalone CCTA, or with hybrid SPECT/CCTA is the best combination of 
diagnostic procedures in these patients. 
 We therefore performed a study to evaluate the added value of hybrid 
SPECT/CCTA imaging beyond pre-test likelihood, X-ECG and standalone SPECT or 
CCTA in patients with an intermediate- to high pre-test likelihood of significant CAD.
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METHodS
Patient population
We prospectively conducted a single center cross-sectional study, in Nieuwegein, The 
Netherlands. Patients with chest pain symptoms and an intermediate to high pre-test 
likelihood of CAD were consecutively recruited for this study from September 2010 
until December 2011. History was taken by physicians and chest pain was categorized 
according to traditional criteria 3, 19-21. Pre-test likelihood was calculated according to 
Diamond and Forrester criteria 19. The boundaries for low, intermediate and high 
pre-test likelihood were set at <20%, 20-80% and > 80% respectively 1, 19. Exclusion 
criteria were a history of surgical revascularization (CABG), stent implantation (PCI), 
an unstable cardiac condition or a cardiac rhythm other than sinus rhythm. The 
study conformed to the principles outlined in the declaration of Helsinki and was 
approved by the local ethics committee. Written informed consent was obtained 
from all patients. Furthermore, the study was conducted and reported in accord with 
STARD guidelines 22.
diagnostic work-up 
At day one of the diagnostic work-up all patients underwent X-ECG or pharmacological 
stress preceding hybrid stress SPECT and CCTA. Within 14 days, on the second 
day of the diagnostic work-up, rest SPECT acquisition and CA with fractional flow 
reserve (FFR) measurements were scheduled (Figure 1). CA and FFR measurements 
served as the reference test for significant CAD (see below). The interpretation of all 
diagnostic tests occurred blinded for all other modalities. Physicians were, however, 
aware of gender, age and clinical history during each test interpretation 23. 
 Prior to the first day of the diagnostic work-up all patients stopped rate 
limiting or anti-anginal medications. Stress SPECT, CCS and CCTA were acquired 
on a Hybrid SPECT-CT system, CardioMD gamma camera and Brilliance 64-slice CT 
scanner (Philips Medical Systems, Best, The Netherlands). The components share a 
common table that is aligned to allow sequential image acquisition. Either X-ECG or 
pharmacological stress (adenosine at standard rate of 0.14mg/kg/min over 6 min) 
were performed prior to stress SPECT acquisition. Inability to perform bicycle stress 
testing or failure to reach 85% of the predicted maximum heart rate was reason to 
switch to pharmacological stress. Directly following stress SPECT acquisition CCS and 
CCTA imaging was performed. All participants presenting with baseline heart rates 
over 60bpm received 100mg oral metoprolol tartrate at the start of the stress test 
preceding SPECT imaging. Patients with an initial heart rate below 60bpm received 
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50mg metoprolol tartrate. Pharmacokinetics of oral metoprolol do not allow for 
an immediate effect that would interfere with X-ECG acquisition. Preceding CCTA 
additional intravenous metoprolol was administered to achieve a heart rate below 
62bpm. In patients with a normal stress SPECT (normal perfusion and gated data) no 
rest SPECT was acquired. Inability to perform acquisition of prospectively triggered 
CCTA (heart rate >62-64bpm) was reason to exclude patients (N=31, 15.1%) from 
the study. For radiation dose saving purposes the study protocol did not allow 
for retrospectively gated CCTA. Mean radiation dose for SPECT was 6.3±2.5MSv 
and mean radiation dose for CCTA was 4.1±2.2MSv. CA and FFR measurements 
were performed in all patients with a completed non-invasive imaging sequence, 
including those with normal non-invasive test results. Mean radiation dose for CA 
was 10.5±4.8MSv.
figure 1: Sequence of diagnostic work-up.
X-ECG, exercise stress electrocardiography. SPECT, myocardial perfusion SPECT. CCS, coronary 
calcium score. CCTA, CT coronary angiography. CA, invasive coronary angiography.
index tests
Exercise stress electrocardiography
Bicycle stress electrocardiography was performed according to a previously 
described stepwise protocol 24. All X-ECG results were reviewed in consensus by two 
experienced physicians blinded for all other diagnostic tests. An abnormal X-ECG 
was defined as ≥0.1mV horizontal shift of the ST segment at 80ms after the J-point 
in three consecutive beats 24, 25. Non-conclusive X-ECG was defined as typical angina 
during stress, >30mmHg decrease in systolic blood pressure, uninterpretable ECG 
as a result of an unstable baseline or inability to reach at least 85% of the predicted 
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heart rate without electrocardiographic evidence of ischemia. Normal X-ECG was 
defined as the absence of any of the aforementioned criteria. The predicted heart 
rate was corrected for length, age and sex, making use of a standardized table 24.
Myocardial perfusion SPECT
SPECT imaging was performed as previously described using a weight-adjusted 
dose of 400-600 MBq of 99mTc-sestamibi 8. Attenuation correction was performed 
for all images using a non-enhanced CT scan. Stress and rest SPECT images were 
interpreted in consensus by two experienced nuclear medicine physicians blinded for 
all other diagnostic tests as previously described 8, 26, 27. In brief, summed stress score 
and summed rest score were calculated after scoring for perfusion defects according 
to a five-point scoring system (0 = normal to 4 = absence of tracer uptake) and a 
17-segment model. Gated data and semi quantitative perfusion data were assessed 
using the QGS/QPS software package (Cedars-Sinai Medical Center, Los Angeles, Ca, 
USA). For the definition of normal, non-conclusive and abnormal myocardial perfusion 
on SPECT according to segmental scores we used the definition provided by Abidov 
et al.26. SPECT with a non-conclusive perfusion score was regarded abnormal.
Coronary computed tomography angiography
CCTA was acquired with a prospectively ECG-triggered scan mode as previously 
described and according to the guidelines provided by the society of cardiovascular 
computed angiography 28. Prior to CCTA, a non-enhanced scan to calculate the CCS 
and determine scan length was performed. CCTA’s were read in consensus by two 
experienced cardiologists blinded for all other diagnostic tests. They categorized 
obstructive severity according to a 16-segment model and 5 categories of luminal 
loss: no CAD (0% area stenosis), mild lesion severity (0 – 50% area stenosis), 
intermediate lesion severity (50 – 70% area stenosis), severe lesions (70 – 99% area 
stenosis) and total occlusion. If the category of luminal loss could not be determined 
(e.g. due to motion artifact or severe calcifications) a segment was categorized as 
non-conclusive. Subsequently a vessel based analysis was performed from which 
diagnostic accuracy on a per-patient level was determined. Vessels were categorized 
as abnormal if at least one segment had a percent diameter stenosis >50%. All non-
conclusive segments were defined abnormal.
Hybrid SPECT/CCTA imaging analysis
According to our pre-defined protocol all patients were included in hybrid imaging 
evaluation. Interpretation was performed in consensus by two independent 
experienced physicians blinded for X-ECG, CA and FFR measurements. The integrated 
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interpretation of all imaging data led to the categorization of all vessels and patients 
as normal or abnormal. Concordant normal or abnormal findings by SPECT and CCTA 
led to a similar interpretation of the hybrid imaging result. In patients with a normal 
CCTA and a discordant abnormal or non-conclusive SPECT, the hybrid imaging result 
was defined normal. In patients with a non-conclusive CCTA, the normal or abnormal 
SPECT result was decisive for the hybrid imaging result. In patients with an abnormal 
CCTA and a discordant normal SPECT, CCTA prevailed only in those patients with a 
definitely abnormal CCTA. In patients with an abnormal CCTA and a discordant non-
conclusive SPECT, the hybrid imaging result was defined abnormal 29.
Reference test: invasive coronary angiography
A FFR measurement <0.80 was defined abnormal and served as the reference test for 
significant CAD. FFR measurements were acquired in 104 patients (61%) of patients 
that underwent CA. All other angiograms were interpreted in consensus by two 
experienced cardiologists for obstructive severity according to a 16-segment model 
similar to the interpretation of CCTA. Interpretation occurred blinded for all other 
diagnostic modalities. They were aware of age, gender and clinical history 23. Lesions 
with >50% obstructive disease were considered abnormal (significant CAD). Vessel-
based analysis was performed from which diagnostic accuracy on a per-patient level 
was determined.
 CA was acquired on Allura catheterization equipment (Philips Medical 
Systems, Best, The Netherlands) via femoral or radial artery access. Biplane views 
were acquired from all major coronary arteries. FFR measurements were performed 
as previously described 30. 
Statistical analysis
First, in accordance with recent methodological recommendations, all missing test 
results in our study were multiply (10 times) imputed using regression techniques 31-
33. Then 4 different logistic regression models were fitted in each of the 10 individual 
imputed datasets and subsequently combined across imputations using Rubin’s Rule 
34, 35, resulting in 4 ‘combined’ models. These ‘combined’ models were then used to 
calculate the added value measures (i.e. AUC and NRI) for each model. To resemble 
routine clinical work-up 36, 37 we first fitted the basic logistic regression model (model 
1) including the pre-test likelihood of CAD plus X-ECG as independent diagnostic 
predictors (index tests) and CAD presence (yes/no) based on CA as outcome. The 
model’s C-index or area under the receiver operating characteristics curve (Roc 
area) was computed. The added value of additional imaging tests (i.e. SPECT, CCS 
plus CCTA and hybrid SPECT/CCTA) beyond the basic model was quantified by 
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consecutively extending the basic model with these tests and assessing the increase 
in C-index. The models of interest are shown in Table 1. We included CCS in the 
model evaluating CCTA, since acquisition of CCS is commonly performed prior 
to CCTA. Furthermore, the number of patients correctly reclassified after adding 
the various imaging modalities to the basic model, was expressed using the net 
reclassification improvement (NRI). This measure, summarizing the reclassification 
table, is calculated by subtracting the proportion of subjects classified worse by the 
new model from the proportion of patients that is better classified by the new model. 
As cut-off values for the reclassification table and related measures, we used three 
common CAD probability categories; low (probability <20%), intermediate (20-80%) 
and high (>80%) for CAD 1, 18, 38. Data were analyzed using R (Version 2·13·1) 39. 
Table 1: models of interest
Model 1: Probability of coronary artery disease (basic model*) =
1/(1+exp-(-2.496 + 0.026*Pre-test likelihood† + 1.014*X-ECG))
Model 2: Probability of coronary artery disease after adding SPECT to Model 1 =
1/(1+exp-(-2.186 + 0.008*Pre-test likelihood† + 0.800*X-ECG + 2.2628*SPECT))
Model 3: Probability of coronary artery disease after CCS and CCTA to Model 1 =
1/(1+exp-(-3.989 + 0.012*Pre-test likelihood† + 1.098*X-ECG + 0.001*CCS + 3.3160*CCTA))
Model 4: Probability of coronary artery disease after adding CCS and hybrid SPECT/
CCTA to Model 1 =
1/(1+exp-(-2.450 – 0.010*Pre-test likelihood + 0.555*X-ECG + 0.001*CCS + 5.393*hybrid 
SPECT/CCTA
Table 1 reports the ‘combined’ logistic regression models 1 to 4, which were first fitted in 
each of the 10 individual imputed datasets and subsequently combined across imputations 
using Rubin’s Rule. * Basic model = Pre-test likelihood + X-ECG. † Pre-test likelihood was 
used as a continues variable in all models.  X-ECG, exercise stress electrocardiography. SPECT, 
myocardial perfusion SPECT. CCS, coronary calcium score. CCTA, CT coronary angiography.
RESulTS
Study population
205 adult patients were included in the study. Patient characteristics are displayed 
in Table 2. 
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diagnostic value of pre-test likelihood and exercise stress electrocardiography 
(Model 1)
In the basic multivariable model for detecting CAD the independent variables were 
pre-test likelihood and X-ECG. Pre-test likelihood alone, used as a continuous 
variable, had a C-index of 0.67 (0.59-0.74). The combination of pre-test likelihood and 
X-ECG (model 1; Table 1) resulted in a C-index of 0.73 (95% CI; 0.66-0.80) (Figure 2).
Added diagnostic value of SPECT, CCS+CCTA, and Hybrid SPECT/CCTA (Models 
2-4)
Adding further imaging techniques, i.e. SPECT, CCS+CCTA and Hybrid SPECT/CCTA 
(models 2-4; Table 1) to the basic model (model 1; Table 1) resulted in a significant 
increase in C-index from 0.73 (95%CI; 0.66-0.80) to 0.85 (0.80 - 0.91), 0.90 (0.85 - 
0.94) and 0.96 (0.92-0.99) respectively (Figure 2).  
figure 2: Areas under the receiver operator characteristics curves for all diagnostic models.
C-index (95% CI)
Model 1: Basic model* (red line) 0.73 (0.66 - 0.80)
Model 2: Basic model + SPECT (blue line) 0.85 (0.80 - 0.91)
Model 3: Basic model + CCS + CCTA (green line) 0.90 (0.85 - 0.94)
Model 4: Basic model + CCS + Hybrid SPECT/CCTA (black line) 0.96 (0.92 - 0.99)
* Basic model = Pre-test likelihood + X-ECG. X-ECG, exercise stress electrocardiography. SPECT, 
myocardial perfusion SPECT. CCS, coronary calcium score. CCTA, CT coronary angiography.
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Table 2: Characteristics of the patients included in the analysis, N = 205
Patient characteristics N (%) Missings (%)
Age (years) * 62.7 ± 9.7 0 (0)
Gender, men / women 127 (62) / 78 (38) 0 (0)
Risk factors 0 (0)
 Smoking
    Current 44 (21)
    Past 35 (17)
 Hypertension 134 (65)
 Diabetes mellitus 35 (17)
 Dyslipidaemia 130 (63)
 Family history of premature atherosclerosis 120 (59)
Risk factors ≥ 3 105 (51)
Angina pectoris 0 (0)
  Non-anginal 1 (1)
  Atypical 67 (33)
  Typical 137 (67)
CaCS Angina Class 0 (0)
  Class I 14 (7)
  Class II 172 (84)
  Class III 19 (9)
  Class IV 0 (0)
Pre-test likelihood † 0.87 (0.22 – 0.95) 0 (0)
  Low  0 (0)
  Intermediate  90 (44)
  High  103 (50)
  Unknown‡ 12 (6)
Exercise stress electrocardiography (N= 158) § 37 (18) §
 Normal 119 (58)
 Abnormal 43 (21)
 Non-conclusive 6 (3)
Coronary Calcium Score (N=204)* 536 ± 800 1(1)
Myocardial perfusion SPECT (N=204) 1 (1)
 Normal 115 (56)
 Abnormal 89 (43)
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Patient characteristics N (%) Missings (%)
CT coronary angiography (N=163) 41 (20)
 Normal 69 (34)
 Abnormal 95 (46)
Hybrid SPECT/CCTA (N=163) 41 (20)
 Normal 91 (44)
 Abnormal 73 (36)
invasive coronary angiography (N=171)  ¶ 34 (17)
 Normal 85 (41)
 Abnormal 86 (42)
Values are shown as number and percentage unless otherwise noted. * Values expressed as 
mean ± standard deviation, † Values expressed as median (range). ‡ Patients with atypical 
angina pectoris and >70 years old. § Adenosine stress was performed in 37 (18%) patients 
prior to stress SPECT acquisition. ¶ Of 7 patients without a completed non-invasive imaging 
sequence invasive coronary angiography was acquired with a clinical indication. CaCS, 
Canadian Cardiovascular Society.
Reclassification by Hybrid SPECT/CCTA
Using the basic model (Model 1), the estimated probability of CAD was calculated 
for each patient. Of the patients with a low estimated probability of CAD (<20%, 
n=16), 13 did not have significant CAD (negative predictive value; NPV 81%) (Table 
3). In those with a high predicted probability (>80%, n=13), 8 had significant CAD 
(positive predictive value; PPV 62%), Table 3. Adding Hybrid SPECT/CCTA (Model 4) 
increased the number of patients with estimated low probability from 16 to 107, of 
whom 101 did not have significant CAD (NPV 94%). The number of high probability 
patients increased from 13 to 97, of whom 91 indeed had significant CAD (PPV 94%). 
Addition of Hybrid SPECT/CCTA did not change the estimated probability class (low, 
intermediate or high) in 22 patients (11%). Hybrid SPECT/CCTA correctly increased 
the estimated diagnostic probability in 83 patients with CAD, and 89 patients without 
CAD were correctly reclassified to lower probability groups. 5 patients with CAD 
were incorrectly reclassified to lower probability groups and 6 patients without CAD 
were incorrectly reclassified to higher probability groups (Table 3). The imaging 
characteristics of these patients who were incorrectly reclassified, were a very 
challenging CCTA (CCS >800 or motion artifacts) in combination with either a false 
positive or false negative SPECT (n=5), discordant SPECT and CCTA findings (n=3), or 
an unavailable reference test (n=3). The NRI for the addition of hybrid SPECT/CCTA 
was therefore 1.57 (95%CI; 1.31 - 1.83) (Table 3). The NRI for the addition of SPECT or 
CCS+CCTA was 0.82 (0.62-1.02) and 0.86 (0.66 – 1.06) respectively.
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Table 3: Reclassification table according to low (<20%), intermediate (20-80%) and high 
probability (>80%) groups: basic model (model 1) versus hybrid SPECT/CCTA 
(model 4).
Model 4: Basic model*  + Hybrid SPECT/CCTA
Model 1: Basic model*
Patients with CAD
Probability group for CAD <20% 20-80% >80% Total
<20% 1 0 2 3
20-80% 5 0 81 86
>80% 0 0 8 8
Total 6 0 91 97
Patients without CAD
Probability group for CAD <20% 20-80% >80% Total
<20% 13 0 0 13
20-80% 84 0 6 90
>80% 4 1 0 5
Total 101 1 6 108
Reclassification improvement is 0.80 among patients with CAD (83-5 of 97) and 0.77 
among patients without CAD (89-6 of 108), resulting in a net reclassification improvement 
of 0.80+0.77=1.57 (95% CI; 1.11-1.59). * Basic model = Pre-test likelihood + X-ECG. X-ECG, 
exercise stress electrocardiography. SPECT, myocardial perfusion SPECT. CCS, coronary 
calcium score. CCTA, CT coronary angiography. CAD, coronary artery disease. Grey shaded 
numbers are patients classified in agreement according to the model with and without hybrid 
SPECT/CT.
diSCuSSioN
This study shows that in the clinical work-up of patients with an intermediate to high 
pre-test likelihood, addition of hybrid SPECT/CCTA imaging analysis yields the most 
accurate diagnosis of the presence or absence of significant CAD (C-index 0.96). 
Further, addition of hybrid SPECT/CCTA to pretest information and X-ECG better 
reclassifies patients when compared to addition of only SPECT or CCTA (NRI of 1.57 
vs. 0.82 and 0.86 respectively). 
 Non-invasive tests beyond pre-test likelihoods are needed to correctly 
reclassify patients from high probability to low probability and thus correctly defer 
them from CA, since the clinical reality is that only 36% of patients referred for CA 
prove to suffer from significant CAD 1, 2. In the subset of patients with an intermediate 
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to high pre-test likelihood of CAD, the routinely performed X-ECG or CCS alone 
are not sufficient to provide adequate discrimination between patients with and 
without CAD 7-9. This is also demonstrated in the current study (C-index of 0.73 and 
0.75 respectively vs. pre-test likelihood alone with a C-index of 0.67. Performance 
of standalone SPECT or CCTA in addition to the aforementioned tests seems much 
more accurate (C-index of 0.85 and 0.90 respectively). However, available literature 
describes a limited diagnostic accuracy of SPECT or CCTA in high pre-test likelihood 
patients 40-42. The high negative predictive value of CCTA could be challenged due 
to increased amount of coronary calcifications in high pre-test likelihood patients 
43, 44. Diagnostic performance of SPECT in these patients is known to be limited, due 
to a given amount of non-conclusive SPECT results due to small perfusion defects, 
inadequate heart rate response or discrepant clinical data (anginal complaints 
during stress or positive X-ECG result) 45. The advantage of hybrid imaging lies in the 
compensation for the weak properties of CCTA and SPECT, and the dissolution of non-
conclusive results of both as standalone imaging procedures. As such, to overcome 
the diagnostic uncertainty in high pre-test likelihood patients and in patients with 
non-conclusive imaging results, hybrid SPECT/CCTA has been proposed 11, 12, 29, 46. 
The yet available studies show that when used in isolation this test has a 
very promising diagnostic value with a sensitivity 89%-99% and specificity of 67-
95% 11-15. The current study not only confirms this finding, but more importantly 
proofs that hybrid SPECT/CCTA has added value over standalone SPECT or CCTA in 
a high pre-test likelihood population. As such hybrid imaging is specifically relevant 
for the subset of patients with continued diagnostic uncertainty despite conclusive 
imaging results or patients with non-conclusive imaging results per se. And it has the 
potential to guide decisions on the necessity of revascularization 47.
Several limitations to our study should be acknowledged. Recent reports 
have shown that the model we used to calculate pre-test likelihood CAD (Diamond 
and Forrester) heavily overestimates the presence of CAD 48, 49. The presence of a 
non-sinusal heart rhythm was an exclusion criterion for our study; in clinical practice 
this could constitute a considerable number of patients. We had missing test results 
and are well aware of the fact that missing data rarely occur completely at random 
and may therefore hamper the results. However, the number of missing data was 
limited and we used multiple imputations to alleviate the problem of missing test 
results. FFR measurements were available in 61% of patients that underwent CA, 
whereas for the remainder we used an anatomical reference test (>50% obstructive 
disease as diagnostic for significant CAD), which is known to be imperfect. According 
to available literature it is safe to assume that lesions with <50% stenosis have no 
hemodynamic significance 50. FFR-measurements were available from 78% of patients 
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with angiographically 50-70% and 68% of patients with 70-95% obstructive disease. 
We chose a boundary of 20-80% for an intermediate probability of significant CAD; 
this is supported by available literature 1. However, boundaries of 10-90% or 15-85% 
are also commonly used. According to our analysis a boundary of 10-90% would 
leave 24 patients (12%) and a boundary of 15-85% would leave 1 patient (0.5%) 
with and without CAD in the intermediate group after hybrid SPECT/CCTA imaging 
analysis versus 1 patient (0.5%) if a boundary of 20-80% was used for intermediate 
probability. The NRI of 1.57 for the addition of hybrid SPECT/CCTA is indeed very high. 
In part, this is explained by the fact that these models include imaging modalities 
that evaluate the same characteristics of coronary artery disease. Also, this high value 
occurs as a result of the chosen probability thresholds of 20% and 80%, 176 of 205 
patients (86%) are estimated to have an intermediate probability using the basic 
model (pre-test likelihood and X-ECG). The extended model is far better in predicting 
low probability (<20%) and high probability (>80%) patients, thus leading to a high 
NRI. Healthcare policies advocate a stepwise imaging protocol in the diagnostic 
work-up of patients, for radiation dose saving purposes and a cost effective use of 
diagnostic modalities. As such, a hybrid imaging approach should not be the primary 
imaging strategy for all patients presenting with angina pectoris.
CoNCluSioNS
Our study is the first to demonstrate the added diagnostic value of the complementary 
nature of hybrid SPECT/CCTA imaging. With an analysis resembling clinical routine 
of layered testing, the impressive diagnostic accuracy of hybrid SPECT/CCTA beyond 
X-ECG and SPECT or CCTA is demonstrated in intermediate to high pre-test likelihood 
patients. We show that these patients can be accurately reclassified into low- or high 
probability groups of CAD, as such deferring them from CA and probably indicate 
revascularization.
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AbSTRACT
objectives 
To evaluate to what extent treatment decisions for patients with stable angina 
pectoris can be made based on hybrid myocardial perfusion SPECT (SPECT) and 
CT Coronary Angiography (CCTA). It has been shown that hybrid SPECT/CCTA has 
good performance in the diagnosis of significant coronary artery disease (CAD). The 
question remains whether these imaging results lead to similar treatment decisions 
as compared to standalone SPECT and invasive coronary angiography (CA).
design 
We prospectively included 107 patients (mean age 62.8±10.0 years, 69% male) with 
stable anginal complaints and an intermediate to high pre-test likelihood for CAD. 
Hybrid SPECT/CCTA was performed prior to CA in all patients. 
Main outcome measures 
The study outcome was the treatment decision categorized as: no revascularization, 
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). 
These treatment decisions were made by a panel of two interventional cardiologists 
and one cardio-thoracic surgeon in two steps: first based on the results of hybrid 
SPECT/CCTA, and on a second occasion based on SPECT and CA. Percent agreement 
of treatment decisions based on both diagnostic strategies were calculated in all 
patients, including patients with matched, unmatched and normal hybrid SPECT/
CCTA findings.
Results 
Revascularization (PCI or CABG) was indicated in 54 (50%) patients based on SPECT 
and CA. Percent agreement of treatment decisions in all patients based on hybrid 
SPECT/CCTA versus SPECT and CA on the necessity of revascularization was 92%. 
Percent agreement of treatment decisions in patients with matched, unmatched and 
normal hybrid SPECT/CCTA findings was 95%, 84% and 100% respectively.
Conclusions 
Panel evaluation shows that patients could be accurately indicated for and deferred 
from revascularization based on hybrid SPECT/CCTA.
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iNTRoduCTioN
Current guidelines on the management of patients with stable chest pain syndromes 
recommend revascularization in patients with persistent limiting symptoms, high 
risk anatomy, or significant ischemic territory (>10% of the myocardium) 1, 2. Since 
intervention of functionally irrelevant lesions is associated with the risks but not the 
benefits of revascularization, preferably (non-)invasive evidence of the functional 
significance of each lesion is available 1, 3, 4. As such, myocardial perfusion imaging 
with single-photon emission computed tomography (SPECT) has been suggested 
as a non-invasive gatekeeper for invasive coronary angiography (CA) 5, 6. Also, with 
the advent of CT coronary angiography (CCTA), reliable non-invasive anatomical 
information on the coronary arteries can now be obtained 7. Like CA however, 
standalone CCTA lacks functional information on lesion severity and thereby is 
unsuitable for therapeutic decision making 8, 9.The availability of hybrid SPECT/CCTA 
as anatomical and functional imaging technique generated the interest in non-
invasive imaging as a tool to guide therapeutic decision making, e.g. to decide on 
necessity of revascularization or even the choice of the method of revascularization 
10-13.
 Hybrid SPECT/CCTA has good diagnostic performance in patients who are 
evaluated for the presence of coronary artery disease (CAD) when compared to CA 
10, 11, 14-16. The value of hybrid imaging lies not only in the correlation of perfusion 
abnormalities on SPECT with coronary stenosis on CCTA. Rather, complimentary 
results of hybrid imaging may compensate for the respective diagnostic pitfalls of 
each technique as stand-alone imaging procedure 10, 17. Recently, prognosis and effect 
on choice of treatment strategy in subgroups of patients with matched, unmatched 
and normal hybrid SPECT/CCTA findings have been analyzed 12, 13. However, a direct 
comparison of the effect of hybrid SPECT/CCTA versus traditional work-up using 
SPECT and CA on the choice of treatment strategy is lacking. 
 For several decades, cardiologists and cardio-thoracic surgeons have been 
meeting in “heart- teams” to decide on the necessity of coronary revascularization 
based on CA and (non-) invasive evidence of myocardial ischemia 1, 2. With the 
demonstrated reliability of hybrid SPECT/CCTA we hypothesized that in a similar 
setting, treatment decisions can be made for patients with stable angina pectoris 
using hybrid SPECT/CCTA just as good as with SPECT and CA. Also, we evaluated 
the reliability of these treatment decisions in groups of patients with matched, 
unmatched and normal hybrid SPECT/CCTA findings. 
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METHodS
Patient population
Patients with an intermediate to high pre-test likelihood of CAD were prospectively 
enrolled in this study from September 2010 until December 2011. Pre-test likelihood 
was calculated according to Diamond and Forrester criteria 18. Exclusion criteria were 
a history of surgical revascularization (CABG), stent implantation (PCI), an unstable 
cardiac condition or a cardiac rhythm other than sinus rhythm. After acquisition 
of all imaging data each case was evaluated during a routine heart team meeting. 
Additionally, as we discuss below in more detail, a panel evaluation took place on a 
separate occasion. The study conformed to the principles outlined in the declaration 
of Helsinki and was approved by the local ethics committee. Written informed 
consent was obtained from all patients.
imaging procedure and interpretation
Gated SPECT and CCTA data were acquired on a hybrid SPECT/CT system, CardioMD 
gamma camera and Brilliance 64-slice CT scanner (Philips Medical Systems, Best, The 
Netherlands). On the first imaging day stress SPECT and CCTA data were acquired. 
Patients started with exercise (82 patients, 77%) or pharmacological (25 patients, 
23%) stress after which stress SPECT was acquired. For stress and rest SPECT a weight 
adjusted dose of 400-600MBq 99mTc-sestamibi was used. Attenuation correction was 
performed on all images using a non-enhanced CT scan. Directly following stress 
SPECT acquisition, all patients underwent prospectively ECG-triggered axial CCTA 
according to the guidelines provided by de society of cardiovascular computed 
angiography 19. All participants presenting with baseline heart rates over 60 bpm 
received 100mg oral metoprolol tartrate at the start of the stress test preceding SPECT 
imaging. Patients with an initial heart rate below 60 bpm received 50mg metoprolol 
tartrate. CA was scheduled within 14 days from the first image acquisition, preceded 
by rest SPECT image acquisition on the same day, only in those patients with an 
abnormal stress SPECT. As part of the prospective study, CA was performed in all 
patients, including those with normal non-invasive test results. CA was acquired on 
Allura (Philips Medical Systems, Best, The Netherlands) catheterization equipment via 
femoral or radial artery access. Biplane views were acquired from all major coronary 
arteries. Fractional flow reserve measurements (FFR) were performed at discretion of 
the performing operator and available in 72 (67%) patients. 
 Hybrid SPECT/CCTA data were interpreted with regard to functional relevance 
of coronary stenosis, in consensus by two experienced physicians blinded for other 
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imaging procedures using dedicated software (Intellispace Portal 5.0, Philips, Best, 
The Netherlands). Stress and rest SPECT images were interpreted as previously 
described according to a 17-segment model and scored for perfusion defects using 
a five-point scoring system (0 = normal to 4 = absence of tracer uptake) 20-22. CCTA 
images were read according to a 16-segment model and 5 categories of luminal loss: 
no CAD (0% luminal loss), mild lesion severity (luminal loss 0 – 50%), intermediate 
lesion severity (luminal loss 50 – 70%), severe lesions (luminal loss 70 – 99%) and 
total occlusion. Significant disease was defined as the presence of >50% luminal loss 
on CCTA. 
 Similar to a previous study on the impact of hybrid SPECT/CCTA on choice 
of treatment strategy 12, we assessed the panel decisions and the frequency of 
revascularization in patients with normal, unmatched and matched hybrid imaging 
findings. A matched hybrid finding was defined as a reversible defect on SPECT in a 
myocardial territory subtended by a stenotic coronary artery with a lesion exceeding 
50% luminal loss. An ischemic finding on SPECT was defined as a SDS of ≥1 in a 
myocardial territory corresponding to one supplying coronary artery. An unmatched 
hybrid finding was defined as an ischemic SPECT finding without a lesion >50% 
luminal loss in the corresponding coronary artery, or as a lesion >50% luminal loss 
in a coronary artery on CCTA, without an ischemic finding in the corresponding 
myocardial territory on SPECT. If no stenosis was present on CCTA and SPECT 
was normal, the hybrid finding was regarded normal. Subsequently, patients were 
assigned to one of the following three categories: matched-, unmatched or normal 
hybrid SPECT/CCTA finding.
Panel evaluation
To quantify the percent agreement of treatment decisions between the new work-
up including hybrid SPECT/CCTA imaging and the traditional diagnostic work-up 
using SPECT and CA, a design of two panel evaluations was chosen (Figure 1). The 
treatment decision consisted of three categories: no revascularization, PCI or CABG. 
The panel consisted of one cardio-thoracic surgeon (TdK) and two interventional 
cardiologists (BR and JVdH). First, the panel decided on the choice of treatment 
based on hybrid SPECT/CCTA findings. These sessions consisted of the evaluation 
of all available images and were chaired by two experienced readers (JS and FV). 
The choice for revascularisation was made in the presence of clear significant CAD, 
which could be an unmatched or matched hybrid SPECT/CCTA finding (Figures 
2 and 3). All panel members were unaware of the CA results. Secondly, on a next 
occasion with a time frame of at least 4 weeks, treatment decisions were based on 
the evaluation of SPECT and CA images, which served as the reference method. The 
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choice for revascularization was made in the presence of significant disease defined 
as a >50% luminal loss on CA with evidence of myocardial ischemia (FFR <0.80 or 
ischemic SPECT findings). During both sessions the panel members were supplied 
with anonymous baseline clinical characteristics of the patient; medical history, 
medication use, clinical symptoms, physical examination, risk factors and baseline 
ECG. Also the results of exercise stress ECGs were disclosed when available, prior to 
evaluation of the imaging data.
 
figure 1  Panel design. The panel first decided on the treatment strategy after evaluation of 
hybrid single photon emission computed tomography (SPECT) and CT coronary 
angiography (CCTA) images. Treatment decisions were made according to three 
categories. 1. No revascularization, 2. Percutaneous coronary intervention (PCI) and 
3. Coronary artery bypass surgery (CABG).
figure 2  A 66 year-old female patient with typical anginal complaints and normal myocardial 
perfusion on SPECT (Panel A, stress SPECT). However, CCTA revealed severe stenosis 
of the circumflex artery (Panel B), which was confirmed by CA (Panel C). Based on 
evaluation of both hybrid SPECT/CCTA and SPECT and CA the panel decided on 
percutaneous coronary intervention.
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figure 3  A 71 year-old male patient with typical anginal complaints and a severe reversible 
perfusion defect anterior and apical on SPECT (Panel A, stress SPECT). CCTA was 
largely unevaluable due to severe coronary calcifications (CCS of 2279). Although 
a severe stenosis in the proximal left anterior descending (LAD) artery could be 
suspected (Panel B). The presence of a significant stenosis in the proximal LAD was 
confirmed by invasive coronary angiogram (CA) (Panel C). Based on evaluation of 
both hybrid SPECT/CCTA and SPECT and CA the panel decided on percutaneous 
coronary intervention.
Statistical analysis
The primary outcome was defined as the percent agreement on the necessity of 
revascularization (no revascularization versus revascularization) between the new 
diagnostic strategy using hybrid SPECT/CCTA versus conventional SPECT and CA. 
Secondary outcome was defined as the percent agreement of decisions on the method 
of revascularization, PCI versus CABG, in patients referred for revascularization based 
on hybrid SPECT/CCTA. Primary and secondary outcomes were calculated for all 
patients combined and for the subgroups of patients with matched, unmatched and 
normal hybrid SPECT/CCTA findings. The Chi-square test was used to compare rates 
of indicated revascularizations based on SPECT and CA in the three patient groups 
with matched, unmatched and normal hybrid SPECT/CCTA findings. A p-value of 
<0.05 was considered statistically significant. Statistical analyses were performed 
with SPSS software (V. 18.0, IBM Corporation, Somers, New York, USA). 
RESulTS
Study population
In total 107 patients (mean age 62.8±10.0 years, 69% male) with stable anginal 
complaints and median pre-test likelihood of CAD of 87% (range 22-95%) were 
included. Complete characteristics of the study population are shown in Table 1. 
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Hybrid SPECT/CCTA imaging findings
SPECT revealed reversible perfusion defects in myocardial segments subtended by 
one coronary artery in 61 (57%) patients. At least one stenosis of >50% in a coronary 
segment on CCTA was observed in 63 patients (59%). 40 patients (37%) showed at 
least one matched SPECT and CCTA finding, only unmatched findings were present 
in 44 patients (41%), and normal findings on both SPECT and CCTA in the remainder.
Radiation dose analysis
Average effective dose of CCTA was 4.2±1.0 mSv 23. Average effective dose of SPECT 
was 6.8±2.4 mSv 24. This brings the average effective dose for hybrid SPECT/CCTA 
on 11.1±2.8 mSv. The average effective dose of CA was 10.5±4.9 mSv 24. Mean total 
effective dose was 21.7±6.4 mSv per patient.
Treatment decisions in all patients
The overall percent agreement of treatment decisions based on hybrid SPECT/CCTA 
versus SPECT and CA was 92% (95% CI; 85-96) for the primary outcome measure (No 
revascularization versus revascularization) (Table 2A). Overall percent agreement for 
the secondary outcome measure on method of revascularization (PCI versus CABG) 
was 74% (95% CI; 60-84) (Table 2B).
 The percentage of patients with matched, unmatched and normal hybrid 
findings indicated for revascularization based on SPECT and CA is presented in Figure 4.
Treatment decisions in patients with matched hybrid SPECT/CCTA findings
In patients with matched findings on SPECT and CCTA the overall percent agreement 
of decisions based on hybrid SPECT/CCTA versus SPECT and CA was 95% (95% CI; 
83-99) for the primary outcome measure (Table 3A). Two patients with a matched 
hybrid SPECT/CCTA result were indicated for PCI based on the hybrid findings and 
optimal medical treatment based on SPECT and CA. One patient had a difficultly 
interpretable CCTA (CCS 877) and ischemia on SPECT (SDS of 6) that turned out to 
be a false-positive finding. 
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Table 1  Characteristics of the patients included in the analysis, n = 107
Age (years) * 62.8 ± 10.0
Gender, men / women 74 / 33 69.2 / 30.8 %
Risk factors
 Smoking
    Current 24 22.4%
    Past 19 17.8%
 Hypertension 68 63.6%
 Diabetes mellitus 18 16.8%
 Dyslipidaemia 72 67.3%
 Family history of premature 
atherosclerosis 65 60.7%
Risk factors ≥ 3 55 51.4%
Angina pectoris
 Non-anginal 1 0.9%
 Atypical 33 30.8%
 Typical 73 68.2%
CaCS Angina Class
  Class I 5 4.7%
  Class II 90 84.1%
  Class III 12 11.2%
  Class IV 0 0.0%
Pre-test likelihood † 0.87 (0.22 – 0.95)
 Low  0 0.0%
 Intermediate  46 43.0%
 High  56 52.3%
 Unknown  5 4.7%
Values are shown as number and percentage unless otherwise noted. * Values expressed 
as mean ± standard deviation, † Values expressed as median (range). CaCS = Canadian 
Cardiovascular Society.
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The second patient showed total occlusion of the proximal RCA both on CCTA and 
CA. Based on hybrid SPECT/CCTA the panel opted for PCI, however based on CA this 
segment was regarded as unsuitable for revascularization. 
The percent agreement for the used method of revascularization, PCI or CABG, in 
patients with matched findings was 72% (95% CI; 56-84) (Table 3B).
figure 4  Frequency of revascularization as indicated by the panel based on SPECT and CA 
in patients with normal, unmatched and matched hybrid SPECT/CCTA findings was 
significantly different (P < 0.001 by Chi-square test).
Table 2  Treatment decisions for all patients. categorized for the necessity of revascularization.
A. Treatment decisions categorized for necessity of revascularization (N = 107).
SPECT and CA Percent Agreement
Revascularization No Revascularization
Hybrid 
SPECT/
CCTA
Revascularization 50 5
No Revascularization 4 48 92%
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b. Treatment decisions on type of revascularization (N = 50).
SPECT and CA Percent Agreement
PCI CABG
Hybrid 
SPECT/
CCTA
PCI 18 10
CABG 3 19 74%
Agreement tables for panel decisions based on hybrid SPECT/CCTA and SPECT and CA in all 
patients. Panel A. Decisions on the necessity of revascularization (no revascularization versus 
PCI or CABG) in all patients. Percent agreement was 92% (95% CI; 85-96). 
Panel b. Decisions on the type of revascularization (PCI versus CABG) in the group of patients 
indicated for revascularization based on hybrid SPECT/CCTA. Percent was 74% (95% CI; 60-84).
Table 3.  Treatment decisions for patients with matched, unmatched and normal findings by 
hybrid SPECT/CCTA
A. Treatment decisions on necessity of revascularization.
Matched hybrid SPECT/CCTA (N = 40)
SPECT and CA Percent Agreement
Revascularization No Revascularization
Hybrid 
SPECT/
CCTA
Revascularization 36 2
No Revascularization 0 2 95%
unmatched hybrid SPECT/CCTA (N = 44)
Revascularization No Revascularization
Hybrid 
SPECT/
CCTA
Revascularization 14 3
No Revascularization 4 23 84%
Normal hybrid SPECT/CCTA (N = 23)
Revascularization No Revascularization
Hybrid 
SPECT/
CCTA
Revascularization 0 0
No Revascularization 0 23 100%
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b. Treatment decisions on type of revascularization.
Matched hybrid SPECT/CCTA (N = 36)
SPECT and CA Percent Agreement
PCI CABG
Hybrid 
SPECT/
CCTA
PCI 11 8
CABG 2 15 72%
unmatched hybrid SPECT/CCTA (N = 14)
PCI CABG
Hybrid 
SPECT/
CCTA
PCI 7 2
CABG 1 4 79%
Normal hybrid SPECT/CCTA (N = 0)
PCI CABG
Hybrid 
SPECT/
CCTA
PCI 0 0
CABG 0 0 N.A.
Agreement tables for panel decisions based on hybrid SPECT/CCTA versus SPECT and CA. In 
patients with matched, unmatched and normal findings by hybrid SPECT/CCTA.
Panel A. Decisions on the necessity of revascularization (no revascularization versus PCI or 
CABG). Percent agreement in the matched, unmatched and normal group was 95% (95% CI; 
83-99), 84% (95% CI; 71-92) and 100% (95% CI; 86-100) respectively.
Panel b. Decisions on the type of revascularization (PCI versus CABG) in the group of patients 
indicated for revascularization based on hybrid SPECT/CCTA. Percent agreement in the 
matched, unmatched and normal group was 72% (95% CI; 56-84), 79.0% (95% CI; 52-92) and 
not available (N.A.) respectively.
Treatment decisions in patients with unmatched hybrid SPECT/CCTA findings
In patients with unmatched findings on SPECT and CCTA the overall percent 
agreement of decisions based on hybrid SPECT/CCTA versus SPECT and CA was 84% 
(95% CI; 71-92). (Table 3A)
 All three patients that would have been treated with PCI based on hybrid 
findings had challenging CCTA’s; two as a result of high CCS and one with a motion 
artefact. Of four cases that would have been treated conservatively based on hybrid 
SPECT/CCTA and revascularized based on SPECT and CA, three patients showed 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
111
1
3
4
5
6
7
8
9
10
11
2
Hybrid myocardial perfusion SPECT/CCTA and invasive coronary angiography in patients with stable 
angina pectoris lead to similar treatment decisions
a normal SPECT probably as a result of balanced ischemia. The fourth patient 
suffered from very diffuse CAD resulting in very small coronary arteries, as such 
revascularization for this patient was almost impossible despite severe ischemia on 
SPECT (SDS = 11). The panel gave this patient the benefit of the doubt indicating him 
for PCI based on SPECT and CA. 
The overall percent agreement for the used method of revascularization, PCI or 
CABG, in patients with unmatched findings was 79% (95% CI; 52-92) (Table 3B).
Treatment decisions in patients with normal hybrid SPECT/CCTA findings
No patients with normal non-invasive imaging findings were proven to suffer from 
significant CAD (N=23). As such panel decisions based on hybrid SPECT/CCTA 
findings were in complete agreement with decisions made based on SPECT and CA 
(Table 3A and B).
diSCuSSioN
The current study is the first to show that similar treatment decisions can be made 
by a non-invasive workup using hybrid SPECT/CCTA when compared to a traditional 
work up using SPECT and CA. Our primary outcome measure evaluating decisions on 
the necessity of revascularization showed a high overall agreement (92%). Our unique 
study design of panel decisions on treatment strategy resembles the routine work-up 
of patients in so-called heart team meetings. As such it allows for conclusions on the 
clinical value in therapeutic decision making of this imaging procedure compared to 
the conventional imaging procedure including CA commonly used in clinical practice. 
 Specific attention should be paid to patients with unmatched hybrid SPECT/
CCTA findings. Compared to the percent agreement on treatment decisions in the 
matched and normal group (95% and 100% respectively) the percent agreement of 
84% in this group was low. Unmatched findings predominantly arise in patients with 
minor ischemic findings on SPECT. In these patients the high negative predictive 
value of CCTA should be of added value 25. Conversely, only in patients with definite 
high grade stenosis on CCTA, normal or equivocal SPECT findings could be overruled. 
As such, the combination of a negative or equivocal SPECT and a non-conclusive 
CCTA (e.g. 50-70% luminal loss or high CCS) will remain most problematic. In these 
instances possible high risk CAD (e.g. left main or proximal LAD disease on CCTA) 
should be treated with great caution when evaluated on the basis of hybrid SPECT/
CCTA alone. These patients should be referred for CA. Further research should 
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explore how to reduce the incidence of unmatched hybrid SPECT/CCTA findings.
 The incremental value of hybrid SPECT/CCTA in the assessment of 
the prognosis and impact on choice of treatment strategy in patients under the 
evaluation of CAD has been described recently 12, 13. The authors demonstrated an 
increased incidence of revascularization procedures and adverse cardiac events 
in patients with matched abnormalities on SPECT and CCTA versus patients with 
unmatched abnormalities or normal scans. They described a patient population with 
an intermediate pre-test likelihood of CAD referred for hybrid SPECT/CCTA imaging. 
CA data were not available from all patients. Reasons for referral to or deference from 
CA were not described. A significantly lower number of revascularization procedures 
was observed in the group of patients with unmatched findings compared to the 
group of patients with a matched perfusion defect and anatomic abnormality on 
CCTA. These findings are consistent with our results. However, for a technique 
with excellent diagnostic performance it could be argued that the percentage of 
revascularization procedures, 41%, in the matched group is rather low. According to 
our analysis in the group of patients with matched findings on SPECT and CCTA the 
revascularization rate is high, up to 90%. Despite the different characteristics of our 
patient population, the reason for this difference remains unexplained. This should 
lead to further comparison of the results of hybrid SPECT/CCTA.
 Several limitations to our study should be acknowledged. The panel of two 
cardiologists and one thoracic surgeon are very experienced members of routine 
clinical heart teams, but less experienced with making treatment decisions based 
on hybrid SPECT/CCTA imaging. The performance of SPECT or CCTA as stand 
alone procedure in the process of clinical decision making was not addressed in 
this analysis. It is reasonable to assume that in patients with normal findings on 
standalone SPECT or CCTA the decisions would be in high agreement with decisions 
based on SPECT and CA. We chose an SDS ≥1 in myocardial territory subtended by 
one coronary artery as threshold for significant ischemia on SPECT when evaluating 
the three groups of matched, unmatched and normal findings by SPECT and CCTA. 
This threshold is lower and different from the chosen threshold by Pazhenkottil 
et al. 12, 13. In our opinion a threshold of a SSS ≥4 with a SRS ≤1 is correct for a 
patient based analysis. However, since matching of a reversible perfusion defect and 
its anatomical substrate is performed at a per vessel level a different threshold is 
needed. We chose the lowest possible level for reversible perfusion defect to match 
with coronary stenosis on CCTA. This could cause high numbers of false positive 
results and subsequently unnecessary referral for revascularization. However, this 
is not reflected in our analysis; a high percentage of patients with matched hybrid 
SPECT/CCTA findings was referred for revascularization based on SPECT and CA. 
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Current healthcare policies advocate a stepwise imaging protocol in the diagnostic 
work-up of patients, for radiation dose saving purposes and a cost effective use of 
diagnostic modalities. As such, a hybrid imaging approach should not be the primary 
imaging strategy for all patients presenting with angina pectoris. Patients with 
non-conclusive SPECT or CCTA results could be referred for either CCTA or SPECT 
respectively. Subsequent hybrid depiction of coronary anatomy and myocardial 
perfusion should lead to an adequate therapeutic decision, which is demonstrated 
by the current report. However, it is to be expected that only in very specific cases 
the surgeon will plan surgery solely based on these non-invasive imaging data 17. 
Scientific proof that reliable depiction of functional relevance of CAD is feasible 
with CT myocardial perfusion imaging is growing 26-28. The availability of anatomic 
and functional information on CAD from one imaging modality obviously has great 
advantages. Data on clinical benefit of hybrid SPECT/CCTA cannot be obtained 
from this patient subset since actual therapy was instituted after routine heart team 
evaluation of all clinical cases after acquisition of the CA. Randomization to different 
imaging strategies would be needed to address this subject.
CoNCluSioNS
 Overall, our study is the first to show that with a workup including hybrid 
SPECT/CCTA similar treatment decisions can be reached as compared to a traditional 
workup including invasive coronary angiography. We show in a large prospectively 
acquired population that patients with an intermediate to high pre-test likelihood 
could be accurately deferred from, or indicated for revascularization based on hybrid 
SPECT/CCTA. In selected cases percutaneous and possibly surgical revascularization 
could even be instituted on the basis of the findings by hybrid SPECT/CCTA.
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Chapter 7.1
To THE EdiToR,
We read with great interest the study of Schaap et al 1.  During a 14-months period, 
they investigated patients with stable angina and compared a hybrid SPECT/CT 
coronary angiography (CA) versus the combination of SPECT and CA on treatment 
decisions. Thus, they concluded that similar decisions can be reached using the non-
invasive approach. While there is great potential of such a hybrid work-up, we would 
like to point out some aspects of their study that may mitigate their conclusion. 
 They included 107 patients, aged 62.8 years, diabetes mellitus in 16.8%, 
most of them having a class II angina. Although these characteristics are somewhat 
similar to the one of patients included in the COURAGE study 2, they recommended 
revascularization procedures in 54/107 of the cohort, a proportion higher than 
expected based on recent studies on stable angina 2, 3.  In addition, we wonder 
whether revascularization strategy is not mainly driven by clinical characteristics, 
which may explain at least in part the fair overall agreement they observed between 
the two methods. Second, coronary artery bypass grafting (CABG) was recommended 
in 29/50 patients based on SPECT and coronary angiography. In the COURAGE trial, 
from 35539 patients selected, 2987 patients had contraindication to PCI and 947 
had left main trunk stenosis, which corresponds to a maximum of 11% of the cohort 
with possible indication to CABG 2. The results of the SPECT/CTCA procedure might 
be considered as unfair as they observed unmatched results in 41% of the patients. 
While they advocate that the limitation of one method is counterbalanced by the 
other this may be a limitation in less experimented heart teams; in addition, the 
agreement between the noninvasive and the invasive work-up is only of 72% in the 
subgroup of patients with matching results. Overall, we wonder if their conclusion is 
not slightly optimistic.
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Chapter 7.2
To THE EdiToR,
We were intrigued by the comments from Meune et al. on our article on treatment 
decisions based on hybrid SPECT/CCTA for patients with stable anginal complaints 1. 
 Prognosis and relief of anginal complaints determine the treatment strategy 
for each individual patient with coronary artery disease (CAD) 2. In patients with high-
risk CAD (two-vessel disease (VD) involving the left anterior descending, three-VD, or 
left main disease), revascularization is associated with better outcome compared to 
medical therapy 3. Moreover, CABG is the standard of care for patients with three-VD 
or left main disease 4. Fifty-one percent of all included patients included in our study 
suffered from significant CAD, based on angiography.  Of them, 37 (67%) had high-
risk CAD. Twenty-two percent of patients with non-high-risk CAD were on dual anti-
anginal medication. As such, despite similar baseline characteristics, the population 
differed from patients included in the COURAGE study with regard to severity of 
CAD. In patients with significant CAD, revascularization was chosen as treatment 
strategy for prognostic reasons in two thirds, as the next best strategy for relief of 
anginal complaints in 8% and for “clinical reasons” in the remainder.
 As was shown in the SYNTAX trial, technical aspects of revascularization 
(number of lesions, lesion location, and angiographic complexity) predicts outcome 
after PCI or CABG 4. Our study was designed to evaluate whether hybrid SPECT/
CCTA would be able to depict the complexity of CAD with enough detail to allow 
for a reliable treatment decision. We demonstrated an excellent agreement (92%) 
of panel decisions on the necessity of revascularization. Despite unmatched SPECT 
and CCTA results in 41% of patients, the panel correctly appreciated the significance 
of CAD in these patients. Indeed, a modest agreement was found in the decision 
on the actual revascularization strategy. Hybrid SPECT/CCTA was not able to depict 
angiographic complexity of CAD to allow for a reliable choice between PCI and CABG 
in patients with an indication for revascularization. Of course, in heart teams with less 
experience in evaluating hybrid SPECT/CCTA images these findings will be different.
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A 66-year-old male with a history of surgically closed secundum type atrial 
septal defect (ASD) during childhood and a percutaneous coronary intervention 
complained of recurrent stable angina. Clinical investigation and 12-lead ECG were 
unremarkable. He was referred for hybrid myocardial perfusion SPECT (SPECT) and 
64-slice CT coronary angiography (CCTA). SPECT showed normal perfusion of the left 
ventricle (LV) and an enlarged right ventricle (RV). Gated images showed a decreased 
LV ejection fraction of 50% due to septal wall motion abnormalities suggestive of RV 
overload. Prospectively ECG-triggered CCTA revealed minor coronary atherosclerosis 
and a patent stent. Severe dilatation of the RV (388 mL mid-diastolic) was confirmed. 
By coincidence, an inferior sinus venosus defect with an unroofed coronary sinus 
with the right-sided superior vena cava was observed (situs solitus, atrio-ventricular, 
and ventriculo-arterial concordance). Middle and great ardiac veins were inserted 
into the roof of the left atrium and a clear left-to-right shunt was visualized by CTA. 
Three-dimensional transoesophageal echocardiography showed the circular ASD (14 
mm) near the inferior vena cava. Right heart catheterization confirmed the left-to-
right shunt (Qp:Qs 2.1) and pulmonary arterial hypertension (mean PAP 29 mmHg 
and PVR 106 dynes/s/cm25). Invasive oronary angiography confirmed the absence 
of recurrent significant CAD. This case was discussed in our grown-up-congenital-
heart-disease team, and the patient underwent surgical closure of the defect, which 
is the treatment of choice in patients without Eisenmenger syndrome. Currently, 4 
months after surgery, the patient is free from anginal complaints.
figure 1A.  Quantitative gated SPECT showing bulls eye of left ventricle (LV) motion with a 
septal wall motion abnormality (black arrow).
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without persistent left superior vena cava
figure 1 b.  Myocardial perfusion SPECT, attenuation corrected, showing an enlarged 
right ventricle (RV) and normal perfusion of the LV.   
IVS indicates interventricular septum, LV, left ventricle; RV, right ventricle.
figure 2A.  Computed tomography coronary angiography showing an interatrial connection 
with left-to-right shunt (black arrow) and insertion of the great cardiac vein in 
the left atrium (LA) (white arrow). 
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figure 2b.  Computed tomography coronary angiography showing an enlarged RV, 388ml 
mid-diastolic.       
RVOT indicates right ventricular outflow tract; AoV, aortic valve; RA, right atrium; 
LA, left atrium, LV, left ventricle; RV, right ventricle.
figure 3A.  Transesophageal color-doppler echocardiography showing severe interatrial 
left-to-right shunting (white arrow). 
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without persistent left superior vena cava
figure 3b.  Three-dimensional transesophageal echocardiography view from LA towards 
the interatrial septum showing an atrial septal defect (black arrow).  
RA indicates right atrium; LA, left atrium;IAS, interatrial septum.
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Chapter 9
A 73-year-old male with a history of mechanical aortic valve replacement and DDD 
pacemaker implantation was referred to our hospital with progressive anginal 
complaints. Invasive coronary angiography (CA) revealed systolic compression of the 
left main coronary artery (LMCA), suggesting an extra-cardiac mass compromising 
blood flow.  Single Photon Emission Computed Tomography (SPECT) and 
Multislice Computed Tomography – CA (MSCT-CA) were obtained which revealed 
a pseudoaneurysm originating from half the circumference of the left ventricular 
outflow tract (LVOT) extending over the aortic root. The main stem of the left 
coronary artery and its proximal circumflex and anterior descending branches were 
embedded in the aneurysm. Stress SPECT images did not reveal ischemia. The 
extensive dehiscence of the aortic root, also depicted by the tilting of the mechanical 
aortic valve on the invasive angiogram, was reason to perform a re-operation with 
implantation of Bentall prosthesis. A Bio Valsalva 25mm prosthesis was implanted 
on the remaining LVOT at the level of the mitral valve annulus. Cultures obtained 
during the operation grew coagulase negative staphylococci; the pseudoaneurysm 
might be caused by a low-grade infectious process. Post-operatively antibiotics were 
continued for six weeks. Currently ten months after operation the patient is doing 
reasonably well, follow-up MSCT-CA revealed no paravalvular cavities or valvular 
abnormalities.
 LVOT pseudoaneurysm is a rare and serious complication after implantation 
of a mechanical aortic valve. It is associated with a history of endocarditis and the 
development of anginal complaints. Surgery is the first-line therapeutic option. 
Reports exist on successful stent implantation in the LMCA and percutaneous closure 
of the pseudoaneurysm. 
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Case report – Left ventricular outflow tract pseudoaneurysm compromising blood flow through the left 
main coronary artery after mechanical aortic valve implantation
Panel A.  Invasive coronary angiogram right caudal view, showing systolic compression of 
the Left Main coronary artery. 
Panel b.  Multislice Computed Tomography (MSCT) image, showing a large pseudo 
aneurysm originating from the Left Ventricular Outflow Tract (LVOT) just below the 
mechanical aortic valve. 
Panel C.  Volume rendered MSCT coronary angiography angiography image, showing the 
Left Main coronary artery and its proximal anterior descending and circumflex 
branches embedded in the pseudo aneurysm. The pseudo aneurysm extends over 
half the circumference of the aortic root. 
Panel d.  MSCT image showing the post operative situation with the Bentall prothesis 
implanted at the level of the mitral valve annulus. No evidence of residual 
paravalvular aneurysm formation.
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GENERAl diSCuSSioN
With the advent of CCTA and the known reliability of myocardial perfusion SPECT a 
combination of non-invasive imaging modalities became available that could reliably 
diagnose CAD. The current thesis substantiates the role of hybrid SPECT/CCTA 
imaging in clinical practice. It demonstrates the applicability of the combination of 
SPECT and CCTA in diagnosing significant CAD in stable patients with an intermediate 
to high pre-test likelihood of CAD. Furthermore, non-invasive SPECT/CCTA guided 
therapeutic decision making in these patients is demonstrated. 
 However, several questions may require further discussion. Is the technique 
of hybrid imaging fully developed or are there remaining pitfalls? What is the exact 
role for hybrid imaging in the current work-up of patients with chest pain? Does 
hybrid SPECT/CCTA have specific advantages over other imaging modalities and 
what upcoming imaging modalities will challenge its role? This chapter will discuss 
these questions in light of the results of this thesis.
Hybrid SPECT/CCTA image reconstruction and interpretation
In the High and intermediate Risk Spect-Ct OPtimization study (HoRoSCOPe) study, 
a hybrid SPECT-CT system, a CardioMD gamma camera combined with a Brilliance 
64-slice CT scanner were used for the acquisition of all images. The common table 
shared by both components allowed for sequential imaging which should have 
significant benefits during image reconstruction. 
Hybrid SPECT/CCTA image reconstruction
The hybrid system and its nearly simultaneous image acquisition allows for a complete 
reduction of spatial and volumetric differences of the heart during SPECT and CCTA 
acquisition. This facilitates SPECT and CCTA image overlay and fusion, which is 
challenged by intrinsic differences in the ECG-gated CCTA and non-ECG-gated SPECT 
images. Nevertheless, reports exist on successful hybrid image reconstruction from 
images acquired from separate scanners 1-3. Also, the workflow during image post 
processing allows for the introduction of significant changes in the 3D-position of the 
coronary tree derived from CCTA in relation to the LV volume derived from SPECT. 
The example shown in Figure 1 underscores the importance of a correct overlay. This 
patient had a subtotal stenosis in his LAD and a probably significant stenosis in a 
large 1st diagonal branch. SPECT showed a large area of ischemia ranging from the 
inferior myocardial wall, interventricular septum towards the anterior myocardial wall. 
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Anterolateral perfusion seemed preserved, as such excluding a hemodynamically 
significant stenosis in the 1st diagonal. A counterclockwise rotation of the coronary 
tree would position the ischemic myocardium in the area supplied by the 1st diagonal. 
Accurate definition and co-registration of cardiac landmarks on SPECT and CCTA 
images (e.g. base and apex of the heart) should allow for accurate image fusion. 
Nevertheless, fusion from SPECT and CCTA images will remain challenging. The 
fundamentally different imaging techniques cause indelible differences in the partial 
volume of the heart. Acquisition of both anatomic and perfusion images from one 
technique (e.g. CT) should eliminate this problem and allow for consistent image 
fusion.
figure 1  Evolution of hybrid imaging in the HoRoSCOPe study. Examples of hybrid stress 
SPECT/CCTA from one patient are shown. Panel A shows the first result of fusion of 
the LV volume derived from SPECT and the coronary tree derived from CCTA. The 
coronary arteries resembled tubes. Also exact positioning of the LV volume with 
respect to the coronary tree had to be performed manually (Autoquant®, Cedars-
Sinai Medical Center, Los Angeles, Ca, USA). Panel B shows the 2nd generation 
fusion images, which shows an improvement of the visualization of the coronaries, 
now a 3D volume rendered image. Exact positioning of the coronaries still had to 
be performed manually. Panel C and D show the final generation fusion images. 
Both coronary artery tree and LV volume are derived from CCTA. The SPECT LV 
perfusion image is projected onto the CCTA LV volume. Positioning of the SPECT 
LV volume was performed software guided (EBW-NM® software, Philips Medical 
Systems, Best, The Netherlands). Panel E – F show stretched multiplanar reformats 
of all major coronaries.
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 CT attenuation correction of myocardial perfusion SPECT was shown to 
improve image quality and diagnostic accuracy 4-6. Our imaging protocol consisted 
of the acquisition of a breath hold non-enhanced CT scan during stress SPECT and 
CCTA acquisition. And a non-enhanced CT scan during 20 seconds normal breathing 
during rest SPECT acquisition. Both acquisition methods have a different effect on 
the construction of an attenuation map to correct for photon attenuation during 
SPECT imaging. In our eyes, these differences were very small and could be neglected. 
Since during resampling of the attenuation map the original 0.98x0.98x5.0mm grid is 
recalculated into a 6.4x6.4x6.4mm grid, thereby averaging out the level of Hounsfield 
units in each voxel. Registration of the attenuation map with the SPECT volume should 
be performed with great attention to detail. Misregistration could cause significant 
errors in the visualization of regional tracer uptake 7-9.
Hybrid SPECT/CCTA image interpretation
According to the HoRoSCOPe protocol, all vessels and patients were either classified 
as normal or abnormal. We used the categorical evaluation described in Table 1. 
An abnormal hybrid result was defined as a perfusion defect (as defined by Abidov 
et al.) on SPECT with a >50% stenosis in the corresponding coronary artery 10. This 
is conform previous reports on hybrid SPECT/CCTA imaging interpretation 1, 11, 12. 
Pazhenkottil et al. acknowledged that patients with conflicting (“unmatched”) results 
from SPECT and CCTA have a higher annual rate of death or non-fatal myocardial 
infarction compared to patients with normal findings 13, 14. However, none of the 
available reports provide exact definitions for the interpretation of hybrid SPECT/
CCTA in the presence of non-conclusive or conflicting results from SPECT and CCTA 
1, 2, 11-15. 
 In the literature, robust definitions are provided on a per-patient basis for 
normal, equivocal and abnormal LV myocardial perfusion on SPECT 10, 16. Still, SPECT 
has the drawback of underestimating the true extent of CAD. This underestimation is 
hypothesized to be due to balanced ischemia, emphasis on the most severe stenosis 
and the inability of this technique to detect non-flow limiting atherosclerosis 17-19. 
Against this background, a definition should be provided for normal, abnormal and 
equivocal regional myocardial perfusion since hybrid SPECT/CCTA imaging analysis 
allows for the evaluation of myocardial perfusion according to the regional distribution 
of the coronaries. Available literature on hybrid SPECT/CCTA image interpretation 
differ in their methods of image interpretation (visual or semi-quantitative) and are 
largely unclear in their definitions of regional perfusion 1, 2, 11, 12, 15. Slomka et al. were 
most explicit: they solely used semi-quantitative analysis and defined a threshold of 
>2% transient perfusion deficit in a vessel territory as significant 2. 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
139
1
3
4
5
6
7
8
9
10
11
2
General discussion
 As with all anatomical imaging techiques, CCTA precludes a definite 
statement on the functional relevance of a coronary stenosis. In addition, CCTA has 
the tendency to overestimate functional relevance, which is resembled by the limited 
positive predictive value for significant CAD by CCTA 20-22. Available literature on 
CCTA and hybrid SPECT/CCTA predominantly defined the absence of >50% stenosis 
on CCTA as absence of significant CAD 1, 11, 12, 20-22. However, it is known from CA 
studies that a substantial number of vessels with >50% stenosis (visual interpretation 
or quantitative coronary angiography) also do not show functional obstruction when 
evaluated using FFR-measurements 23. Surprisingly, also a limited number of vessels 
with >90% stenosis on CA fail to show functional relevance 23. As such, it should be 
safe to assume absence of functional relevance in the presence of <50% stenosis on 
CCTA. The CCTA should be regarded non-conclusive for the presence or absence 
of significant CAD if the coronary lumen is obscured due to artifacts or coronary 
calcium.  And any cut-off level for significant CAD on CCTA, either >50%, >70% or 
even >90%, should come with some restraint.
CCTA  result
Normal Non-conclusive Abnormal
SPECT  result
Normal Normal Normal
Normal unless 
definitely 
abnormal CCTA
Non-conclusive Normal Normal or abnormal * Abnormal
Abnormal Normal Abnormal Abnormal
Table 1  Hybrid interpretation of imaging results in the HoRoSCOPe study. Interpretation 
was performed on a per-vessel basis.* In the presence of non-conclusive results 
from both SPECT and CCTA, categorization was only performed on a per-patient 
basis. In these instances all available diagnostic data (e.g. X-ECG, CCS and gated 
SPECT data) were taken into account.
 As defined in Table 1, we allowed the strengths of either SPECT or CCTA 
to compensate for the weaknesses of the other modality. Several aspects of this 
table should be discussed. Both non-conclusive and abnormal SPECT results were 
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overruled by a normal CCTA given the high negative predictive value of standalone 
CCTA. In the presence of a non-conclusive CCTA result, a normal or abnormal SPECT 
was decisive for the hybrid diagnosis. This could result in false negative and false 
positive hybrid results, given the reasonable negative and positive predictive values 
of standalone SPECT in this patient category. An obviously abnormal CCTA was 
allowed to compensate for a non- conclusive or (false) negative SPECT result. The 
stenosis grade on CCTA could have been defined more exactly (f.i. >70% stenosis) 
for these patient categories. Despite the excellent diagnostic performance of hybrid 
SPECT/CCTA using the current scheme for image interpretation, a number of imaging 
combinations still did not result in a clear-cut result. In these instances, the weighed 
assessment of all available diagnostic information by experienced readers resulted in 
the final diagnosis. In general, some form of quantification is needed in these patients 
with conflicting or non-conclusive SPECT and CCTA results. To reach a non-invasive 
diagnosis on the presence or absence of significant CAD, either quantification of flow 
by positron emission tomography (PET) or SPECT techniques or quantification of the 
stenosis grade by a computed FFR from CCTA images, is needed in this select patient 
category (<5% of patients included in the HoRoSCOPe study) 24, 25. 
The role of hybrid SPECT/CCTA in clinical practice
Patient selection for hybrid SPECT/CCTA imaging
Despite a median pre-test likelihood according to Diamond and Forrester criteria 
of 87%, approximately half of the HoRoSCOPe study population was free from 
significant CAD 26-29. This overestimation of disease presence in patients referred for 
(non-)invasive cardiac imaging by risk scores that calculate the pre-test likelihood of 
CAD, has been confirmed in several publications 22, 30-33. As such, it seems reasonable 
to perform non-invasive imaging as an initial step in the diagnostic work-up of 
patients with an intermediate to high pre-test likelihood.
 It is clear that hybrid SPECT/CCTA imaging should not be the method of 
choice in all of these patients; in a substantial number of patients CAD can be reliably 
ruled out by CCTA alone. We have shown a negative predictive value of 96% from 
CCTA in patients with conclusive imaging results. Additionally, from standalone 
SPECT we demonstrated a positive predictive value of 96% in patients with conclusive 
imaging results; depending on the severity of ischemia a substantial number of 
patients could have been sent for CA without additional CCTA. Nevertheless, we 
demonstrated increased diagnostic accuracy and added value of hybrid SPECT/CCTA 
imaging, specifically in patients with non-conclusive results from either SPECT or 
CCTA. It is impossible to predict from pre-test likelihood calculation alone which 
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patient will have a non-conclusive SPECT or CCTA result and/or will benefit from 
hybrid imaging. Additional information is needed; e.g. patients who are obese, need 
pharmacological stress prior to SPECT, suffer from left or right bundle branch block, 
have high baseline heart rates or known with high CCS are likely to benefit and 
could be scheduled for hybrid SPECT/CCTA imaging beforehand 34 35. However, for 
the majority of patients, a step-wise imaging approach should be used so as to limit 
radiation exposure and minimize costs17.
figure 2 Proposed imaging sequence in patients with an intermediate pre-test likelihood 
of CAD to be used with a hybrid SPECT/CT system. Adapted from the proposed 
imaging sequence by Tamarappoo et al. 36. Additional CCTA and hybrid SPECT/CCTA 
interpretation could be performed in patients with concerns of underestimation 
of the ischemic burden. * Hybrid SPECT/CCTA imaging could also be performed 
in patients with normal SPECT and discrepant clinical data from stress testing 
or poor heart rate response during exercise stress preceding SPECT acquisition. 
§ To facilitate subsequent therapeutic decision making and guidance of the 
revascularization strategy, additional CCTA and hybrid SPECT/CCTA interpretation 
could also be performed in patients with abnormal SPECT.
 Although we did not perform a formal health economic analysis the hybrid 
SPECT-CT system as we have used in the HoRoSCOPe study may facilitate a cost 
effective use of staff and imaging devices since it allows for a one-stop-shop imaging 
protocol. The main challenge for an imaging protocol with a hybrid system is the 
order in which SPECT and CCTA are acquired, since both modalities require specific 
patient preparation. For patients with a low to intermediate pre-test likelihood the 
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high negative predictive value of CCTA justifies its use as an initial test 17, 36. In patients 
with low prevalence of CAD, the high negative predictive value of CCTA allows for 
a reliable rule-out of CAD 36. Subsequent non-invasive functional imaging can be 
applied in patients with >50% stenosis to either rule out myocardial ischemia or 
determine the extent of the myocardial area at risk to justify subsequent medical 
therapy or revascularization 36, 37. In patients with an intermediate- to high pre-test 
likelihood of disease, SPECT could be used as an initial test 36. As described in Figure 
2, additional CCTA could be performed in patients with uncertainty about the result 
of the perfusion study17 34, 36.  Moreover, additional CCTA in patients with an abnormal 
SPECT could be of value as well in the process of therapeutic decision making.
Therapeutic decision making using hybrid SPECT/CCTA imaging
The prognosis and relief of anginal complaints determine the treatment strategy 
for each individual patient with CAD. Both standalone SPECT and CCTA as well 
as hybrid SPECT/CCTA are reliable in detecting high-risk CAD 14, 37-40. Diagnostic 
accuracy of standalone SPECT or CCTA to diagnose significant CAD in individual 
coronaries is limited, as discussed before. Therefore, it is impossible to decide on the 
actual treatment strategy (optimal medical treatment (OMT), PCI or CABG) for each 
individual patient based on these images alone. The sole exception is a (secondary) 
preventive treatment regimen if significant CAD is reliably ruled out. With the 
excellent performance of hybrid SPECT/CCTA in the diagnosis of significant CAD, the 
next challenge was to examine whether, based on these images, the decision could 
be made whether the patient needed OMT, PCI or CABG.
 We evaluated the clinical applicability of hybrid SPECT/CCTA in a setting 
resembling the routine clinical heart team. This is fundamentally different from earlier 
studies that evaluated the role of imaging procedures in determining prognosis and 
detecting high-risk CAD 14, 37-39. The panel meetings evaluated each case for the best 
treatment strategy (OMT or revascularization) to improve prognosis and relieve 
anginal complaints. In addition to clinical characteristics and prognosis based on 
available imaging, also the technical aspects of revascularization (lesion frequency, 
location, and angiographic complexity) were evaluated 41, 42. As such, our evaluation 
of panel meetings allowed for conclusions on the clinical value in therapeutic 
decision making of this new imaging procedure compared to conventional imaging 
procedure including CA. 
 We found an excellent percent agreement of decisions on the necessity 
of revascularization. Overall, 92% of these decisions based on hybrid SPECT/CCTA 
images matched with the decisions based on SPECT and CA. We were unable to 
compare the decisions on the necessity of revascularization based on standalone 
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SPECT or CCTA with the reference standard of decisions based on SPECT and CA. 
However, it is likely that the diagnostic accuracy of both standalone techniques 
largely predict the agreement in treatment decisions. As such, a percent agreement 
of 75-85% is to be expected.
 The decisions on the actual revascularization strategy (PCI or CABG) had a 
moderate percent agreement of 74%. This is different from the diagnostic accuracy 
of hybrid SPECT/CCTA on per vessel basis, which showed a PPV of 84% and a NPV 
of 87%. The case presented in chapter 2 is an excellent example of a patient that 
could have been sent for CABG based on hybrid SPECT/CCTA alone, without invasive 
coronary angiography prior to actual surgery. However, the limited spatial resolution 
of CCTA compared to CA and artifacts as a result of extensive calcifications on CCTA 
proved to be very challenging for the technical decision whether PCI or CABG was 
most suitable for the case at hand. Additionally, the tendency of SPECT to emphasize 
the most severe stenosis and show normal perfusion in other significant lesions was 
the reason that some patients were falsely diagnosed with single vessel disease and 
subsequently indicated for PCI based on hybrid SPECT/CCTA images. Improvement 
of CCTA contrast- and spatial resolution are needed before the technical treatment 
decision whether PCI or CABG is most appropriate, can be made for all patients 
based on CCTA images. Additionally, quantification of flow either by CCTA- or by PET 
techniques are needed to determine the true extent of multivessel CAD 18, 25.
future challenges
Over the last decade, hybrid SPECT and PET-CT have made a great leap into clinical 
practice. In the fields of oncology and orthopedic surgery, the combination of 
structure and function images have had a great impact on diagnostics and clinical 
practice. Hybrid imaging in cardiology was developed on the waves of these success 
17. However, it is still challenged with respect to clinical practice and research. 
Challenges for clinical practice
Regardless of the hybrid technique, uniform criteria are needed that address specific 
problems in image interpretation. The hybrid interpretation of non-conclusive and 
conflicting results from myocardial perfusion SPECT and CCTA requires specific 
guidelines.
 One third of our patient population was excluded from further imaging due 
to failed acquisition of a prospectively ECG-triggered CCTA. Further modifications 
of the acquisition protocol, e.g. using only pharmacological stress prior to SPECT 
acquisition, are needed to allow for higher success rate of CCTA acquisition without 
the loss of SPECT diagnostic accuracy.  
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Challenges for further research
Obviously, acquisition of both coronary anatomy and function from one imaging 
technique in a stepwise imaging protocol would have great advantages. Computed 
tomography offers this possibility, either FFR-CT or CT myocardial perfusion in 
combination with CCTA are of great potential 43-46. Further research is needed to 
show whether either the combination of CCTA plus FFR-CT, or myocardial perfusion 
studies from CT, cardiac magnetic resonance imaging, SPECT or PET has higher 
diagnostic accuracy and which option is most cost effective and which has the least 
radiation exposure.
 A comprehensive health economic analysis should provide guidance towards 
a cost effective use of the hybrid SPECT-CT system used in the HoRoSCOPe study. 
This would demonstrate the cost-effectiveness of a one-stop-shop imaging protocol 
using a hybrid SPECT-CT system. 
Finally, we evaluated whether hybrid SPECT/CCTA could play a central role in the 
clinical work-up of patients with anginal complaints and whether this protocol could 
be used to decide on the revascularization strategy. Besides improved contrast 
and spatial resolution of CCTA, a direct comparison of the non-invasive work-up 
versus the work-up including invasive CA is also needed. A trial including patients 
with similar characteristics as included in the HoRoSCOPe study which randomizes 
participants between invasive and non-invasive imaging with subsequent decisions 
would be of great value.
CoNCluSioNS
Our studies demonstrate the clinical usefulness of hybrid SPECT/CCTA in patients 
with an intermediate to high pre-test likelihood of CAD. The limited value of X-ECG 
and CCS and the need for advanced non-invasive imaging in these patients is 
also underscored. Hybrid SPECT/CCTA has excellent diagnostic accuracy and is of 
added value over standalone SPECT or CCTA. The strength of hybrid imaging lies 
in the compensation for the weak properties of standalone CCTA and SPECT, as 
such resolving non-conclusive results of both imaging procedures. Patients can be 
accurately deferred from, or indicated for revascularization based on hybrid SPECT/
CCTA. In selected cases, percutaneous and possibly surgical revascularization could 
even be instituted on the basis of the findings by hybrid SPECT/CCTA alone.
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SuMMARy
For several decades invasive coronary angiography (CA) has been the reference 
standard in the assessment of coronary artery disease (CAD) severity 1, 2. However, 
several factors motivate the need for a reliable non-invasive imaging modality, 
especially in the patients with a high pre-test likelihood. Not only to rule out, but 
also to diagnose significant CAD and guide therapeutic decision making. Data 
demonstrating the applicability of hybrid myocardial perfusion SPECT (SPECT) and 
coronary computed tomography angiography (CCTA) in diagnosing significant CAD 
in stable patients with an intermediate to high pre-test likelihood of CAD are still 
lacking. Let alone, that the contribution of these tests to therapeutic decision making 
in these patients is known. Providing evidence on both issues was therefore the main 
objective of this thesis. 
Chapter 1.1 describes the High and intermediate Risk Spect and Ccta OPtimization 
study (HoRoSCOPe). The current thesis is based on the results of this study. The main 
objective was to evaluate the clinical value of hybrid SPECT/CCTA in an unselected, 
prospectively acquired population. Patients with stable chest pain symptoms referred 
for myocardial perfusion SPECT and an intermediate to high pre-test likelihood of 
CAD based on Diamond and Forrester criteria were included 3. Patients with a history 
of surgical revascularization, stent implantation and patients with an unstable cardiac 
condition were excluded.
Chapter 2 is a case report to introduce the advantage of the combination of SPECT 
and CCTA imaging, and also the strengths and weaknesses of each standalone 
imaging technique. We describe a female patient with typical complaints of angina 
pectoris, referred for SPECT. The SPECT result should be regarded non-conclusive; 
the subsequently performed CCTA clearly demonstrated severe left main stenosis. 
The catch of this case was the coronary calcium score of zero. 
In Chapter 3 the limited role of standalone exercise stress electrocardiography (X-ECG) 
and coronary calcium scoring (CCS) in symptomatic patients with an intermediate to 
high pre-test likelihood of CAD is demonstrated. Receiver operator characteristics 
(ROC) curve analysis revealed an increased diagnostic yield for significant CAD for the 
combination of CCS and X-ECG (area under the curve (AUC) 0.84) versus standalone 
CCS (AUC 0.69) or X-ECG (AUC 0.65). However, 6 (9%) patients with CCS 0 – 400 and 
negative X-ECG suffered from significant CAD and 37 (54%) patients with either CCS 
>400 or abnormal X-ECG were free from significant CAD. 
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In Chapter 4 we evaluated the usefulness of CCS in addition to SPECT in the diagnosis 
of CAD. In patients with normal SPECT findings a high CCS could be suggestive 
of significant CAD 6-8. CCS cut-off values of 709 and 1000 were suggested; above 
these values an increased incidence of significant CAD was reported in the presence 
of normal SPECT 6-8. In our hands, SPECT alone had reasonable performance with 
a negative predictive value (NPV) of 82% and an AUC of 0.88 as determined by 
ROC curve analysis. By adding CCS information the NPV increased to 94%, but at 
the cost of a substantial number of false positives. As such the increased AUC of 
0.92 did not differ significantly from SPECT as standalone procedure. Moreover, 
balanced ischemia and severe stenoses as a result of soft plaque (CCS of 0) caused 
the combination to fail in detecting significant CAD in three patients. 
In chapter 5 the incremental diagnostic accuracy of hybrid imaging is discussed. 
We performed hybrid SPECT/CCTA in a population with an intermediate- to high 
pre-test likelihood of CAD. A high number of patients had non-conclusive SPECT 
(11.2%) or CCTA (23.5%) results. Hybrid image interpretation led to an overall 
increase in diagnostic accuracy, from a NPV of 89% and positive predictive value 
(PPV) of 85% for SPECT and a PPV of 77% for CCTA to a NPV of 96% and PPV of 
95% for hybrid imaging interpretation. In the group of patients with non-conclusive 
results from either SPECT or CCTA, hybrid image interpretation had a NPV and PPV 
of 90% and 91% respectively. We concluded that this population demonstrates the 
complementary nature of hybrid SPECT/CCTA imaging best; in over 40% of patients 
CAD could reliably be ruled out. This study demonstrated that the advantage of 
hybrid imaging lies in the fact that both techniques compensate for the weak 
properties of the other, as such dissolving non-conclusive results. 
In chapter 6 we evaluated the added value of hybrid SPECT/CCTA, beyond pre-
test likelihood and X-ECG, in the diagnosis of significant CAD. In chapter 5 we 
demonstrated the single test accuracy of hybrid SPECT/CCTA. The added value of 
hybrid SPECT/CCTA beyond the usual clinical work-up, or the use of each of these 
tests separately, remained unclear. Added value of hybrid SPECT/CCTA to the basic 
model of pre-test likelihood combined with X-ECG was quantified using logistic 
regression analysis. Model differences were assessed using differences in C-index 
and in net reclassification improvement (NRI). The basic model had a C-index of 
0.73 (95%CI 0.66-0.80). This significantly increased to 0.85 (95%CI 0.80-0.91) by 
addition of only SPECT, to 0.90 (95%CI 0.85-0.94) when adding only CCS and CCTA, 
and to 0.96 (95%CI 0.92-0.99) when adding hybrid SPECT/CCTA. The accompanying 
NRIs were 0.82 (95%CI 0.62-1.02), 0.86 (95%CI 0.66–1.06) and 1.57 (95%CI 1.11-
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1.59) respectively. The current analysis resembled clinical routine of layered testing 
and showed that hybrid SPECT/CCTA imaging has a substantially higher yield than 
standalone SPECT or CCTA in the diagnosis of patients suspected of significant CAD. 
In chapter 7 we evaluated to what extend treatment decisions could be based on 
hybrid SPECT/CCTA images. A treatment decision was made by two interventional 
cardiologists and one cardiothoracic surgeon in two steps:  first, based on the results 
of hybrid SPECT/CCTA; second, based on SPECT and CA. Percent agreement of 
treatment decisions (optimal medical therapy or revascularization) based on both 
diagnostic strategies were calculated in all patients, and in subgroups of patients with 
matched, unmatched and normal hybrid SPECT/CCTA findings. Revascularization 
(percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)) 
was indicated in 54 (50%) patients based on SPECT and CA. Percentage agreement of 
treatment decisions in all patients based on hybrid SPECT/CCTA versus SPECT and CA 
on the necessity of revascularization was 92%. Percentage agreement of treatment 
decisions in patients with matched, unmatched and normal hybrid SPECT/ CCTA 
findings was 95%, 84% and 100%, respectively. We concluded that similar treatment 
decisions can be made by a non-invasive workup using hybrid SPECT/CCTA when 
compared to a traditional work up using SPECT and CA. And that in selected cases 
PCI and possibly CABG could even be instituted on the basis of the findings by 
hybrid SPECT/CCTA alone. We demonstrated that specific attention should be paid 
to patients with unmatched hybrid SPECT/CCTA findings. 
Chapter 8 is a case description of a male patient with a history of coronary stent 
implantation and recurrent angina pectoris. SPECT was true negative for myocardial 
ischemia of the LV; it did however show signs of right ventricle overload. CCTA very 
clearly showed an inferior sinus venosus defect with unroofed coronary sinus with 
right sided superior vena cava and no recurrent significant CAD and a patent stent. 
Chapter 9 is the description of a case demonstrating the power of CCTA to depict 
cardiac and coronary anatomy. The patient in this report suffered from a giant 
pseudoaneurysm encapsulating two thirds of the aortic root and thereby also the 
left main coronary artery.
Chapter 10 offers a general discussion. Firstly, image hybrid SPECT/CCTA 
reconstruction is discussed, stressing the challenges in achieving a correct overlay 
and fusion of both images. Also, challenges with respect to attenuation correction 
of SPECT using non-enhanced CT scans are discussed. Secondly, hybrid SPECT/
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CCTA image interpretation is discussed. The HoRoSCOPe protocol for hybrid image 
interpretation is regarded in view of available literature on SPECT and CCTA image 
interpretation. Thirdly, patient selection for hybrid SPECT/CCTA imaging is discussed 
against the background of the accuracy of standalone SPECT and CCTA imaging, pre-
test likelihood estimation, and radiation dose form hybrid imaging. A proposition 
for an imaging sequence using a hybrid SPECT-CT system is given. Fourthly, 
therapeutic decision making using hybrid SPECT/CCTA imaging is discussed. Finally, 
recommendations for further studies are given, followed by the conclusions of this 
thesis. 
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Sedert enkele decennia is invasieve coronaire angiografie (CA) de referentie standaard 
voor de beoordeling van de ernst van coronairlijden (CAD) 1, 2. Echter, verschillende 
factoren onderbouwen de noodzaak voor betrouwbare niet-invasieve beeldvorming, 
met name voor patiënten met een hoge voorafkans op CAD. Niet alleen om uit te 
sluiten, maar zeker ook om hemodynamisch significant CAD aan te tonen. Gegevens 
die de toepasbaarheid van hybride myocard perfusie SPECT (SPECT)  en CT coronaire 
angiografie (CCTA) demonstreren in een stabiele patiënten populatie met een 
intermediaire tot hoge voorafkans op hemodynamisch significant CAD, ontbreken 
nog. Laat staan dat bekend is wat de bijdrage is van deze tests aan de therapeutische 
besluitvorming bij deze patiënten. Het wetenschappelijk onderbouwen van deze 
beide zaken was het belangrijkste doel van dit proefschrift. 
Hoofdstuk 1.1 beschrijft de “High and intermediate Risk Spect and Ccta OPtimization 
study” (HoRoSCOPe). Dit proefschrift is volledig gebaseerd op de gegevens die uit 
deze studie werden verkregen. Het belangrijkste doel van de studie was de evaluatie 
van de klinische waarde van hybride SPECT/CCTA in een prospectief verkregen 
patiëntenpopulatie. Patiënten met stabiele symptomen van thoracale pijn en een 
intermediaire- tot hoge voorafkans op significant coronairlijden op basis van 
Diamond and Forrester criteria werden geïncludeerd 3. Patiënten met daarentegen 
een voorgeschiedenis van chirurgische myocard revascularizatie (CABG), coronaire 
stent implantatie (PCI) of een onstabiele cardiale toestand werden geëxcludeerd. 
Hoofdstuk 2 betreft de beschrijving van een patiëntencasus om zowel de voordelen 
van de combinatie van beeldvorming met SPECT en CCTA, als de voor- en nadelen 
van deze technieken als alleenstaande modaliteit, te introduceren. We beschrijven 
de casus van een patiënte met een blanco voorgeschiedenis en typische angina 
pectoris. Het resultaat van het SPECT onderzoek, waar zij voor was verwezen, was 
niet-conclusief. Het vervolgens gemaakte CCTA liet echter een ernstige stenose  van 
de hoofdstam van de linker coronair. Het bijzondere aan deze casus was dat deze 
stenose werd veroorzaakt door “zachte plaque”; de coronaire calciumscore (CCS) 
was 0.
In hoofdstuk 3 beschrijven we de beperkte waarde van inspannings electrocardiografie 
(X-ECG) en CCS voor de diagnostiek van significant CAD bij symptomatische patiënten 
met een intermediaire tot hoge voorafkans. Analyse met behulp van “receiver 
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operator characteristics” (ROC) grafieken liet wel een toegenomen diagnostische 
opbrengst zien voor de combinatie van CCS en X-ECG in de diagnostiek naar 
significant coronairlijden (oppervlakte onder de curve (AUC) 0.84) versus alleen CCS 
(AUC 0.69) of X-ECG (AUC 0.65). Echter, 6 (9%) patiënten met een CCS 0 – 400 en een 
negatief X-ECG leden aan significant CAD. Ook waren 37 (54%) patiënten met of een 
CCS >400 of een abnormaal X-ECG vrij van significant CAD. 
In hoofdstuk 4 evalueren wij de toegevoegde waarde van CCS aan SPECT in de 
diagnostiek van significant CAD. Bij patiënten met een normale SPECT kan een hoge 
CCS een aanwijzing zijn voor het bestaan van significant CAD 6-8. Afkapwaarden voor 
CCS van 709 en 1000 zijn beschreven, hierboven werd een toegenomen incidentie 
van significant CAD waargenomen ondanks een normale SPECT 6-8. In onze handen 
had SPECT een redelijke diagnostische accuratesse met een negatief voorspellende 
waarde (NPV) van 82% en een AUC van 0.88 zoals bepaald door analyse van ROC 
grafieken. Door het toevoegen van CCS nam de NPV toe tot 94%, maar dit ging ten 
koste van een groot aantal vals positieven. Zodoende verschilde de toegenomen 
AUC van 0.92 voor de combinatie van SPECT en CCS niet significant van de AUC van 
SPECT als enkele test. Bovendien veroorzaakte gebalanceerde ischaemie als gevolg 
van ernstige stenoses door “zachte plaque” (CCS van 0), dat de combinatie van SPECT 
en CCS faalde in het detecteren van significant CAD in drie patiënten. 
In hoofdstuk 5 bediscussiëren wij de diagnostische accuratesse van hybride 
beeldvorming. Hybride SPECT/CCTA werd verricht bij patiënten met een 
intermediaire- tot hoge voorafkans op significant CAD. Van deze patiënten had een 
groot percentage niet-conclusieve bevindingen bij SPECT (11.2%) of CCTA (23.5%). 
Hybride interpretatie van SPECT en CCTA beelden leidde in de gehele populatie 
tot een toegenomen diagnostische accuratesse; van een NPV van 89% en positief 
voorspellende waarde (PPV) van 85% voor SPECT en een PPV van 77% voor CCTA 
naar een NPV van 96% en een PPV van 95% voor de hybride interpretatie. In de 
groep van patiënten met niet-conclusieve bevindingen bij SPECT of CCTA had de 
hybride interpretatie respectievelijk een NPV en een PPV van 90% en 91%. Wij 
concluderen dat in onze populatie het complementaire karakter van hybride SPECT/
CCTA beeldvorming optimaal tot uiting komt; in meer dan 40% van de patiënten kon 
CAD betrouwbaar worden uitgesloten. Deze studie demonstreert dat het voordeel 
van hybride beeldvorming ligt in het feit dat beide technieken kunnen compenseren 
voor de zwakke eigenschappen van de ander, waardoor niet-conclusieve bevindingen 
worden verholpen.
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In hoofdstuk 6 evalueren wij de toegevoegde waarde van hybride SPECT/CCTA aan 
de vooraf kans op CAD en X-ECG, in de diagnostiek van significant CAD. In hoofdstuk 
5 hebben we de diagnostische accuratesse beschreven van hybride SPECT/CCTA als 
enkele test. De toegevoegde waarde van hybride SPECT/CCTA aan de gebruikelijke 
klinische work-up en SPECT of CCTA als enkele tests bleef echter onopgehelderd. De 
toegevoegde waarde van hybride SPECT/CCTA aan het basis model van voorafkans 
en X-ECG werd gekwantificeerd met behulp van logistische regressie analyse. De 
verschillen tussen de modellen werden onderzocht met behulp van de verschillen 
in C-index en netto verbetering van de reclassificatie (NRI). Het basismodel had een 
C-index van 0.73 (95%CI 0.66-0.80). Dit verbeterde significant naar 0.85 (95%CI 0.80-
0.91) na toevoegen van SPECT, naar 0.90 (95%CI 0.85-0.94) na toevoegen van CCS 
en CCTA, en naar 0.96 (95%CI 0.92-0.99) na toevoegen van hybride SPECT/CCTA. Be 
bijbehorende NRI’s waren respectievelijk 0.82 (95%CI 0.62-1.02), 0.86 (95%CI 0.66–
1.06) en 1.57 (95%CI 1.11-1.59). De huidige analyse lijkt sterk op de klinische praktijk 
van gelaagd testen en demonstreert dat hybride SPECT/CCTA een aanzienlijk groter 
diagnostisch bereik heeft dan SPECT of CCTA als enkele test in de diagnostiek van 
coronairlijden. 
In hoofdstuk 7 evalueren we in hoeverre therapeutische besluiten kunnen worden 
gebaseerd op hybride SPECT/CCTA beelden. Therapeutische besluiten werden in 
twee stappen genomen door een panel van twee interventiecardiologen en een 
cardio-thoracaal chirurg; eerst op basis van de bevindingen bij hybride SPECT/CCTA 
en in tweede instantie op basis van SPECT en CA. Het percentage overeenkomende 
therapeutische besluiten (optimale medicamenteuze therapie of revascularizatie) op 
basis van beide diagnostische strategieën werden berekend voor alle patiënten en 
subgroepen van patiënten met een gematchte abnormale SPECT en CCTA, een niet-
gematchte abnormale SPECT of CCTA en normale bevindigen bij zowel SPECT als 
CCTA. Revascularizatie (PCI of CABG) was noodzakelijk voor 54 (50%) patiënten op 
basis van de bevindingen bij SPECT en CA. Voor alle patiënten was het percentage 
overeenkomende therapeutische besluiten gebaseerd op hybride SPECT/CCTA 
versus SPECT en CA voor wat betreft de noodzaak van revascularizatie 92%. 
Voor subgroepen van patiënten met gematchte abnormale SPECT en CCTA, niet-
gematchte abnormale SPECT of CCTA en normale bevindigen bij zowel SPECT als 
CCTA was het percentage overeenkomende therapeutische besluiten respectievelijk 
95%, 84% en 100%. Wij concluderen dat op basis van niet-invasieve beeldvorming 
tot overeenkomende therapeutische besluiten kan worden gekomen vergeleken met 
de gebruikelijke invasieve beeldvorming met behulp van CA en SPECT. En ook dat 
in geselecteerde casus tot PCI en mogelijk CABG kan worden besloten op basis van 
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alleen de bevindingen bij hybride SPECT/CCTA. Wel moet speciale aandacht worden 
geschonken aan patiënten met niet-gematchte bevindingen bij hybride SPECT/CCTA. 
Hoofdstuk 8 betreft de beschrijving van de casus van een patiënt met een 
voorgeschiedenis van coronaire stent implantatie en recidief angina pectoris. SPECT 
was correct negatief voor ischaemie van het linker kamer myocard, het liet echter 
wel tekenen van rechterkamer volume en/of druk overbelasting zien. CCTA liet zeer 
duidelijk een sinus venosus inferior defect zien met een ontbrekend dak van de sinus 
coronarius. Er was sprake van een normale rechtszijdige vena cava superior en geen 
recidief significant coronairlijden, ook de stent was fraai open.
 
Hoofdstuk 9 betreft de beschrijving van een casus die de kracht van CCTA in het 
afbeelden van de cardiale en coronaire anatomie demonstreert. De patiënt die in dit 
hoofdstuk wordt beschreven leed aan een groot pseudoaneurysma dat ca. 2/3e van 
de aortawortel omsloot en daarmee ook de hoofdstam van de linker coronair.
Hoofdstuk 10 betreft de generale discussie. Allereerst wordt de reconstructie van 
hybride SPECT/CCTA beelden bediscussieerd. De uitdagingen voor het verkrijgen 
van een juiste fusie van de beelden worden benadrukt. Ook worden de uitdagingen 
met betrekking tot verzwakkingcorrectie van SPECT met behulp van CT beelden 
bediscussieerd. Als tweede wordt de interpretatie van de hybride SPECT/CCTA 
beelden behandeld. Het HoRoSCOPe protocol voor de interpretatie van deze beelden 
wordt beschouwd in het licht van de beschikbare literatuur over dit onderwerp. 
Ten derde, wordt de patiënten selectie voor hybride SPECT/CCTA bediscussieerd 
tegen de achtergrond van de inschatting van de voorafkans, de diagnostische 
accuratesse van SPECT en CCTA als afzonderlijke beeldvormingsmodaliteiten, en de 
stralingsdosis die gepaard gaat met hybride beeldvorming. Een voorstel voor een 
beeldvormingsprotocol met een hybride SPECT-CT systeem wordt beschreven. Als 
vierde wordt de therapeutische besluitvorming met behulp van hybride SPECT/CCTA 
beelden bediscussieerd. Tenslotte worden aanbevelingen voor volgende studies 
gegeven gevolgd door de conclusies van dit proefschrift. 
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Daar waar het onderwerp van mijn onderzoek slechts hybride is, daar is de 
totstandkoming van dit proefschrift een perfect samenspel geweest van een veelheid 
aan disciplines en personen. Mijn dank is bijzonder groot aan iedereen die aan dit 
proefschrift heeft meegewerkt. In het bijzonder wil ik de volgende personen noemen.
Zoals ieder klinisch onderzoek zou ook de HoRoSCOPe studie nooit mogelijk zijn 
geweest zonder de bereidheid van patiënten om deel te nemen. Mijn eerste dank 
is aan hen.
Mijn promotor, Prof. dr. J.f. Verzijlbergen. Beste Fred, jouw gaves om te inspireren 
en te motiveren gaan hand in hand met je talent voor mensenkennis en cynische 
commentaren. Hierdoor ben ik op de juiste momenten voorzien van een extra peper 
en behoed voor het gevoel dat ik het Nobelprijs Comité alvast een briefje moest gaan 
sturen. Je visie dat non-invasieve cardiale beeldvorming alleen door de combinatie 
van vorm en functie op het hoogste niveau te krijgen is, is de basis geweest voor dit 
onderzoek. We hebben helaas even geduld moeten hebben voordat de “First of a 
Kind” Hybride SPECT-CT werd geïnstalleerd, maar daarna liet je me direct volledig vrij 
met deze machine en op jouw afdeling. Hierdoor is mijn promotietraject niet alleen 
wetenschappelijk, maar zeker ook op persoonlijk vlak enorm leerzaam geweest. Dat 
jijzelf de afgelopen jaren ook een paar maal promotie hebt gemaakt, is gelukkig 
nooit een te grote hobbel voor dit boekje gebleken; het is een enorme eer dat je nu 
niet mijn co-, maar mijn promotor bent.
Mijn tweede promotor Prof. dr. k.G. Moons. Beste Carl, jouw input was onontbeerlijk 
bij het ontwerp van deze studie. Door je enthousiaste en zeer heldere uitleg over 
onderzoek naar diagnostiek en therapeutische beslissingen heb ik vooraf kunnen 
begrijpen waar ik aan zou beginnen. De eerste versie van het protocol heb je, ik denk 
tijdens een hele lange vlucht, volledig herschreven. Gelukkig is gaandeweg minder 
en minder tijd nodig gebleken en kon uiteindelijk tijdens een wedstrijd Celtic – Ajax 
(niet onbelangrijk) het laatste manuscript van commentaar worden voorzien.
dr. b.J.w.M. Rensing. Beste Benno, jij hebt me op het pad van dit promotie 
onderzoek gezet. Ik kwam met de ambitie om te promoveren en “bij het begin te 
beginnen”, dat heb ik geweten. Je steun in woord en daad waren onontbeerlijk voor 
het welslagen van dit project, bedankt. Gelukkig lardeer je een gesprek niet zelden 
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met een vergeten songtekst of citaat van Drs P., anders waren onze gesprekken nog 
korter en bondiger geweest. 
dr. k. Nieman. Beste Koen, ik heb niet meer kunnen tellen hoe vaak ik de laptop 
met de laatst verkregen CT’s bij je heb ingeleverd. Ik weet wel dat ik telkenmale 
kon rekenen op een paar aanmoedigende woorden en, nog waardevoller, een paar 
kritische opmerkingen ten aanzien van de geplande analyses. Dank dat je je grote 
kennis en kunde op het gebied van CT coronaire angiografie in dienst hebt willen 
stellen van mijn proefschrift!
dr. J.A. de Groot. Beste Joris, precies op het juiste moment werd je mijn vraagbaak 
voor de laatste statistische mogelijkheden en stand van zaken. Je hebt me een paar 
maal moeten uitleggen dat voor een vraag die ik wilde beantwoorden waarschijnlijk 
het 10-voudige aantal patiënten geïncludeerd had moeten worden. Toch hebben we 
een paar fraaie analyses op papier gezet; zonder jouw hulp had ik het niet uit kunnen 
rekenen.
De leden van de beoordelingscommissie, Prof. Dr. B.L.F. van Eck – Smit, Prof. 
Dr. D.J.G.M. Duncker en Prof. Dr. P.J. de Feyter wil ik danken voor hun snelle en 
deskundige beoordeling van het manuscript. 
dr. M.C. Post. Marco, misschien is dit “Plokkeren”? Altijd oprecht vol optimisme 
over het welslagen van deze promotie, nooit te beroerd met raad en daad terzijde 
te staan, en een neus en feilloos inzicht voor een goede hypothese. In ieder geval 
beheers je dit met een hoofdletter P. Enorm bedankt, je bemoedigende woorden zijn 
van wezenlijk belang geweest om niet gedesillusioneerd te raken.
De maatschap Cardiologie van het St. Antonius Ziekenhuis ben ik veel dank 
verschuldigd. De in dit boekje beschreven beeldvorming was volledig nieuw, en 
niet geheel vanzelfsprekend, voor het St. Antonius Ziekenhuis. Toch heb ik als niet-
invasieve beeldvormer alle ruimte en ondersteuning gekregen om het protocol in 
de praktijk te brengen. In het bijzonder wil ik Dr. H.W. M., Thijs, Plokker danken. 
Je hebt van begin tot eind aandacht gehad voor het welslagen van dit project. De 
electrofysiologen Dr. L.V.A. Boersma, Dr. M.C.E.F. Wijffels en Dr. E.F.D. Wever wil ik 
bedanken voor de gelegenheid die zij mij hebben geboden de laatste fase van het 
onderzoek te combineren met een fellowship device therapie. 
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De maatschap Nucleaire Geneeskunde van het St. Antonius Ziekenhuis heeft me 
altijd gesteund bij het doen van dit onderzoek. Veel dank voor jullie betrokkenheid 
en adviezen. 
dr. J. A. S. Van der Heijden en T.l. de kroon. Beste Jan en Thom, jullie completeerden 
de panels en zijn niet zelden later thuis gekomen omdat er aan het einde van de dag 
nog enkele “non-invasieve besluiten”  genomen moesten worden. Enorm veel dank 
voor jullie toewijding. Thom, het was toch een kleine overwinning toen je bekende 
een patiënt met een schitterend voorbeeld van non-invasieve beeldvorming ook 
zonder invasief angiogram te kunnen opereren.
dr. S.M. boekholdt en dr. w.b. Meijboom. Beste Matthijs en Bob, enorm veel dank 
dat jullie je expertise op het gebied van coronaire CT angiografie in dienst hebben 
willen stellen van mijn promotie. Dank voor de uren die jullie hebben geïnvesteerd in 
het beoordelen van de, niet al te gemakkelijke, CT angiogrammen.
dr. H.w. van Es. Beste Wouter, dank voor je betrokkenheid bij dit onderzoek. De 
goede samenwerking met de afdeling radiologie is van groot belang geweest. In 
het begin bij het opstarten van het CT programma op de nucleaire geneeskunde en 
gedurende het gehele onderzoek voor de deskundige blik op al die andere organen 
in de thoraxholte.
R. M. kauling. Beste Martijn, je bent een waardig en veelbelovend opvolger. Ik weet 
zeker dat er nog een boek te schrijven is op basis van de database. Deze was er niet 
geweest zonder al jouw inspanningen bij de inclusie van patiënten en het invoeren 
van gegevens.
Nog voordat ik op het pad van de hybride beeldvorming was beland, was er het 
telefoontje van dr. Arend Mosterd, ik denk op een vrijdag namiddag, met Benno 
Rensing. Niet alleen als kruiwagen maar vooral als opleider en rolmodel heb ik enorm 
veel geluk gehad met de cardiologen en internisten in het Meander Medisch 
Centrum. Zoals met iedereen die het promoveren “er even bij doet”, ben ook ik in de 
spagaat van de combinatie van kliniek en wetenschap gekomen. Mijn eerste drie jaar 
opleiding bij jullie hebben me geleerd dat de combinatie van uitstekende klinische 
zorg én vooruitstrevende wetenschap op een soms hilarische manier te maken is.
J. van ‘t Hoenderdaal. Jeroen, we hebben heel wat uren samen achter een EBW 
doorgebracht om tal van vormen van fusie te bespreken. Je uitgesproken, en 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
165
1
3
4
5
6
7
8
9
10
11
2
Dankwoord
onomwonden geventileerde, mening over heel veel onderwerpen en ook over de 
fusie van SPECT en CCTA is nog steeds bijzonder vermakelijk. Je bent onmisbaar 
geweest voor het uiteindelijk slagen van de fusie van vorm en functie. Dank voor je 
trouwe en deskundige hulp! 
M. bosschaert. beste Mike, dankzij jouw uren en uren database bouwen kon ik in 
L.A. en Kaapstad nog even wat invoeren of analyseren. Ik ben je enorm dankbaar, 
mijn vrouw misschien iets minder, voor de schitterende online database!
fellows en assistenten cardiologie in Nieuwegein. Dames en heren, dankzij jullie niet 
aflatende stroom aan binnen de inclusie criteria vallende personen is dit proefschrift 
geworden wat het is. Daarenboven was het een genot om met jullie samen te werken, 
ik kijk terug op een fantastische tijd als assistent. De laatste anderhalf jaar als fellow 
met Ben van den Branden (Dankzij jou ben ik nu Brabander, dank daarvoor! ), Marco 
Post, Justin Luermans, Jippe Balt, Arno van Oostrom (Hou je taai!), Ben Swinkels, Bas 
Schölzel en Frouke Gorré was nog mooier. Samen met onze rots in de branding en 
hoop in bange dagen, Mary den Dekker, in een iets te kleine kamer, het is ontstellend 
jammer dat dat slechts tijdelijk is geweest. 
De klinisch fysici: leo Romijn, Jan Habraken en olga beregovaya. In het begin 
snapte ik nog niets van de natuurkunde achter de nucleaire beeldvorming, later 
moest er worden uitgerekend worden hoeveel mSv was uitgedeeld en uiteindelijk 
moest er voldoende netwerksnelheid of databaseruimte geregeld worden. En jullie 
waren nooit te beroerd behulpzaam te zijn.
de “Hybride” laboranten van de nucleaire geneeskunde. Marion Schwillens, 
Rob van der Boor, Aldrick Peterson, Martine van Rutte en Kirsten Poelma. Wat is 
het een enorm feest geweest om met jullie samen te werken. Jullie bereidwilligheid 
en leergierigheid om je een nieuwe techniek eigen te maken en werkelijk tot in de 
puntjes te beheersen, is zeldzaam. Naast jullie waren Paddy Okletey, Harold ”Chief” 
Eugenia, Kees Roeterdink, Mariska Karremans een genot om mee samen te werken. 
Cathlab. personeel Nieuwegein en laboranten electrofysiologie. Het was 
fantastisch om met jullie samen te mogen werken! Dank voor de steun tijdens de 
implantaties. En dank voor het registreren van al die millisieverts stralenbelasting en 
branden van extra CD’s met angiogrammen. 
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de secretariaten cardiologie en nucleaire geneeskunde. Dames wat zijn jullie een 
partij flexibel geweest. Niet zelden moest er iets verzet, nog snel een brief verzonden, 
een extra postzegel geleend, ja zelfs langs een brievenbus gefietst worden om de 
hele keten van inclusie en beeldvorming intact te houden. Met name het geduld 
en incasseringsvermogen van Carola, Sandra, Arda en Irene met deze hongerige 
promovendus is legendarisch, dank-jullie-wel! 
Dear Christiana, thank you for your valuable comments on the introduction and 
general discussion.
De bredase Maatschap Cardiologie. Dank voor jullie warme belangstelling voor 
de voortgang van mijn proefschrift en jullie flexibiliteit in de laatste fase van het 
schrijfwerk. Ik ben bijzonder blij nu ruim een jaar deel uit te mogen maken van deze 
maatschap en heb enorm veel zin iets moois te maken van de toekomst van de 
Bredase cardiologie!
Mijn vrienden en vriendinnen. Tussen het promoveren door waren jullie graag bereid 
de broodnodige ontspanning te bieden. Al heb ik een paar etentjes, zeilweekenden 
en dispuutborrels moeten laten schieten. Ik heb me wel eens afgevraagd of dat het 
nu allemaal waard was. In ieder geval is het moment aangebroken dat deze offers 
niet meer gebracht hoeven worden. 
Mijn paranimfen, Maarten en Ruben, we hebben elkaar leren kennen toen Ruben 
bijzonder ambitieus voor de eerste keer aan V5 ging beginnen en Maarten en 
ik dachten: “iets wat je eigenlijk wel kunt, kun je maar beter nog eens dunnetjes 
overdoen”. De bron van onze vriendschappen liggen in die paar jaar. Het doet 
mij bijzonder veel plezier jullie naast me te weten tijdens de verdediging van dit 
proefschrift.
Paul en Mien, mijn schoonouders, en Keanu en Jaimiro mijn zwagers, dank voor de 
familie die jullie voor me zijn. En dank voor het slechts optrekken van een wenkbrauw 
op de momenten dat ik bijvoorbeeld tijdens een skivakantie achterbleef om een 
middag te typen.
Mijn broers. We mogen uiterlijk dan wel wat op elkaar lijken, toch zijn we enorm 
verschillend. Dank voor jullie steun, gelukkig hebben jullie niet al te vaak gevraagd 
of het nou al af was die promotie.
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Pa en Ma. Jullie hebben me de basis gegeven waar al het moois op is gebouwd, 
bedankt voor het meegeven van de belangrijkste levenslessen. Pa, dit boekje is ook 
voor jou, heel lang geleden heb je eens gezegd: “Weet je wat jij moet doen? Een 
boek schrijven.” Ik ben blij dat het er nu ligt. Ma, dank voor het thuis dat je ons altijd 
geeft. 
Mijn vrouwen Suleika, Naomi en Esmée. Dames, zonder jullie was dit alles niet 
mogelijk geweest. Naomi en Esmée hebben, gelukkig, weinig meegekregen van de 
uren die in dit boekje zijn gaan zitten. Mijn kleine ogen hadden ook net zo goed van 
een nachtelijke fles kunnen zijn. Suleika, liefde van mijn leven, het is onmogelijk in 
woorden te vatten wat je allemaal voor me betekent. Ongelooflijk hoe je me steunt 
en de gelegenheid geeft te doen wat ik leuk vind. Pas als dit boekje verdedigd is zal 
ik je vragen waar je het geduld (wist niet dat je het in je had) vandaan hebt gehaald. 
We hebben een paar fantastische tropenjaren achter de rug die ons ongeveer alles 
hebben gebracht wat we wilden bereiken. Laten we afspreken dat 2014 een jaar 
wordt in een lagere versnelling zodat we hier iets vaker bij stil kunnen staan. Ik hou 
van je. 
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Does radioiodine therapy have disadvantageous effects in non-iodine accumulating 
differentiated thyroid carcinoma?
Schaap J, Eustatia-Rutten CF, Stokkel M, Links TP, Diamant M, van der Velde EA, 
Romijn JA, Smit JW.
Clinical Endocrinology (Oxf) 2002; 57: 117-24.
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